- Trials with a EudraCT protocol (389)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2,088)

These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006). | |
Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records. |
Study title: Long-term results of laser treatment for retinal angiomatosis in von Hippel-Lindau disease. Schmidt D, Natt E, Neumann HP. Eur J Med Res. 2000 Feb 28;5(2):47-58. |
Active substance: FLUORESCEIN |
Study summary document link (including results): Long-term results of laser treatment for retinal angiomatosi.pdf |
View full study record |
Document reference: 28245 |
Study title: Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. [No authors listed] Pediatrics. 2000 Feb;105(2):295-310. |
Active substance: FLUORESCEIN |
Study summary document link (including results): Supplemental therapeutic oxygen for prethreshold retinopathy.pdf |
View full study record |
Document reference: 28246 |
Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FLUCONAZOLE 50/100 MG O.D. IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27785 |
Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FLUCONAZOLE 50/100 MG/DAY IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27589 |
Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FLUCONAZOLE 50/100 MG/DAY IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27952 |
Study title: TO EVALUATE THE EFFICACY AND SAFETY OF FLUCONAZOLE IN THE TREATMENT OF DISSEMINATED CANDIDIASIS AND CRYPTOCOCCAL MENINGITIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27623 |
Study title: TO EVALUATE THE EFFICACY AND SAFETY OF FLUCONAZOLE IN THE TREATMENT OF DISSEMINATED CANDIDIASIS AND CRYPTOCOCCAL MENINGITIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27985 |
Study title: TO EVALUATE THE EFFICACY AND TOLERATION OF A SINGLE 400 MG ORAL/IV DOSE OF FLUCONAZOLE IN PATIENTS SUFFERING FROM CANDIDAL ESOPHAGITIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27394 |
Study title: Chirurg. 2001 Sep;72(9):1071-7. [Clinical value of positron emission tomography (PET) in the diagnosis of bone and soft tissue tumors. 3rd Interdisciplinary Consensus Conference "PET in Oncology": results of the Bone and Soft Tissue Study Group] [Article in German] Franzius C, Schulte M, Hillmann A, Winkelmann W, Jürgens H, Bockisch A, Schober O. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28166 |
Study title: Clin Nucl Med. 2002 Aug;27(8):572-7. F-18 FDG versus Ga-67 for detecting splenic involvement in Hodgkin's disease. Rini JN, Manalili EY, Hoffman MA, Karayalcin G, Mehrotra B, Tomas MB, Palestro CJ. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28156 |
Study title: Clin Nucl Med. 2003 Aug;28(8):648-51. Thymic uptake of radiopharmaceuticals. Connolly LP, Connolly SA. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28143 |
Study title: Clin Nucl Med. 2005 Mar;30(3):170-6. Diagnostic value of FDG PET and salivary gland scintigraphy for parotid tumors. Uchida Y, Minoshima S, Kawata T, Motoori K, Nakano K, Kazama T, Uno T, Okamoto Y, Ito H. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28109 |
Study title: Diabetes Care. 2001 Mar;24(3):555-60. Blood pressure does not rise before the onset of microalbuminuria in children followed from diagnosis of type 1 diabetes. Oxford Regional Prospective Study Group. Schultz CJ, Neil HA, Dalton RN, Konopelska Bahu T, Dunger DB; Oxford Regional Prospective Study Group. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28171 |
Study title: Endocr Pract. 2003 Jul-Aug;9(4):273-9. Comment in: Endocr Pract. 2003 Jul-Aug;9(4):324-6. [18F]fluorodeoxyglucose triple-head coincidence imaging as an adjunct to 131I scanning for follow-up of papillary thyroid carcinoma. Gonzalo IT, Itti E, Mlikotic A, Pham le H, Cesar RB, Meignan M, Mishkin FS. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28140 |
Study title: Epilepsia. 2006;47 Suppl 2:71-5. Neuropsychological findings in Rolandic epilepsy and Landau-Kleffner syndrome. Metz-Lutz MN, Filippini M. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28072 |
Study title: Eur J Appl Physiol Occup Physiol. 1995;70(5):442-50. Pulmonary gas exchange and ventilatory responses to brief intense intermittent exercise in young trained and untrained adults. Chamari K, Ahmaidi S, Fabre C, Ramonatxo M, Préfaut C. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28202 |
Study title: Eur J Haematol. 2007 Mar;78(3):206-12. Epub 2007 Jan 23. Clinical impact of FDG-PET/CT in the planning of radiotherapy for early-stage Hodgkin lymphoma. Hutchings M, Loft A, Hansen M, Berthelsen AK, Specht L. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28069 |
Study title: Eur J Nucl Med Mol Imaging. 2002 Mar;29(3):346-50. CT vs 68Ge attenuation correction in a combined PET/CT system: evaluation of the effect of lowering the CT tube current. Kamel E, Hany TF, Burger C, Treyer V, Lonn AH, von Schulthess GK, Buck A. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28158 |
Study title: Eur J Nucl Med Mol Imaging. 2003 Apr;30(4):581-7. Epub 2003 Jan 30. Extratemporal hypometabolism on FDG PET in temporal lobe epilepsy as a predictor of seizure outcome after temporal lobectomy. Choi JY, Kim SJ, Hong SB, Seo DW, Hong SC, Kim BT, Kim SE. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28152 |
Study title: Eur J Nucl Med Mol Imaging. 2003 Mar;30(3):396-402. Epub 2003 Jan 9. Whole-body FDG-PET in patients with stage I non-seminomatous germ cell tumours. Lassen U, Daugaard G, Eigtved A, Højgaard L, Damgaard K, Rørth M. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28149 |
Study title: Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1064-72. Epub 2004 Mar 11. Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors. Tian M, Zhang H, Oriuchi N, Higuchi T, Endo K. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28131 |
Study title: Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1073-80. Epub 2004 Mar 9. Nodal metastases of nasopharyngeal carcinoma: patterns of disease on MRI and FDG PET. Ng SH, Chang JT, Chan SC, Ko SF, Wang HM, Liao CT, Chang YC, Yen TC. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28133 |
Study title: Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1105-13. Epub 2004 Mar 9. Non-malignant FDG uptake in infradiaphragmatic adipose tissue: a new site of physiological tracer biodistribution characterised by PET/CT. Bar-Shalom R, Gaitini D, Keidar Z, Israel O. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28132 |
Study title: Eur J Nucl Med Mol Imaging. 2004 Jun;31(6):811-9. Epub 2004 Feb 5. Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: correlation with endorectal ultrasound and histopathology. Amthauer H, Denecke T, Rau B, Hildebrandt B, Hünerbein M, Ruf J, Schneider U, Gutberlet M, Schlag PM, Felix R, Wust P. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28135 |
Study title: Eur J Nucl Med Mol Imaging. 2005 Dec;32(12):1422-8. Epub 2005 Aug 31. Respiratory motion artefact in the liver dome on FDG PET/CT: comparison of attenuation correction with CT and a caesium external source. Papathanassiou D, Becker S, Amir R, Menéroux B, Liehn JC. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28098 |
Study title: J Pediatr Hematol Oncol. 2006 Aug;28(8):501-12. Correlative imaging strategies implementing CT, MRI, and PET for staging of childhood Hodgkin disease. Furth C, Denecke T, Steffen I, Ruf J, Voelker T, Misch D, Vondran F, Plotkin M, StÃver B, Henze G, Lemke AJ, Amthauer H. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28078 |
Study title: Jpn Circ J. 1997 Mar;61(3):201-10. Myocardial blood flow and metabolism in patients with hypertrophic cardiomyopathy--a study with carbon-11 acetate and positron emission tomography. Ishiwata S, Maruno H, Senda M, Toyama H, Nishiyama S, Seki A. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28195 |
Study title: Klin Padiatr. 2003 May-Jun;215(3):146-50. [18-FDG-PET-findings in children and adolescents with Hodgkin's disease: retrospective evaluation of the correlation to other imaging procedures in initial staging and to the predictive value of follow up examinations] [Article in German] Wickmann L, Lüders H, DÃrffel W. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28146 |
Study title: Leuk Lymphoma. 1999 Aug;34(5-6):545-51. Positron emission tomography (PET) for staging and evaluation of response to treatment in patients with Hodgkin's disease. Wiedmann E, Baican B, Hertel A, Baum RP, Chow KU, Knupp B, Adams S, HÃr G, Hoelzer D, Mitrou PS. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28184 |
Study title: Leuk Lymphoma. 2004 Jan;45(1):85-92. FDG-PET is superior to gallium scintigraphy in staging and more sensitive in the follow-up of patients with de novo Hodgkin lymphoma: a blinded comparison. Friedberg JW, Fischman A, Neuberg D, Kim H, Takvorian T, Ng AK, Mauch PM, Canellos GP, van den Abbeele AD. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28129 |
Study title: Leuk Lymphoma. 2007 Sep;48(9):1721-7. Comment in:Leuk Lymphoma. 2007 Sep;48(9):1667-9. Randomized comparison of consolidation radiation versus observation in bulky Hodgkin's lymphoma with post-chemotherapy negative positron emission tomography scans. Picardi M, De Renzo A, Pane F, Nicolai E, Pacelli R, Salvatore M, Rotoli B. Leuk Lymphoma. 2007 Sep;48(9):1721-7. Comment in:Leuk Lymphoma. 2007 Sep;48(9):1667-9. Randomized comparison of consolidation radiation versus observation in bulky Hodgkin's lymphoma with post-chemotherapy negative positron emission tomography scans. Picardi M, De Renzo A, Pane F, Nicolai E, Pacelli R, Salvatore M, Rotoli B. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28063 |
Study title: Lung Cancer. 2004 May;44(2):175-81. FDG-PET in staging lung cancer: how does it change the algorithm? Verhagen AF, Bootsma GP, Tjan-Heijnen VC, van der Wilt GJ, Cox AL, Brouwer MH, Corstens FH, Oyen WJ. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28127 |
Study title: TO EVALUATE THE EFFICACY AND TOLERATION OF A SINGLE 400 MG ORAL/IV DOSE OF FLUCONAZOLE IN PATIENTS SUFFERING FROM CANDIDAL ESOPHAGITIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27759 |
Study title: TO EVALUATE THE PHARMACOKINETIC PARAMETERS AFTER IV FLUCONAZOLE IN PATIENTS WITH EITHER 1. AIDS WITHOUT LIVER DISEASE OR 2. LIVER CIRRHOSIS OR SEVERE HEPATIC DISEASE IN COMPARISON WITH HEALTHY SUBJECTS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27427 |
Study title: TO EVALUATE THE PHARMACOKINETIC PARAMETERS AFTER IV FLUCONAZOLE IN PATIENTS WITH EITHER 1. AIDS WITHOUT LIVER DISEASE OR 2. LIVER CIRRHOSIS OR SEVERE HEPATIC DISEASE IN COMPARISON WITH HEALTHY SUBJECTS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27792 |
Study title: TO EVALUATE THE SAFETY AND EFFICACY OF FLUCONAZOLE CAPSULES VS. NYSTATIN SUSPENSION IN THE PREVENTION OF CANDIDIASIS IN LEUKEMIC PATIENTS UNDERGOING CHEMOTHERAPY. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27593 |
Study title: TO EVALUATE THE SAFETY AND EFFICACY OF FLUCONAZOLE CAPSULES VS. NYSTATIN SUSPENSION IN THE PREVENTION OF CANDIDIASIS IN LEUKEMIC PATIENTS UNDERGOING CHEMOTHERAPY. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27956 |
Study title: TO GATHER ADDITIONAL DATA ON THE SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN PATIENTS CRYPTOCOCCAL MENINGITIS. TO MAKE FLUCONAZOLE AVAILABLE FOR USE IN PATIENTS WITH CRYPTOCOCCAL MENINGITIS WHO IN THE INVESTIGATOR JUDGEMENT WOULD BENEFIT FROM TREATMENT WITH THIS AGENT |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27594 |
Study title: TO GATHER ADDITIONAL DATA ON THE SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN PATIENTS CRYPTOCOCCAL MENINGITIS. TO MAKE FLUCONAZOLE AVAILABLE FOR USE IN PATIENTS WITH CRYPTOCOCCAL MENINGITIS WHO IN THE INVESTIGATOR JUDGEMENT WOULD BENEFIT FROM TREATMENT WITH THIS AGENT |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27957 |
Study title: TO INVESTIGATE THE SAFETY AND EFFICACY OF A SINGLE ORAL DOSE OF FCA 150 MG CAPS FOR THE TX OF WOMEN WITH VAGINAL CANDIDIASIS |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27683 |
Study title: Warts in children: Treatment with 5-fluorouracil 5% cream and other painless alternatives. Cunningham B.B. Cosmetic Dermatology ( Cosmet. Dermatol. ) (United States) , May 1, 2004 , 17/5 SUPPL. 1 (9-12) Warts in children: Treatment with 5-fluorouracil 5% cream and other painless alternatives. Cunningham B.B. Cosmetic Dermatology ( Cosmet. Dermatol. ) (United States) , May 1, 2004 , 17/5 SUPPL. 1 (9-12) |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28262 |
Study title: Young patient trabeculectomy: Assessment of risk factors for failure. Sturmer J. Ophthalmology. June 18, 1993, 928-39 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28292 |
Study title: A Double-Blind Placebo-Controlled Study of Fluoxetine and Clomipramine in the Treatment of Panic Disorder |
Active substance: FLUOXETINE |
Study summary document link (including results): Fluoxetine - B1Y-EW-HCHQ Synopsis.pdf |
View full study record |
Document reference: 28335 |
Study title: Discontinuation Of Fluoxetine In Ocd |
Active substance: FLUOXETINE |
Study summary document link (including results): Fluoxetine - B1Y-SZ-IS38 Synopsis.pdf |
View full study record |
Document reference: 28331 |
Study title: "Fluox20mg V Fluox40mg V Clomip75mg Out Pt. Maj. Depression |
Active substance: FLUOXETINE |
Study summary document link (including results): |
View full study record |
Document reference: 28339 |
Study title: Fluoxetine hydrocloride with enteric cover |
Active substance: FLUOXETINE |
Study summary document link (including results): |
View full study record |
Document reference: 28342 |
Study title: A comparison of Fucidin tablets and Flucloxacillin in skin and soft-tissue infections |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28694 |
Study title: Open clinical study to evaluate the reactogenicity of SmithKline Beecham Biologicals' Hib conjugate vaccine mixed with SmithKline Beecham Biologicals' DTPa vaccine when given as a booster dose to children at 15 to 18 months of age, previously primed with SB Bio's Hib tetanus conjugate and DTPa vaccines in study HIB-012. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41133 |
Study title: Open label, randomised comparative assessment of the immunogenicity and reactogenicity of SmithKline Beecham's (SB's) diphteria/tetanus/acellular pertussis (DTPa) vaccine and SB's Hib with commercially available diphtheria/tetanus/whole cell pertussis (DTPw) and SB's Hib. Vaccines to be combined in the same syringe and administered to healthy infants as three consecutive doses at 2, 3 and 4 months of age. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41137 |
Study title: Open randomised clinical study to evaluate the immunogenicity and reactogenicity of SB Biologicals' Hib tetanus conjugate vaccine, co-administered with SB Biologicals' DTPa vaccine either mixed in one syringe, or in two separate injections into opposite limbs, to healthy children around two years of age. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41141 |
Study title: Open study to assess the immunogenicity and reactogenicity of a three-dose primary vaccination course against Haemophilus influenzae type b, diphtheria, tetanus, pertussis and hepatitis B in healthy infants at 6, 10 and 14 weeks of age. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41155 |
Study title: Open, phase II clinical trial to assess long-term antibody persistence, before Td booster vaccination, in healthy children 5 to 6 years old, previously vaccinated with 4 doses of SB Biologicals¿ DTPa vaccine mixed with SB Biologicals¿ Hib conjugate vaccine in primary vaccination study Hib-006 (208108/005) and in booster vaccination study Hib-017 (208108/017). |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41156 |
Study title: Kokki H. et al.: Cerebrospinal Fluid Distribution of Ibuprofen After Intravenous Administration in Children;PEDIATRICS Volume 120, Number 4, October 2007. |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29545 |
Study title: The influence of locally implanted high doses of gentamicin on hearing and renal function of newborns treated for acute hematogenous osteomyelitis.The influence of locally implanted high doses of gentamicin on hearing and renal function of newborns treated for acute hematogenous osteomyelitis. |
Active substance: GENTAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 28886 |
Study title: A phase IIb randomised, multi-site clinical study to assess the immunogenicity and reactogenicity of formulation B of SB Biologicals¿ Hib conjugate vaccine administered mixed as single injection with SB Biologicals¿ DTPa vaccine versus formulation A of SB Biologicals¿ Hib conjugate vaccine administered either mixed as single injection or separately into opposite thighs with SB Biologicals¿ DTPa vaccine as a three-dose primary vaccination course in healthy infants at 3, 4, and 5 months of age. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41147 |
Study title: A post-marketing surveillance study of GlaxoSmithKline Biologicals¿ Haemophilus influenzae type b (Hib) tetanus conjugate vaccine in 3,000 Filipino subjects. Phase IV single-blind randomised study to assess the feasibility of syringe mixing of combined diphtheria, tetanus, whole cell Bordetella pertussis (DTPw) vaccine and Haemophilus influenzae type b (Hib) conjugate vaccine as a three dose primary vaccination course in healthy infants. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41151 |
Study title: An open multicentric post marketing surveillance study of SmithKline Beecham haemophilus influenzae type B tetanus conjugate vaccine-Hiberix- administered according to local recommendations in infants and children up to the age of 5 years. Only Korean version-English title to be provided. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41157 |
Study title: An open, parallel, randomised clinical study to assess the reactogenicity of SB Biologicals¿ Hib conjugate vaccine mixed with SB Biologicals¿ DTPa vaccine in comparison to the Pasteur-Mérieux´s Hib conjugate vaccine mixed with Pasteur-Mérieux´s DTPw vaccine as a booster vaccination to healthy children at 15 to 20 months, previously primed with three doses of commercially available DTPw and Hib conjugate vaccines. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41154 |
Study title: An open, parallel, randomized clinical study to assess the reactogenicity of SmithKline Beecham (SB) Biologicals¿ Hib conjugate vaccine mixed with SB Biologicals¿ DTPa vaccine in comparison to Pasteur-Mérieux Connaught¿s (PMC) Hib conjugate vaccine mixed with PMCs¿ DTPw vaccine, as a three-dose primary vaccination course to healthy infants at 2, 4 and 6 months of age. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41153 |
Study title: An open, randomised clinical study to assess the reactogenicity of SB Biologicals¿ Hib conjugate vaccine administered mixed as single injection with SB Biologicals¿ DTPa vaccine in comparison to commercially available Hib conjugate vaccine and DTPw vaccine administered separately into opposite limbs as a booster vaccination in healthy infants at 18 months of age, previously primed with three doses of DTPw and Hib conjugate vaccines. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41149 |
Study title: Dadamyan Z.S. Aflubin in the treatment and prophylaxis of influenza and other ARVIs in children, Moscow |
Active substance: Gentiana D1, Aconitum D6, Bryonia D6, Ferrum phosphoricum D12, Acidum sarcolacticum D12 |
Study summary document link (including results): |
View full study record |
Document reference: 40008 |
Study title: Petukhova Z.N., Yablonskaya L.V., Burakhova S.V. Clinical effectiveness of Aflubin in the treatment of ARVI and influenza in children with joint diseases, Novosibirsk |
Active substance: Gentiana D1, Aconitum D6, Bryonia D6, Ferrum phosphoricum D12, Acidum sarcolacticum D12 |
Study summary document link (including results): |
View full study record |
Document reference: 40011 |
Study title: Sitnikow I., Kisseljow W., Fjodeorow W., Alexandrowa E., Kremnowa N., Sitnikowa E., Marenko E. The pathogenic mechanisms of Aflubin in children with ARVI, Jaroslawl, 1999 |
Active substance: Gentiana D1, Aconitum D6, Bryonia D6, Ferrum phosphoricum D12, Acidum sarcolacticum D12 |
Study summary document link (including results): |
View full study record |
Document reference: 40010 |
Study title: Utschajkin W.F., Charlamowa F.S., Sawenkowa M.S., Afanassjewa A.A. Aflubin in the treatment of ARVI associated with stenosing laryngotracheitis in children, Moscow, 2000 |
Active substance: Gentiana D1, Aconitum D6, Bryonia D6, Ferrum phosphoricum D12, Acidum sarcolacticum D12 |
Study summary document link (including results): |
View full study record |
Document reference: 40009 |
Study title: An open, randomised post-marketing clinical trial to assess the safety and reactogenicity of GlaxoSmithKline Biologicals¿ Haemophilus influenzae type b (Hib) tetanus conjugate vaccine (Hiberix¿) co-administered with Chinese local DTPw vaccine when compared to Chinese local DTPw vaccine administered alone, in healthy infants at 3, 4 and 5 months of age. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41128 |
Study title: Clinical study to assess the immunogenicity and reactogenicity of a booster dose of formulation B of SB Biologicals¿ Hib conjugate vaccine administered either mixed as a single injection or separate into opposite sites with SB Biologicals¿ DTPa vaccine, or formulation A of SB Biologicals¿ Hib conjugate vaccine separately into opposite sites with SB Biologicals¿ DTPa vaccine at 13 months of age in infants primed in study 208108/032 (Hib-032). |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41150 |
Study title: Clinical study to assess the immunological memory induced by a primary course using different formulations of Hib conjugate vaccines in several combinations with acellular pertussis vaccines by giving one dose of unconjugated PRP co-administered with SB Biologicals¿ DTPa-HBV combined vaccine at 12-24 months of age in infants primed in study DTPa-HBV-037. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41146 |
Study title: Open, randomised, clinical study to evaluate the interference on the immunogenicity of vaccine antigens, when Haemophilus influenzae type b tetanus conjugate and combined diphtheria, tetanus, acellular pertussis vaccines are co-administered, either in one single or two separate injections as a primary vaccination course to healthy infants at 2, 4 and 6 months of age. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41136 |
Study title: Open, randomized clinical study of the immunogenicity and reactogenicity of the SB Biologicals¿ DTPa and Hib conjugate vaccines, either mixed in one syringe or given in two separate injections, to healthy infants at the age of 2, 4, 6 and 18 months, or the administration of a dose of plain PRP at the age of 12 months in infants primed with Hib conjugate vaccine. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41135 |
Study title: Phase II open randomized primary vaccination study to assess the immunogenicity and reactogenicity of GlaxoSmithKline Biologicals (GSK) Haemophilus influenzae type b (Hib) conjugate vaccine administered either mixed or in two separated injections with commercially available DTPw vaccine (Government Pharmaceutical Organization: GPO) as compared to GSK Biologicals¿ Hib administered mixed with GSK Biologicals¿ DTPw vaccine in healthy infants, aged 2, 4 and 6 months. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41158 |
Study title: Phase IV primary vaccination study to assess the immunogenicity and reactogenicity of concomitant administration of Haemophilus influenzae type b (Hib) vaccine with either diphtheria-tetanus-whole cell pertussis vaccine and hepatitis B vaccine or with quadrivalent diphtheria-tetanus-whole cell pertussis-hepatitis B vaccine |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41152 |
Study title: Kraemer C. und Evers S.: Eine randomisierte, doppelblinde, placebokontrollierte, Crossover Studie zur Wirksamkeit von Ibuprofen und Zolmitriptan akuten Migräneattacke bei Kindern; Neurology 2006;67;497-499; original published online Jun 14, 2006. Lewis D. et al.: Children`s Ibuprofen Suspension for the Acute Treatment of Pediatirc Migraine; Headache September 2002. pp:780-786.St. Charles CS et al.: A comparison of ibuprofen versus acetaminophen with codein in the young tonsillectomy. PubMed. Bennie RE et al.: Postoperative analgesia with preoperative oral ibuprofen or acetaminophen in children undergoing myringotomy. PubMed. Kokki H. et al.: Cerebrospinal Fluid Distribution of Ibuprofen After Intravenous Administration in Children;PEDIATRICS Volume 120, Number 4, October 2007. Clark E.... |
Active substance: IBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 29609 |
Study title: A PHASE IV RANDOMIZED STUDY OF THE USE OF FLUCONAZOLE AS CHRONIC SUPPRESSIVE THERAPY VERSUS EPISODIC THERAPY IN HIV POSITIVE SUBJECTS WITH RECURRENT OROPHARYNGEAL CANDIDIASIS. |
Active substance: FOSPHENYTOIN |
Study summary document link (including results): |
View full study record |
Document reference: 28603 |
Study title: A RANDOMIZED, DOUBLE-BLIND COMPARATIVE MULTICENTER STUDY OF FLUCONAZOLE PLUS AMPHOTERICIN B VERSUS FLUCONAZOLE PLUS PLACEBO IN THE TREATMENT OF CANDIDEMIA AND ITS CONSEQUENCES IN NON-NEUTROPENIC PATIENTS |
Active substance: FOSPHENYTOIN |
Study summary document link (including results): |
View full study record |
Document reference: 28602 |
Study title: PILOT STUDY TO DETERMINE THE FEASIBILITY OF FLUCONAZOLE FOR INDUCTION TREATMENT AND SUPPRESSION OF RELAPSE OF HISTOPLASMOSIS IN PATIENTS WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME |
Active substance: FOSPHENYTOIN |
Study summary document link (including results): |
View full study record |
Document reference: 28601 |
Study title: Double-blind, randomised clinical study to evaluate the consistency of the immunogenicity and reactogenicity of three consecutive production lots of SB Biologicals¿ Hib formulation B vaccine, co-administered with SB Biologicals¿ DTPa vaccine into opposite limbs, and in comparison to the SB Biologicals¿ Hib formulation A vaccine co-administered with SB Biologicals¿ DTPa vaccine into opposite limbs, as a primary vaccination course to healthy infants at 3, 4 and 5 months of age. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41140 |
Study title: Double-blind, randomised clinical study to evaluate the immunogenicity and reactogenicity of four different lots of SB Biologicals' Hib vaccine co-administered with SB Biologicals¿ DTPa vaccine into opposite limbs, as a primary vaccination course to healthy infants at the age of 3, 4½ and 6 months. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41138 |
Study title: Double-blind, randomised, comparative, multicentre, clinical study to assess the immunogenicity and reactogenicity of three lots of SmithKline Beecham Biologicals' Haemophilus influenzae type b (Hib) tetanus conjugate vaccine when administered simultaneously with SmithKline Beecham Biologicals' tricomponent DTPa vaccine, reconstituted in one single injection, as a primary vaccination course in healthy infants at the age of 3 and 5 months (referred to in this report as Hib-10). |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41131 |
Study title: Open clinical study to assess the immunogenicity and reactogenicity of a booster dose of formulation B of SB Biologicals¿ Hib conjugate vaccine mixed with SB Biologicals¿ DTPa vaccine as a single injection at 12 or 15-18 months of age in healthy children primed with SB Biologicals¿ Hib conjugate vaccines co-administrated with DTPa-HBV vaccine in study DTPa-HBV-038 |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41144 |
Study title: Open clinical study to assess the immunogenicity and reactogenicity of a dose of SB Biologicals¿ plain PRP vaccine at 12 months of age followed by SB Biologicals¿ DTPa-HBV vaccine at 15 to 18 months of age in children primed with a new formulation of SB Biologicals¿ Hib conjugate vaccine mixed with DTPa-HBV combined vaccine as a single injection (group 5 of study DTPa-HBV-023). |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41143 |
Study title: Open clinical study to assess the safety of SmithKline Beecham Biologicals' Haemophilus influenzae type b conjugate vaccine mixed with SmithKline Beecham Biologicals' diphtheria, tetanus, tricomponent acellular pertussis vaccine and administered in one single injection, given as a primary vaccination course to healthy infants at 3, 4 and 5 months of age. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41132 |
Study title: Open clinical study to evaluate persistence of antibodies induced by a primary vaccination course using SmithKline Beecham Biologicals¿ Hib vaccine mixed with SmithKline Beecham Biologicals' DTPa vaccine, and to assess immunogenicity and reactogenicity of a booster dose of the same vaccines at 15-20 months of age (referred to in this report as Hib-21). |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41134 |
Study title: Open clinical study to evaluate the immunogenicity and reactogenicity of SB Biologicals' Hib vaccine, co-administered with routine DTPw vaccine into opposite limbs, as a primary vaccination course to healthy infants at the age of 2, 4 and 6 months. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41142 |
Study title: Open clinical study to evaluate the priming, in terms of antibody persistence and immunological memory, induced by the administration of SB Biologicals¿ Hib conjugate vaccine administered with DTPa-HBV vaccine in study DTPa-HBV-039 and to evaluate the immunogenicity and reactogenicity of a booster dose of SB Biologicals¿ Hib conjugate vaccine when administered mixed with DTPa-HBV combined vaccine. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41145 |
Study title: Open clinical study to evaluate the priming, in terms of antibody persistence and immunological memory, induced by the administration of SB Biologicals¿ Hib conjugate vaccine administered with DTPa-HBV vaccine in study DTPa-HBV-043 and to evaluate the immunogenicity and reactogenicity of a booster dose of SB Biologicals¿ Hib conjugate vaccine when administered either mixed or separately with DTPa-HBV combined vaccine. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41148 |
Study title: A multi-centre, randomised, double-blind, double-dummy, parallel-group study to determine the clinical equivalence between fluticasone propionate 50μg twice daily delivered via a multidose powder inhaler (MDPI) and the Diskhaler™ in children aged 4-11 years with reversible airways disease |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FMDT01-ICHE3.pdf |
View full study record |
Document reference: 28432 |
Study title: A multi-centre, randomised, double-blind, parallel group study to validate the changes in tidal breathing lung function parameters versus FEV1 and PD20 assessments due to anti-inflammatory treatment in 5 to 10 years old mild to moderately symptomatic children with asthma. Extensive searching has revealed that no clinical report is available for this study. The clinical trial results were reported via publications; see citation below. |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FMS30002-ICHE3.pdf |
View full study record |
Document reference: 28397 |
Study title: A Multi-centre, Randomised, Parallel-Group, Open-Label Study to Assess the Long-Term Safety (Including Growth) of Fluticasone Propionate 100mcg bd via the Metered-Dose Inhaler and BabyhalerTM Spacer Device Compared With Sodium Cromoglycate 5mg qds Delivered via Metered Dose Inhaler and NebuhalerTM Spacer Device in Children aged 12-47 Months With Documented Evidence of Recurrent/Persistent Asthma-Like Symptoms over a 52-Week Treatment Period |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FAS30009-ICHE3.pdf |
View full study record |
Document reference: 28394 |
Study title: A multicenter, randomized, double-blind, parallel group vehicle-controlled study of the efficacy and safety of fluticasone propionate lotion 0.05% applied once daily for four weeks in the treatment of adult and pediatric subjects with moderate to severe atopic dermatitis Report No. NI1999/00008/00 |
Active substance: FLUTICASONE |
Study summary document link (including results): Synopsis-Fluticasone Propionate-CUTIVATE-FPL30003.pdf |
View full study record |
Document reference: 45116 |
Study title: A multicentre, blinded, parallel group, randomized study to compare the efficacy and tolerability of nebulised Fluticasone propionate 0.25mg administered twice daily versus nebulised Budesonide 0.5mg administered twice daily in children with mild asthma.. |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FLIC12-ICHE3.pdf |
View full study record |
Document reference: 28419 |
Study title: A multicentre, randomised, double-blind, parallel group clinical trial to determine the safety and efficacy of nebulised fluticasone propionate 1mg twice daily compared with oral soluble prednisolone administered for 7 days to children aged 4 to 16 years with an acute asthma exacerbation. |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FLTB3002-ICHE3.pdf |
View full study record |
Document reference: 28420 |
Study title: A multicentre, randomised, double-blinded, parallel-group comparison of the efficacy and tolerability of fluticasone propionate 100mcg bid with nedocromil MDI 4mg bid in mild-moderate asthmatic children |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FLIC16-ICHE3.pdf |
View full study record |
Document reference: 28374 |
Study title: A multiple-dose, open-label, 2-way crossover study in pediatric subjects with asthma aged 1 to < 4 years to compare the systemic exposure of fluticasone propionate 88mcg administered via the hydrofluoroalkane metered-dose inhaler using the valved holding chambers, Aerochamber Plus™ and Babyhaler™, with face-masks |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FAS10002-ICHE3.pdf |
View full study record |
Document reference: 28438 |
Study title: A phase III multicentre, open, parallel-group, randomised study to compare the efficacy and tolerability of fluticasone propionate 50 micrograms bd via the Diskhaler™ with inhaled sodium cromoglycate (Intal) 20 milligrams qds via the Spinhaler in asthmatic children with a clinic requirement for inhaled prophylactic therapy. |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FLUPD-AH90-N081-ICHE3.pdf |
View full study record |
Document reference: 28383 |
Study title: A phase III, randomised, double-blind, parallel group study to compare the efficacy of inhaled fluticasone propionate 100μg given once daily and fluticasone propionate 50μg given twice daily, both delivered via the multi-dose powder inhaler, in children aged 4–16 years with mild to moderate, stable asthma. |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FLTB3049-ICHE3.pdf |
View full study record |
Document reference: 28379 |
Study title: Summary of the efficacy and safety and safety of salmeterol 50mcg and fluticasone propionate 100mcg administered in Diskus Dry Powder Inhaler twice daily in steroid experienced children with reversible airways obstruction |
Active substance: FLUTICASONE AND SALMETEROL |
Study summary document link (including results): Fluticasone-Propionate-Sameterol-SAM40121-ICHE3.pdf |
View full study record |
Document reference: 28449 |
Study title: A prospective dose titration study of the efficay and safety (fluvastatin sodium) in the treatment of children with heterozygous familial hypercholesterolemia |
Active substance: FLUVASTATIN |
Study summary document link (including results): |
View full study record |
Document reference: 28455 |
Study title: "Open label, phase III, dose titration, multicenter study to assess the efficacy and safety of fluvastatin sodium capsules and fluvastatin sodium extended-release tablets (20, 40 and 80 mg) given orally at bedtime for 114 weeks in pediatric patiens with heterozygous familial hypercholesterolemia" |
Active substance: FLUVASTATIN |
Study summary document link (including results): |
View full study record |
Document reference: 28456 |
Study title: Fluvoxamine for Children and Adolescents With Obsessive-Compulsive Disorder: A Randomized, Controlled, Multicenter Trial.(Statistical Data Included) Article from: Journal of the American Academy of Child and Adolescent Psychiatry,2001 | RIDDLE, MARK A.; REEVE, ELIZABETH A.; YARYURA-TOBIAS,JOSE A.; YANG, HWA MING; CLAGHORN, JAMES L.; GAFFNEY, GARY; GREIST,JOHN H.; HOLLAND, DONNA; McCONVILLE, BRIAN J.; PIGOTT, TERESA; WALKUP, JOHN T. |
Active substance: FLUVOXAMINE |
Study summary document link (including results): Bayer Pharma_Fluvoxamine Maleate_Riddle MA_2001_publication.pdf |
View full study record |
Document reference: 28457 |
Study title: FLUVOXAMINE IN THE TREATMENT OF OBSESSIVE COMPULSIVE DISORDER: A MULTICENTER DOUBLE-BLIND PLACEBO-CONTROLLED STUDY IN OUTPATIENT CHILDREN AND ADOLESCENTS |
Active substance: FLUVOXAMINE |
Study summary document link (including results): Fluvoxamine-RH.114.02.01.pdf |
View full study record |
Document reference: 47713 |
Study title: Multiple-Dose Pharmacokinetics of Fluvoxamine in Children and Adolescents;J . AM. ACAD. CHILD ADOLESC. PSYCHIATRY, 43:12, DECEMBER 2004 |
Active substance: FLUVOXAMINE |
Study summary document link (including results): A9R1546.pdf |
View full study record |
Document reference: 28458 |
Study title: The Multiple-Dose Pharmacokinetics of Fluvoxamine in Children and Adolescents |
Active substance: FLUVOXAMINE |
Study summary document link (including results): Fluvoxamine-S114.1.102.pdf |
View full study record |
Document reference: 47714 |
Study title: Randomised comparative assessment of the immunogenicity and reactogenicity of three different lots of SmithKline Beecham Biologicals' Haemophilus influenzae type b vaccine and the Pasteur/Mérieux Haemophilus influenzae type b vaccine. The vaccines were administered to healthy infants as a primary vaccination course of three consecutive doses at 2, 4 and 6 months of age. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41130 |
Study title: Randomised, double-blind clinical study to evaluate and compare the immunogenicity and reactogenicity of a booster dose of two formulations of SB Biologicals' Hib conjugate vaccine, when administered mixed in one syringe with SB Biologicals' DTPa vaccine to healthy children in their 2nd year of life. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41139 |
Study title: Placebo controlled randomised study of Haemophilus lnfluenzae type b capsular polysaccharide tetanus conjugate vaccine (PRP-T) associated with Diphtheria-Tetanus-Pertussis and Inactivated Poliomyelitis vaccine (DTP-IPV). |
Active substance: HaemophilusType b Vaccine Conjugated to Tetanus Protein |
Study summary document link (including results): |
View full study record |
Document reference: 47493 |
Study title: Placebo controlled randomized study of Haemophilus influenzae type b capsular polysaccharide tetanus conjugate vaccine (PRP-T) combined with Diphtheria-Tetanus-Pertussis and Inactivated Poliomyelitis vaccine (DTP-IPV). |
Active substance: HaemophilusType b Vaccine Conjugated to Tetanus Protein |
Study summary document link (including results): |
View full study record |
Document reference: 47492 |
Study title: McCoy KS, Castile RG, Allen ED, Filbrun DA, Flucke RL, Bar-Yishay E. Functional residual capacity (FRC) measurements by plethysmography and helium dilution in normal infants. Pediatric pulmonology. 1995;19(5):282-90.McCoy KS, Castile RG, Allen ED, Filbrun DA, Flucke RL, Bar-Yishay E. Functional residual capacity (FRC) measurements by plethysmography and helium dilution in normal infants. Pediatric pulmonology. 1995;19(5):282-90. |
Active substance: HELIUM AND OXYGEN |
Study summary document link (including results): |
View full study record |
Document reference: 29095 |
Study title: Fucidin versus flucloxacillin in skin and soft tissue infection |
Active substance: FUSIDIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 28715 |
Study title: DuRant RH, Dyken PR, Swift AV. J Pediatr Aug 1982;101(2):288-93 [Abstract]. The influence of inosiplex treatment on the neurological disability of patients with subacute sclerosing panencephalitisDuRant RH, Dyken PR, Swift AV. J Pediatr Aug 1982;101(2):288-93 [Abstract]. The influence of inosiplex treatment on the neurological disability of patients with subacute sclerosing panencephalitis |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30100 |
Study title: Effect of topically applied fluorides in dental caries experiences on children residing in fluoride areas1951-Downs |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1951-Downs-Effect of topically applied fluorides in dental caries experiences on children residing in fluoride areas.pdf |
View full study record |
Document reference: 49131 |
Study title: Enamel opacities in the incisors of school children in a community in the canton of ZurichSteiner 1984 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Steiner 1984 Enamel opacities in the incisors of school children.pdf |
View full study record |
Document reference: 49180 |
Study title: Evaluation of a practise based preventative programme for adolescentsBlinkhorn et. al. Community Dent. Oral Epidemiol. 1981: 9: 275-279 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1981-blinkhorn-Evaluation of a Practice Basedpreventive programme for adolescents.pdf |
View full study record |
Document reference: 48771 |
Study title: Fluoride - Ten year prospective study of deciduous and permanent dentitionFrederick J Margolis, Harold R Reames, Ernest Freshman, John C Macauley, Howard Mehaffey. Am J Dis Child - Vol 129. July 1975 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1975-margolis-Fluoride-tenyear prospective study of decidous and permanent dentition.pdf |
View full study record |
Document reference: 48768 |
Study title: Fluoride absorption after the local applicationEinwag 1987 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Einwag 1987 Fluoride absorption after the local application.pdf |
View full study record |
Document reference: 49162 |
Study title: Fluoride excretion in the urine of childrenFeuerle 1989 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Feuerle 1989 Fluoride excretion in the urine of children.pdf |
View full study record |
Document reference: 49164 |
Study title: Fluoride level in surface enamelHotz 1987 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Hotz 1987 Fluoride level in surface enamel.pdf |
View full study record |
Document reference: 49168 |
Study title: A functional magnetic resonance imaging study of the long-term influences of early indomethacin exposure on language processing in the brains of prematurely born children. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29804 |
Study title: Plasma and cerebrospinal fluid concentrations of indomethacin in children after intravenous administration. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29985 |
Study title: PROPHYLAXIS OF FUNGAL INFECTION WITH DIFLUCAN IN PATIENTS WITH COLLAGEN DISEASE ON THE LONG TERM, AND LARGE-DOSAGE STEROID THERAPY. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27865 |
Study title: Prophylaxis, costs and effectiveness of gram positive therapy in neatropenic children |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27454 |
Study title: Prophylaxis, costs and effectiveness of gram positive therapy in neatropenic children |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27818 |
Study title: PROSPECTIVE COMPARATIVE TRIAL OF AMPHOTERICIN B VS. FCA IN NEONATAL SYSTEMIC FUNGAL INFECTIONS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27643 |
Study title: PROSPECTIVE COMPARATIVE TRIAL OF AMPHOTERICIN B VS. FCA IN NEONATAL SYSTEMIC FUNGAL INFECTIONS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 28005 |
Study title: PROSPECTIVE OPEN PILOT COMPARATIVE STUDY OF SAFETY & EFFICACY OF FCA PARENTERAL/ORAL VS STANDARD PROPHYLACTIC REGIMEN IN PREVENTION OF FUNGAL INFECTIONS IN PTS WITH PANCYTOPENIA CAUSED BY CHEMOTHERAPY OR IN PTS SUFFERING FROM APLASTIC ANEMIA |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27396 |
Study title: PROSPECTIVE OPEN PILOT COMPARATIVE STUDY OF SAFETY & EFFICACY OF FCA PARENTERAL/ORAL VS STANDARD PROPHYLACTIC REGIMEN IN PREVENTION OF FUNGAL INFECTIONS IN PTS WITH PANCYTOPENIA CAUSED BY CHEMOTHERAPY OR IN PTS SUFFERING FROM APLASTIC ANEMIA |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27761 |
Study title: RANDOMIZED CONTROLLED STUDY COMPARING ORAL FLUCONAZOLE TO TOPICAL CLOTRIMAZOLE IN THE TREATMENT OF VAGINAL CANDIDIASIS |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27648 |
Study title: RANDOMIZED CONTROLLED STUDY COMPARING ORAL FLUCONAZOLE TO TOPICAL CLOTRIMAZOLE IN THE TREATMENT OF VAGINAL CANDIDIASIS |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 28010 |
Study title: RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY OF THE EFFICACY OF FLUCONAZOLE PARENTERAL/ORAL IN THE PREVENTION OF FUNGAL INFECTIONS IN PATIENTS WITH PANCYTOPENIA CAUSED BY CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA (AML). |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27397 |
Study title: RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY OF THE EFFICACY OF FLUCONAZOLE PARENTERAL/ORAL IN THE PREVENTION OF FUNGAL INFECTIONS IN PATIENTS WITH PANCYTOPENIA CAUSED BY CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA (AML). |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27762 |
Study title: RETROSPECTIVE CONTROLLED ANALYSIS OF FLUCONAZOLE PROPHYLAXIS IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27619 |
Study title: RETROSPECTIVE CONTROLLED ANALYSIS OF FLUCONAZOLE PROPHYLAXIS IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27981 |
Study title: SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN CRYPTOCOCCAL MENINGITIS IN PATIENTS WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27677 |
Study title: SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN CRYPTOCOCCAL MENINGITIS IN PATIENTS WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 28039 |
Study title: A phase III double-blind, randomized, multicentric, comparative vaccination study of the immunogenicity and reactogenicity of a thiomersal-free formulation of Influsplit SSW® 2003/2004 versus the standard formulation of Influsplit SSW® 2003/2004 in children aged from 6 months to <6 years. |
Active substance: Influenza Vaccine (Split Virion, Inactivated) |
Study summary document link (including results): 100351 (FLU-056) synopsis.pdf |
View full study record |
Document reference: 48371 |
Study title: A phase III, open-label, multi-centre study to evaluate the safety, tolerability an immunogenicity of CSL´s influenza vaccine in two paediatric populations, Group A (≥ 6 month to ≥ 3 years) and Group B (≥ 3 years to < 9 years). |
Active substance: Influenza Vaccine (Split Virion, Inactivated) |
Study summary document link (including results): |
View full study record |
Document reference: 47149 |
Study title: A phase III, open-label, multi-centre study to evaluate the safety, tolerability and immunogenicity of CSL´s influenza vaccine in two paediatric populations, Group A (≥ 6 month to ≥ 3 years) and Group B (≥ 3 years to < 9 years). |
Active substance: Influenza Vaccine (Split Virion, Inactivated) |
Study summary document link (including results): |
View full study record |
Document reference: 47150 |
Study title: Concomitant administration of a Haemophilus influenzae type b - Hepatitis b vaccine with a diphtheria, tetanus, acellular pertussis, inactivated polio combination vaccine in healthy infants |
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 41191 |
Study title: Diminution of the anti-polyribosylribito phosphate response to a combined diphtheria-tetanus-acellular pertussis/Haemophilus influenzae Type b vaccine by concurrent inactivated poliovirus vaccination |
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 41205 |
Study title: SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN LIFE THREATENING DEEP MYCOSES |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27674 |
Study title: SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN LIFE THREATENING DEEP MYCOSES |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 28036 |
Study title: A phase IV, open study to evaluate the reactogenicity and immunogenicity of SmithKline Beecham Biologicals' influenza split vaccine in children aged 6-36 months |
Active substance: Influenza Vaccine (Split Virion, Inactivated) |
Study summary document link (including results): 218352-003 (FLUARIX-003) synopsis.pdf |
View full study record |
Document reference: 48372 |
Study title: Clinical Analysis of Influsplit SSW® 94 1 Fluarix in children of the ages of 3-6 years |
Active substance: Influenza Vaccine (Split Virion, Inactivated) |
Study summary document link (including results): Influ 02 94 _Synopsis.pdf |
View full study record |
Document reference: 48375 |
Study title: Clinical Trial of the Reactogenicity and Immunogenicity of INFLUSPLIT SSW®92 in children aged from 1 to 4 years |
Active substance: Influenza Vaccine (Split Virion, Inactivated) |
Study summary document link (including results): INFLU 03 92 INFLU 04 92 synopsis.pdf |
View full study record |
Document reference: 48376 |
Study title: Open immunization study to determine the reactogenicity and immunogenicity of Influsplit SSW® 2000/2001 in children aged from 6 month to <6 years |
Active substance: Influenza Vaccine (Split Virion, Inactivated) |
Study summary document link (including results): 218352-044 (Influ 03-2000) synopsis.pdf |
View full study record |
Document reference: 48374 |
Study title: Open immunization study to determine the reactogenicity and immunogenicity of Influsplit SSW® 98/99 in children upon completion of 6 month of live till completion of 18 years |
Active substance: Influenza Vaccine (Split Virion, Inactivated) |
Study summary document link (including results): 218352-031 (Influ 02-98) synopsis.pdf |
View full study record |
Document reference: 48373 |
Study title: A Randomized, Endpoint-blind, Parallel Group Study to Demonstrate the Non-inferiority of the Subunit Influenza Vaccine Influvac® to the Subunit Influenza Vaccine Agrippal® in Healthy Children, Adults and Elderly in China |
Active substance: influenza vaccine (subunit, inactivated) |
Study summary document link (including results): |
View full study record |
Document reference: 47501 |
Study title: Reactogenicity and Immunogenicity of InfluvacR in high-risk children between 6 months and 4 years of age. |
Active substance: influenza vaccine (subunit, inactivated) |
Study summary document link (including results): |
View full study record |
Document reference: 47502 |
Study title: Factors influencing successful closure with indomethacin of the patent ductus arteriosus in premature infants. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29903 |
Study title: Flurbiprofen in the treatment of ankylosing spondylitis. A comparison with indomethacin. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29905 |
Study title: High efficacy and minor renal effects of indomethacin treatment during individualized fluid intake in premature infants with patent ductus arteriosus. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29909 |
Study title: SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN PATIENTS WITH NON-LIFE THREATENING MYCOSIS WHO CANNOT BE TREATED ADEQUATELY TREATED WITH AVAILABLE AGENTS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27676 |
Study title: SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN PATIENTS WITH NON-LIFE THREATENING MYCOSIS WHO CANNOT BE TREATED ADEQUATELY TREATED WITH AVAILABLE AGENTS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 28038 |
Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN CANCER PATIENTS WITH OROPHARYNGEAL AND OESOPHAGEAL CANDIDIASIS |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27651 |
Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN CANCER PATIENTS WITH OROPHARYNGEAL AND OESOPHAGEAL CANDIDIASIS |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 28013 |
Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN PATIENTS WITH LIFE THREATENING DEEP MYCOSES. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27675 |
Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN PATIENTS WITH LIFE THREATENING DEEP MYCOSES. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 28037 |
Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN PATIENTS WITH LIFE-THREATENING DEEP MYCOSES, WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27449 |
Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN PATIENTS WITH LIFE-THREATENING DEEP MYCOSES, WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27813 |
Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27426 |
Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27791 |
Study title: SAFETY AND EFFICACY OF FLUCONAZOLE PO VS. AMPHOTERICIN B SUSPENSION IN PREVENTION OF CANDIDIASIS IN LEUKEMIC PATIENTS UNDERGOING CHEMOTHERAPY. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27961 |
Study title: SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FLUCONAZOLE IN PATIENTS WITH GASTRO-INTESTINAL CANDIDIASIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27419 |
Study title: Fluoride tablets in prevention of tooth decayG. Stolte, Aus dem Gesundheitsamt der Stadt SolingenM.Hoskova 1968. Ceskoslovenska pediatrie praha |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1968-hoscowa-Fluoride tablets in prevertion od tooth decay.pdf |
View full study record |
Document reference: 48784 |
Study title: Fluoride toothpastes for preventing dental caries in children and adolescents2009-marinho, the cochrane collaboration |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 2009-marinho-fluoride toothpastes for preventing dental caries in children and adolescents.pdf |
View full study record |
Document reference: 49091 |
Study title: Schöneberger Einfluß der immunstimulierenden Wirkung von Preßsaft aus Herba Echinaceae purpureae auf Verlauf und Schweregrad von Erkältungskrankheiten (EC31J0.05)Z. für Immunbiologie in der Praxis, 2 (8), 1992, 18-22 |
Active substance: (HERB) Purple cone flower, dried pressed juice, 31.5 - 53.6 : 1, 85 % |
Study summary document link (including results): |
View full study record |
Document reference: 39721 |
Study title: Fluoride tablets in pre-school age - effect on primary and permanent teethRoland Andersson, Hans Grahnen. Swed Dent J69 137 - 143 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1969-anderesson-Fluoride Tablets in Preschool Age - Effect on Primary and Permanent Teeth.pdf |
View full study record |
Document reference: 48767 |
Study title: Evaluation of safety and immunogenicity of inactivated flu vaccine in children with underlying disease |
Active substance: INACTIVATED INFLUENZA SPLIT VIRION VACCINE (TRITON X 100) |
Study summary document link (including results): |
View full study record |
Document reference: 41289 |
Study title: Immunogenicity and safety of the inactivated, split virion influenza vaccine in high risk children aged from 3 to 8 years |
Active substance: Inactivated Influenza Split Virion Vaccine (Triton x 100) |
Study summary document link (including results): |
View full study record |
Document reference: 41221 |
Study title: Immunogenicity and safety of the inactivated, split virion influenza vaccine in high risk children aged from 3 to 8 years |
Active substance: INACTIVATED INFLUENZA SPLIT VIRION VACCINE (TRITON X 100) |
Study summary document link (including results): |
View full study record |
Document reference: 41290 |
Study title: Immunogenicity and safety of the inactivated, split virion influenza vaccine in high risk children aged from 6 to 35 months |
Active substance: INACTIVATED INFLUENZA SPLIT VIRION VACCINE (TRITON X 100) |
Study summary document link (including results): |
View full study record |
Document reference: 41291 |
Study title: Evaluation of safety and immunogenicity of inactivated flu vaccine in children with underlying disease |
Active substance: Inactivated Influenza Split Virion Vaccine (Triton x 100) without Thiomersal |
Study summary document link (including results): |
View full study record |
Document reference: 41217 |
Study title: Comparison between fluproquazone and indomethacin in treatment of primary dysmenorrhoea. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29843 |
Study title: Effects of pH-neutral, bicarbonate-buffered dialysis fluid on peritoneal transport kinetics in children, 2002 |
Active substance: HYPERTONIC SOLUTIONS |
Study summary document link (including results): |
View full study record |
Document reference: 29378 |
Study title: Reduced Advanced Glycation Endproduct (AGE) Levels in Children on Automated Peritoneal Dialysis (PD) with PD-Fluids Containing Less Glucose Degradation Products (GDPs), 2003 |
Active substance: HYPERTONIC SOLUTIONS |
Study summary document link (including results): |
View full study record |
Document reference: 29379 |
Study title: Immunogenicity and safety of P.M.sv, inactivated split influenza vaccine in children between 6 months and 3 years old |
Active substance: Inactivated Influenza Split Virion Vaccine (Triton x 100) without Thiomersal |
Study summary document link (including results): |
View full study record |
Document reference: 41477 |
Study title: Immunogenicity and safety of the inactivated, split virion influenza vaccine in high risk children aged from 3 to 8 years |
Active substance: Inactivated Influenza Split Virion Vaccine (Triton x 100) without Thiomersal |
Study summary document link (including results): |
View full study record |
Document reference: 41474 |
Study title: Immunogenicity and tolerability of the Aventis Pasteur inactivated flu vaccine (IMOVAX GRIPE) in high risk and healthy children aged from 6 to 35 months |
Active substance: Inactivated Influenza Split Virion Vaccine (Triton x 100) without Thiomersal |
Study summary document link (including results): |
View full study record |
Document reference: 41476 |
Study title: Safety of inactivated split-virion influenza vaccine administered by the intradermal route in healthy children |
Active substance: Inactivated Influenza Split Virion Vaccine (Triton x 100) without Thiomersal |
Study summary document link (including results): |
View full study record |
Document reference: 45254 |
Study title: Immunogenicity and safety of the inactivated, split virion influenza vaccine in high risk children aged from 6 to 35 months |
Active substance: Inactivated Influenzae Split Virion Vaccine |
Study summary document link (including results): |
View full study record |
Document reference: 41475 |
Study title: Large scale safety study of the DTacP-IPV {acellular TETRACOQ®) vaccine, administered in combination (one injection site) or in assocation two injection sites) with Haemophilus influenzae Type b vaccine (Act-HIB®) for primary and booster immunisation |
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 41203 |
Study title: Randomised open trial of the safety and the immunogenicity of a combined dihtheria, tetanus, acellular pertussis and inactivated polio vaccine (DTacP-IPV) mixed with Haemophilus influenzae type b vaccine (Act-HIB®) given either at 3-5 and 12 or 2-4-6 and 13 months of age |
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 41190 |
Study title: Safety and immunogenicity of a diphteria, tetanus, acellular pertussis, enhanced inactivated trivalent poliovirus vaccine administered separately or combined with Haemophilus influenzae type b vaccine, to healthy Chilean infants |
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 41188 |
Study title: A Stratified, Multicenter, Randomized, Double-Blind, Parallel Group, 4-Week Comparison of Fluticasone Propionate/Salmeterol DISKUS Combination Product 100/50mcg BID versus Fluticasone Propionate DISKUS 100mcg in Pediatric and in Adolescent Subjects with Activity-Induced Bronchospasm. Report No. RM2005/00345/00 |
Active substance: SALMETEROL |
Study summary document link (including results): |
View full study record |
Document reference: 35593 |
Study title: Interaction between flurbiprofen and indomethacin in rheumatoid arthritis. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29948 |
Study title: Fluoride varnish for community based caries prevention in children1997-peterson |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1997-peterson-Fluoride varnish for community based caries prevention in children.pdf |
View full study record |
Document reference: 49124 |
Study title: Fluoride varnish versus acidulated phosphate fluoride gel1995-seppa |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1995-seppa-Fluoride varnish versus acidulated phosphate fluoride gel.pdf |
View full study record |
Document reference: 49120 |
Study title: Fluoride varnishes in caries prevention. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42420 |
Study title: Double-blind cross-over comparison of flurbiprofen and indomethacin in osteoarthritis of the knee and hip |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29862 |
Study title: Safety and immunogenicity of PMSV diphtheria, tetanus, acellular pertussis, polio (DTacP-IPV) vaccine given mixed or separately with Haemophilus influenzae type b (Act-HIB®) vaccine, as a primary series. Comparison of three lots of DTacP-IPV vaccine given combined or separately with Act-HIB® |
Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
Study summary document link (including results): |
View full study record |
Document reference: 41189 |
Study title: A double-blind cross-over study of niflumic acid and indomethacin in rheumatoid arthritis. |
Active substance: INDOMETHACIN |
Study summary document link (including results): |
View full study record |
Document reference: 29802 |
Study title: Effects of pH-neutral, bicarbonate-buffered dialysis fluid on peritoneal transport kinetics in children, 2002 Reduced Advanced Glycation Endproduct (AGE) Levels in Children on Automated Peritoneal Dialysis (PD) with PD-Fluids Containing Less Glucose Degradation Products (GDPs), 2003 |
Active substance: ISOTONIC SOLUTIONS |
Study summary document link (including results): |
View full study record |
Document reference: 30758 |
Study title: Duraphat varnish a 2 year clinical trial in 5 year old childeren1977-murray, Brit. Dental J |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1977-murray-Duraphat varnish a 2 year clinical trial in 5 year old childeren.pdf |
View full study record |
Document reference: 49103 |
Study title: Effect of a partial substitution of invert sugar for surcose in combination with Duraphat treatment in caries development in pre-school children1991-frostell |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1991-frostell-Effect of a partial substitution of invert sugar for surcose in combination with Duraphat treatment in caries development in pre-scho... |
View full study record |
Document reference: 49116 |
Study title: Effect of fluoride varnish (Duraphat) treatment every 6 months compared with weekly mouthrinsing with 02 percent NaF solution on dental caries1979-koch |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1979-koch-Effect of fluoride varnish (Duraphat) treatment every 6 months compared with weekly mouthrinsing with 02 percent NaF solution on dental c... |
View full study record |
Document reference: 49105 |
Study title: Effect of topical applied stannous fluoride on dental caries experience children1955-Howell |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1955-Howell-Effect of topical applied stannous fluoride on dental caries experience children.pdf |
View full study record |
Document reference: 49132 |
Study title: Procedure Guideline for Tumor Imaging Using Fluorine- 1 8-FDGJ Nucl Med 1998; 3&13&1305. Heinrich R. Schelbert, Carl K. Hoh, Henry D. Royal, Manuel Brown, Magnus N. Dahlbom, Farrokh Dehdashti and Richard L. Wahl |
Active substance: Steripet |
Study summary document link (including results): schelbert-1998.pdf |
View full study record |
Document reference: 48744 |
Study title: The dental caries experience of 12 year old children in England and Wales2002-Pitts, Community Dental Health 2002 19, 46-53 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 2002-Pitts-the dental caries experience of 12 year old children in England and Wales.pdf |
View full study record |
Document reference: 49089 |
Study title: The effect of a fluoride gel used for supervising toothbrushing 15 to 30 times per yearMarthaler 1970 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Marthaler 1970 The effect of a fluoride gel.pdf |
View full study record |
Document reference: 49172 |
Study title: The effect on human dental caries of weekly oral rinsing with a sodium fluoride mouth wash duraphat rinse clinical1971-Horowitz |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1971-Horowitz-the effect on human dental caries of weekly oral rinsing with a sodium fluoride mouthwashduraphat rinse clinical.pdf |
View full study record |
Document reference: 49127 |
Study title: The effects of aminfluoride on nibition of caries in pre-school children and school children in rijekaOstric 1977 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Ostric 1977 The effects of aminfluoride.pdf |
View full study record |
Document reference: 49173 |
Study title: The rationale for the administration of a NaF tablet supplement during pregnancy and postnatally in a private practice setting.Frances B. Glenn 1981, Journal of Dentistry for Children |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1981-Glenn-The Rationale for the Administration od a NaF Tablet Supple,ment during Pregnancy and Postnatally in a private practice setting.pdf |
View full study record |
Document reference: 48778 |
Study title: The reduction of dental caries through use of a sodium fluoride mouthwash1960-Weisz |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1960-Weisz-the reduction of deental caries through use of a sodium fluoride mouthwash.pdf |
View full study record |
Document reference: 49125 |
Study title: The relative anticaries effectiveness of three fluoride-containing dentifrices in Puerto Rico2004-stookey, caries research |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 2004-stookey-the relative anticaries effectiveness of three fluoride-containing dentifrices in Puerto Rico.pdf |
View full study record |
Document reference: 49090 |
Study title: The results of 3 year prophylaxis of caries through fluoride preparations in a solinger kindergarden G. Stolte, Aus dem Gesundheitsamt der Stadt Solingen |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1968-stolte-Ergebnisse dreijähriger Kariesprophylaxe durch orale Fluoridgaben in Solinger Kindergarten.pdf |
View full study record |
Document reference: 48783 |
Study title: Use of fluorides by Finnish adolescentsHonkala ., Nyssonen V, Rimpela A, Scand J Dent Res 1984; 92: 517-23 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1984-honkala-Use of fluoride by finnish adolescents.pdf |
View full study record |
Document reference: 48769 |
Study title: use of professionally administered flouride among Danish children1992-ambjerg |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1992-ambjerg-use of professionally administered flouride among Danish children.pdf |
View full study record |
Document reference: 49118 |
Study title: Variation in caries prevalence related to combinations of dietary andoral hygiene habits and chewing fluoride tablets in 4 year old childrenLars-Eric Granath, Holger Rootzen, Elso Liljegren, Kerstin Hoist, Lennart Kohler 1978. Caries Res 12: 83-92 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1978-granath-Caries prevalence related to combinations of dietary and oral hygiene habits and chewing fluoride tablets in 4 years old children.pdf |
View full study record |
Document reference: 48781 |
Study title: |
Active substance: LEFLUNOMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 47352 |
Study title: The superiority of topical application of stannous fluoride on primary teeth1957-McDonald |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1957-McDonald-the superiority of topical application of stannous fluoride on primary teeth.pdf |
View full study record |
Document reference: 49135 |
Study title: The use of a sodium fluoride mouthwash in reducing the dental caries increment in eleven year old english school children1972-Brandt |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1972-Brandt-the use of a sodium fluoride mouthwash in reducing the dental caries increment in eleven year old english school children.pdf |
View full study record |
Document reference: 49128 |
Study title: Three year report on caries prevention using I fluoride varnish for caries risk children in a community with fluoridated water1982-seppa |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1982-seppa-Three year report on caries prevention using I fluoride varnish for caries risk children in a community with fluoridated water.pdf |
View full study record |
Document reference: 49109 |
Study title: Topical application of a fluoride protective varnish for caries prophylaxis1973-maiwald |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1973-maiwald-Topical application of a fluoride protective varnish for caries prophylaxis.pdf |
View full study record |
Document reference: 49101 |
Study title: Trends in total caries experience2000-Brown |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 2000-Brown-trends in total caries experience.pdf |
View full study record |
Document reference: 49097 |
Study title: Two-year clinical tests with different methods of local caries-preventive fluorine application in swedish school-children1965-Torell |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1965-Torell-two-year clinical tests with different methods of local caries-preventive fluorine application in swedish school-children.pdf |
View full study record |
Document reference: 49126 |
Study title: Fluorine concentration in primary tooth enamel in 6 year olds after 3 years of daily intake of fluoride-containing tablets.J. Widenheim, Lars G Petersson, Goran Koch 1984, Swed Dent J |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1984-widenheim-Fluoide concentration in primary tooth enamel in 6 years oldy after 3 years of daily intake of fluoridecontaining tablets.pdf |
View full study record |
Document reference: 48777 |
Study title: Fluroide in the prevention of caries in the pre-school childRugg 19990. J. Dent |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1990-Rugg_Gunn-Fluoride in the Prevention of Caries in the Pre-school Child.pdf |
View full study record |
Document reference: 48774 |
Study title: Four year study of caries inhibition of intensive Duraphat application in 11-15 year old children1994-skold, Community Dent. Oral Epidemiol. 1994 22:18-24 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1994-skold-Four year study of caries inhibition of intensive Duraphat application in 11-15 year old children.pdf |
View full study record |
Document reference: 49119 |
Study title: Gingival recession and wedge-shaped defects with regular use of an amine fluoride-containing gel applied with a toothbrushSchiffner 1995 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Schiffner 1995 Gingival recession and wedge-shaped.pdf |
View full study record |
Document reference: 49177 |
Study title: High-fluoride toothpaste and no post-brushing water rinsing on enamel demineralization using an in-sit caries model with orthodontic bands2010-AlMulla |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 2010-AlMulla-high-fluoride toothpaste and no post-brushing water rinsing on enamel demineralization using an in-sit caries model with orthodontic b... |
View full study record |
Document reference: 49098 |
Study title: |
Active substance: LEFLUNOMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 47353 |
Study title: |
Active substance: LEFLUNOMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 47354 |
Study title: Double-blind, eight-month extension study to collect durability of efficacy data and additional safety data in patients with juvenile rheumatoid arthritis completing the double-blind comparison study HWA486/3503 of leflunomide versus methotrexate |
Active substance: LEFLUNOMIDE |
Study summary document link (including results): Leflunomide-Study 3.pdf |
View full study record |
Document reference: 47350 |
Study title: Efficacy and safety of leflunomide versus methotrexate in the treatment of pediatric patients with juvenile rheumatoid arthritis (JRA) |
Active substance: LEFLUNOMIDE |
Study summary document link (including results): Leflunomide-Study 2.pdf |
View full study record |
Document reference: 47349 |
Study title: Phase IB Trial of Leflunomide in Pediatric Subjects with Polyarticular Course Juvenile Rheumatoid Arthritis (JRA) |
Active substance: LEFLUNOMIDE |
Study summary document link (including results): Leflunomide-Study 1.pdf |
View full study record |
Document reference: 47348 |
Study title: Population pharmacokinetics of A77 1726 (M1) after oral administration of leflunomide in pediatric subjects with polyarticular course juvenile rheumatoid arthritis |
Active substance: LEFLUNOMIDE |
Study summary document link (including results): Leflunomide-Study 4.pdf |
View full study record |
Document reference: 47351 |
Study title: Q Clinical impact of fluorine-18fluorodeoxyglucose positron emission tomography in cancer patients. A comparative study between dedicated camera and dual-head coincidence gamma camera.JNucl Med Mol Imaging. 2006 Mar;50(1):68-77. Andrieux A 2006 |
Active substance: SteriPET |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48624 |
Study title: Schmitz A, Risse JH, Grünwald F, Gassel F, Biersack HJ, Schmitt O.. Fluorine-18 fluorodeoxyglucose positron emission tomography findings in spondylodiscitis: preliminary results. [schmitz-2001]Eur Spine J. 2001 Dec;10(6):534-9. Schmitz A 2001 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48696 |
Study title: Shulkin BL, Goodin GS, McCarville MB, Kaste SC, Krasin MJ, Hudson MM, Metzger M.. Bone and [18F]fluorodeoxyglucose positron-emission tomography/computed tomography scanning for the assessment of osseous involvement in Hodgkin lymphoma in children and young adults. [shulkin-2009 Leuk Lymphoma. 2009 Nov;50(11):1794-802. Shulkin BL 2009 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48698 |
Study title: Shulkin BL, Hutchinson RJ, Castle VP, Yanik GA, Shapiro B, Sisson JC.. Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy. [shulkin-1996]Radiology. 1996 Jun;199(3):743-50. Shulkin BL 1996 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48697 |
Study title: Incremental rates of dental caries after repeated topical sodium fluoride applications in children with lifelong consumption of fluoridated water1971-Englander |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1971-Englander-incremental rates of dental caries after repeated topical sodium fluoride applications in children with lifelong consumption of fluo... |
View full study record |
Document reference: 49093 |
Study title: Jarman underproveleged area scores, tooth decay and the effect of water fluoridation1997-jones |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1997-jones-Jarman underproveleged area scores, tooth decay and the effect of water fluoridation.pdf |
View full study record |
Document reference: 49123 |
Study title: Kollective Karies pravention in Vorchulatter unter Verwendung eines Fluoridhaltingen lackes1980-treide |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1980-treide-Kollective Karies pravention in Vorchulatter unter Verwendung eines Fluoridhaltingen lackes.pdf |
View full study record |
Document reference: 49107 |
Study title: Kollektive VorbeugungsprogrammeMagri 1986 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Magri 1986 Kollektive Vorbeugungsprogramme.pdf |
View full study record |
Document reference: 49169 |
Study title: Long term evaluation of a SnF2 gel for control of gingivitis and decalcification in adolescent orthodontic patients1994-boyd |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1994-boyd - long term evaluation of a SnF2 gel for control of gingivitis and decalcification in adolescent orthodontic patients.pdf |
View full study record |
Document reference: 49157 |
Study title: NHS dental epidemology programme for England2010-Rooney |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 2010-Rooney-NHS dental epidemology programme for England.pdf |
View full study record |
Document reference: 49092 |
Study title: Perspectives on the use of Prenatal Fluoride Administration for Prevention of Dental Caries: a reactors comments1981-Stamm. Journal of Dentistry for Children, March - April, 1951 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1981-Stamm-Perspectives on the use of Prenatal Fluoride Administration for Prevention of Dental Caries.pdf |
View full study record |
Document reference: 48772 |
Study title: Pharmacokinetics of Fluoride gelsEkstrand 1981, Caries Res 15:213 - 220 (1981) |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Ekstrand 1981 Pharmacokinetics of Fluoride gels.pdf |
View full study record |
Document reference: 49163 |
Study title: Pilot caries prevention- Modellversuch der KariesprophylaxeStöhr 1979 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Steiner 1984 Enamel opacities in the incisors of school children.pdf |
View full study record |
Document reference: 49181 |
Study title: Plasma fluoride concentration and urinary fluoride excretion in children following application of the fluoride containing varnish Duraphat1980-ekstrand, Caries Res, 14: 185-189 1980 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1980-ekstrand-Plasma fluoride concentration and urinary fluoride excretion in children following application of the fluoride containing varnish Dur... |
View full study record |
Document reference: 49106 |
Study title: Pre-eruptive effect of NaF tablets on caries in children from 12 to 17 years of ageJ. Widenheim, Dowen Birked, Lars Granath, Georg Lindgren 1986. Community Dent Oral Epidemiol |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1986-Widenheim-Preeruptive effect of NaF Tablets on Caries in Children from 12 to 17 years of age.pdf |
View full study record |
Document reference: 48776 |
Study title: Pretreatment of teeth with sodium fluoride prior to stannous fluoride applications1959-Abdul-Gaffar, J DENT RES 1959 38: 901 H. Abdul-Ghaffar and Joseph C. Muhler |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1959-Abdul-Gaffar- Pretreatment of teeth with sodium fluoride prior to stannous fluoride applications.pdf |
View full study record |
Document reference: 49136 |
Study title: Prevention of caries progress in xerostomic patients by topical fluoride applicationsMarkitziu 1982 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Markitziu 1982 Prevention of caries progress.pdf |
View full study record |
Document reference: 49171 |
Study title: Bastiaannet E, Oyen WJ, Meijer S, Hoekstra OS, Wobbes T, Jager PL, et al.. Impact of 18F] fluorodeoxyglucose positron emission tomography on surgical management of melanoma patients. [bastiaannet-2006]Br J Surg. 2006 Feb;93(2):243-9. Bastiaannet E 2006 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48631 |
Study title: Borgwardt L, Højgaard L, Carstensen H, Laursen H, Nowak M, Thomsen C, et al.. Increased fluorine-18 2-fluoro-2-deoxy-Dglucose (FDG) uptake in childhood CNS tumors is correlated with malignancy grade: a study with FDG positron emission tomography/magnetic resonance imaging coregistration and image fusion. [borgwardt-2005]J Clin Oncol. 2005 May 1;23(13):3030-7. Borgwardt L 2005 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48634 |
Study title: Buchmann I, Reinhardt M, Elsner K, Bunjes D, Altehoefer C, Finke J, et al.. 2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial. [buchmann-2001]Cancer. 2001 Mar 1;91(5):889-99. Buchmann I, 2001 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48636 |
Study title: Prevention of decalcification in orthodontic patients by daily self treatment with 0.4 percent SnF2 gel1979-shannon |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1979-shannon - prevention of decalcification in orthodontic patients by daily self treatment with 0.4 percent SnF2 gel.pdf |
View full study record |
Document reference: 49154 |
Study title: Preventive effect of high-fluoride dentifrice in caries-active adolescents2010-Nordstrom |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 2010-Nordstrom-preventive effect of high-fluoride dentifrice in caries-active adolescents.pdf |
View full study record |
Document reference: 49099 |
Study title: Reduction in dental caries with four concentrations of sodium fluoride in a dentifrice: a meta-analysis evaluation2001-Bartizek, The journal of clinical dentistry |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 2001-Bartizek-reduction in dental caries with four concentrations of sodium fluoride in a dentifrice.pdf |
View full study record |
Document reference: 49087 |
Study title: Relative anti-caries efficacy of 1100, 1700, 2200 and 2800 ppm fluoride ion in a sodium fluoride dentifrice over 1 year2001-Biesbrock, Community dentistry and oral epidemiology |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 2001-Biesbrock-relative anti-caries efficacy of 1100, 1700, 2200 and 2800 ppm fluoride ion in a sodium fluoride dentifrice over 1 year.pdf |
View full study record |
Document reference: 49088 |
Study title: Results of a 3-year oral hygiene programmeDénes 1991, european Journal of Orthodontics 13 (1991) 129-133 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Dénes 1991 Results of a 3-year oral hygiene programme.pdf |
View full study record |
Document reference: 49161 |
Study title: Results of a group prophylaxis programmeBüttner 1985 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Büttner 1985 Results of a group prophylaxis programme.pdf |
View full study record |
Document reference: 49158 |
Study title: Results of a three-year investigation about Zahneputzen with an amine fluoride gels - Ergebnisse einer dreijährigen untersuchung uber Zahneputzen mit einem Aminfluorid-geleSzöke 1989 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Szöke 1989 Ergebnisse einer dreijährigen.pdf |
View full study record |
Document reference: 49182 |
Study title: Results of the Sherbrooke-Lac Megtanic fluoride varnish study after 20 months1985-clark |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1985-clark-Results of the Sherbrooke-Lac Megtanic fluoride varnish study after 20 months.pdf |
View full study record |
Document reference: 49112 |
Study title: Sodium fluoride tablets for childrenFrancis A. Arnold, F.J. McClure, Carl. L. White. Dental Vol 1. No. 1. October 1960 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1960-Arnold-Sodium fluoride tablets for children.pdf |
View full study record |
Document reference: 48766 |
Study title: stannous fluoride topically applied os effective-data at the end of a five years study1965-Rothhaar |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1965-Gish-Effect on dental caries in children in a natural fluoride area of combined use of three agents containing stannous fluoride.pdf |
View full study record |
Document reference: 49148 |
Study title: Stannous fluoride versus sodium fluoride in preventive treatment of orthodontic patients1977-shannon |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1977-shannon - stannous fluoride versus sodium fluoride in preventive treatment of orthodontic patients.pdf |
View full study record |
Document reference: 49153 |
Study title: Benefit of fluoroscopically guided intraarticular, long-acting corticosteroid injection for subtalar arthritis in juvenile idiopathic arthritis.; CAHILL AM; Pediatr. Radiol.; 2007 vol.37 p544 548Benefit of fluoroscopically guided intraarticular, long-acting corticosteroid injection for subtalar arthritis in juvenile idiopathic arthritis.; CAHILL AM; Pediatr. Radiol.; 2007 vol.37 p544 548 |
Active substance: IOVERSOL |
Study summary document link (including results): |
View full study record |
Document reference: 30397 |
Study title: Acta Radiol. 1989 Nov-Dec;30(6):643-6 Influence of urography on renal function in children. A double blind study with metrizoate and iohexol. Stake G, Monn E, Rootwelt K, Golman K, Monclair T Acta Radiol. 1989 Nov-Dec;30(6):643-6 Influence of urography on renal function in children. A double blind study with metrizoate and iohexol. Stake G, Monn E, Rootwelt K, Golman K, Monclair T |
Active substance: IOHEXOL |
Study summary document link (including results): |
View full study record |
Document reference: 30362 |
Study title: Choi SJ, Kim JS, Kim JH, Oh SJ, Lee JG, Kim CJ, et al.. Epub 2005 Feb 15. [18F]3'-deoxy-3'- fluorothymidine PET for the diagnosis and grading of brain tumors. [choi-2005]Eur J Nucl Med Mol Imaging. 2005 Jun;32(6):653-9. Choi SJ 2005 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48637 |
Study title: Fluorides in community programms-A study of four years of various fluorides applied topically to the teeth of children in fluoridated communities1972-Swejda |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1972-Swejda-Fluorides in community programms-A study of four years of various fluorides applied topically to the teeth of children in fluoridated c... |
View full study record |
Document reference: 49150 |
Study title: Fluorine concentration in primary tooth enamel in 6 year old after 3 years of daily intake1984-Widenheim |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1984-Widenheim-Fluorine concentration in primary tooth enamel in 6 year old after 3 years of daily intake.pdf |
View full study record |
Document reference: 49155 |
Study title: Effect on a 30 second topical stannous fluoride treatement on dental caries reductions in children1964-Mercer |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1964-Mercer-Effect on a 30 second topical stannous fluoride treatement on dental caries reductions in children.pdf |
View full study record |
Document reference: 49146 |
Study title: Effect on dental caries in children in a natural fluoride area of combined use of three agents containing stannous fluoride1965-Gish |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1965-Gish-Effect on dental caries in children in a natural fluoride area of combined use of three agents containing stannous fluoride.pdf |
View full study record |
Document reference: 49147 |
Study title: Effect on dental caries in children in a non fluoride area of combined use of three agents containing stannous fluoride1964-Bixler |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1964-Bixler-Effect on dental caries in children in a non fluoride ares of combined use of three agents containing stannous fluoride.pdf |
View full study record |
Document reference: 49145 |
Study title: Effectiveness of fornightly tooth brushing with amine fluorides in caries-prone subjectsRan 1991 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Ran 1991 Effectiveness of fornightly tooth brushing.pdf |
View full study record |
Document reference: 49176 |
Study title: Effectiveness of visible light fissure sealant (Delton) versus fluoride varnish (Duraphat) 24 month clinical trial1996-bravo, Community Dent. Oral Epidemiol. 1996: 24: 42-6 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1995-seppa-Fluoride varnish versus acidulated phosphate fluoride gel.pdf |
View full study record |
Document reference: 49121 |
Study title: Influence of urography on renal function in children. A double blind study with metrizoate and iohexol. Acta Radiol. 1989 Nov-Dec; 30(6):643-6 Stake G 1989 |
Active substance: IOHEXOL |
Study summary document link (including results): Stake G 1989.pdf |
View full study record |
Document reference: 48872 |
Study title: Dietlein M, Krug B, Groth W, Smolarz K, Scheidhauer K, Psaras T, et al.. Positron emission tomography using 18Ffluorodeoxyglucose in advanced stages of malignant melanoma: a comparison of ultrasonographic and radiological methods of diagnosis. [dietlein-1999]Nucl Med Commun. 1999 Mar;20(3):255-61. Dietlein M 1999 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48640 |
Study title: Open Study to determine the concentration of telithromycin in middle ear fluid and plasma in infants/children with acute otitis media or otitis media with effusion after single oral administration of 20mg/kg or 30mg/kg of a telithromycin pediatric suspension |
Active substance: telithromycin |
Study summary document link (including results): |
View full study record |
Document reference: 41566 |
Study title: Furth C, Steffen IG, Amthauer H, Ruf J, Misch D, Schönberger S, Kobe C, Denecke T, Stöver B, Hautzel H, Henze G, Hundsdoerfer P.. Epub 2009 Aug 10.Early and late therapy response assessment with [18F]fluorodeoxyglucose positron emission tomography in pediatric Hodgkin's lymphoma: analysis of a prospective multicenter trial. [furth-2009]J Clin Oncol. 2009 Sep 10;27(26):4385-91. Furth C 2009 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48651 |
Study title: effects of self-applied topical fluoride preparations in orthodontic patients2000-alexander |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 2000-alexander-effects of self-applied topical fluoride preparations in orthodontic patients.pdf |
View full study record |
Document reference: 49096 |
Study title: Enamel changes and dental caries in 7 years old children given fluoride tablets from shortly after birthA. Thylstrup, O. Fejerskov, C. Brunn, J. Kann 1979. Brit Dent. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1979-thylstrup-Enamel Changes and Dental Caries in 7-Year-Old children fiven fluoride tablets from shortly after birth.pdf |
View full study record |
Document reference: 48779 |
Study title: A 3 year oral health dose response study of sodium monofluorophosphate dentifrices with and without zinc citrate1988-Stephen, Community Dent Oral Epidemiology 16:321-5 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1988-Stephen-a 3 year oral health dose response study of sodium monofluorophosphate dentifrices with and without zinc citrate.pdf |
View full study record |
Document reference: 49085 |
Study title: A 48-month survival analysis comparing sealant (Delton) with fluoride varnish (Duraphat) in 6-8 year old children1997-bravo |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1996-bravo-Effectiveness of visible light fissure sealant (Delton) versus fluoride varnish (Duraphat) 24 month clinical trial.pdf |
View full study record |
Document reference: 49122 |
Study title: A Community Study of Fluoride Tablets for School Children in Portsmouth1982-Allmark. Br Dent J 1982: 153: 426 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1982-Allmark-A Community Study od Fluoride Tablets for School Children in Portsmouth.pdf |
View full study record |
Document reference: 48773 |
Study title: A home care program of chemical preventive dentistry for orthodontic patients1973-landry |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1973-landry-a home care program of chemical preventive dentistry for orthodontic patients.pdf |
View full study record |
Document reference: 49151 |
Study title: a new approach to the topical application of fluorides for the reduction od dental caries in children-results at the end of five years1962-Gish |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1962-Gish-a new approach to the topical application of fluorides for the reduction od dental caries in children-results at the end of five years.pdf |
View full study record |
Document reference: 49143 |
Study title: A new approach to the topical application of fluorides for the reduction of dental caries in children1957-gish |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1957-gish-a new approach to the topical application of fluorides for the reduction of dental caries in children.pdf |
View full study record |
Document reference: 49133 |
Study title: A new approach to the topical application of fluorides in children with results at the end of four years1959-Gish |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1959-Gish-A new approach to the topical application of fluorides in children with results at the end of four years.pdf |
View full study record |
Document reference: 49137 |
Study title: A newapproach to the topical application of fluorides in children with results at the end of two years1957-gish |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1957-Gish-A newapproach to the topical application of fluorides in children with results at the end of two years.pdf |
View full study record |
Document reference: 49134 |
Study title: A study of a single application of eight persent stannous fluoride1959-Jordan |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1959-Jordan-A study of a single application of eight persent stannous fluoride.pdf |
View full study record |
Document reference: 49138 |
Study title: A three year clinical comparison of a sodium monofluorophosphate dentifrice with sodium fluoride dentifrices on dental caries in children1987-Lu, Journal of dentistry for children, July-August 1987 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1987-Lu-a three year clinical comparison of a sodium monofluorophosphate dentifrice with sodium fluoride dentifrices on dental caries in children.pdf |
View full study record |
Document reference: 49083 |
Study title: Influence of iodine supplementation on serum insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) levels in severe iodine deficiency. ;Özön-A. Turkish Journal of Pediatrics, 2004, Vol/Iss/Pg. 46/4 (303-308)Influence of iodine supplementation on serum insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) levels in severe iodine deficiency. ;Özön-A. Turkish Journal of Pediatrics, 2004, Vol/Iss/Pg. 46/4 (303-308) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30265 |
Study title: Influence of nutritional state on the disposal of orally and intramuscularly administered iodized oil to iodine repleted older children and adult women. Fierro-Benitez-R. Journal of Endocrinological Investigation, 1989, Vol/Iss/Pg. 12/6 (405-407)Influence of nutritional state on the disposal of orally and intramuscularly administered iodized oil to iodine repleted older children and adult women. Fierro-Benitez-R. Journal of Endocrinological Investigation, 1989, Vol/Iss/Pg. 12/6 (405-407) |
Active substance: IODINE |
Study summary document link (including results): |
View full study record |
Document reference: 30266 |
Study title: Amounts of fluorides in self administered dental products: safety considerations for childrenStanley B Heifetz, Herschel S Horowitz. Pediatrics Vol 77No. 6 June 1986 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1986-heifetz-Amounts of fluoride in self-administered dental products-safety consideration for children.pdf |
View full study record |
Document reference: 48770 |
Study title: An assessment of two dental health education programmes for school children in the Lothian region of ScotlandC. Wight, A.S. Blinkhorn 1988. Journal of Pediatric Dentistry |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1988-wight-An Assessment of Two Dental Health Education programmes for school children in the lothian region of scotland.pdf |
View full study record |
Document reference: 48775 |
Study title: An open study to investigate what happens with a lozenge that is given to a 3-5 year old child that are told to leave it be in their mouth.Mejàre et al. (1987-09-23) |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 48943 |
Study title: Assessment of the effectiveness of supervised oral hygiene programmes by means of different indicesMaiwald 1993 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Maiwald 1993 Assessment of the effectiveness.pdf |
View full study record |
Document reference: 49170 |
Study title: Caries epidemiological studies- Kariesepidemiologische UntersuchungenBüttner 1995 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Büttner 1995 Kariesepidemiologische Untersuchungen.pdf |
View full study record |
Document reference: 49160 |
Study title: Caries increment in primary teeth after application of Duraphat fluoride varnish1982-grogzka |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1982-grogzka-Caries increment in primary teeth after application of Duraphat fluoride varnish.pdf |
View full study record |
Document reference: 49108 |
Study title: Pediatr cardiol. 2005 Jul-Aug: 26(4):413-7: Safety and Efficacy of Itravenous Contrast Imaging in Pediatrich Echocardiography.Pediatr cardiol. 2005 Jul-Aug: 26(4):413-7: Safety and Efficacy of Itravenous Contrast Imaging in Pediatrich Echocardiography. |
Active substance: Perflutren |
Study summary document link (including results): |
View full study record |
Document reference: 41585 |
Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Lamioflur (drops) [AWB-AT] |
Active substance: Lamioflur |
Study summary document link (including results): |
View full study record |
Document reference: 40045 |
Study title: Caries increments-tooth discoloration-and state of oral hygiene in children1965-Wellock |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1965-Wellock-Caries increments-tooth discoloration-and state of oral hygiene in children.pdf |
View full study record |
Document reference: 49149 |
Study title: Caries inhibiting effect of different modes of Duraphat reapplication-A three year radiographic study1991-peterson, Caries Res. 1991:25:70-73 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1991-peterson-Caries inhibiting effect of different modes of Duraphat reapplication-A three year radiographic study.pdf |
View full study record |
Document reference: 49117 |
Study title: Caries inhibition of mixed NaF-Na2PO3F dentifrices containing 1000 and 2500 ppmF1988-Ripa- JADA Volume 116, January 1988 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1988-Ripa-caries inhibition of mixed NaF-Na2PO3F dentifrices containing 1000 and 2500 ppmF.pdf |
View full study record |
Document reference: 49084 |
Study title: Caries prevention by daily fluoride mouthrinsingRugg-Gunn 1973 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Rugg-Gunn 1973 Caries prevention by daily fluoride mouthrinsing.pdf |
View full study record |
Document reference: 49129 |
Study title: Caries preventive effect of Duraphat Varnish versus fluoride mouthrinses-5 year data1986-kirkegaard |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1986-kirkegaard-Caries preventive effect of Duraphat Varnish versus fluoride mouthrinses-5 year data.pdf |
View full study record |
Document reference: 49113 |
Study title: Caries preventive effect of fluoride varnish application performed two or four times a year1990-seppa |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1990-seppa-Caries preventive effect of fluoride varnish application performed two or four times a year.pdf |
View full study record |
Document reference: 49115 |
Study title: Guidelines for paediatric bone scanning with 99mTc-labelled radiopharmaceuticals and 18F-fluoride. Stauss J, Hahn K, Mann M, De Palma D. Eur J Nucl Med Mol Imaging. (8 pages) Published online: www.eanm.org/scientific_info/guidelines/EJNMMI_Bone_Scintigraphy_in_Children.pdf |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 48759 |
Study title: Reflux of nasopharyngeal content into middle ear through the eustachian tube Eur Arch Otorhinolaryngol. 2004 Sep;261(8):439-44. Epub 2003 Nov 18. Ayanoglu E 2003 |
Active substance: TECHNETIUM (99m) |
Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
View full study record |
Document reference: 48794 |
Study title: Hain SF, O'Doherty MJ, Lucas JD, Smith MA. Nucl Med Commun. 1999 Sep;20(9):845-8. Fluorodeoxyglucose PET in the evaluation of amputations for soft tissue sarcoma. [hain-1999] Hain SF, O'Doherty MJ, Timothy AR, Leslie MD, Harper PG,. Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse. [hain-2000]Huddart RA. Br J Cancer. 2000 Oct;83(7):863-9. Hain SF 2000 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48656 |
Study title: Hoegerle S, Juengling F, Otte A, Altehoefer C, Moser EA, Nitzsche EU.. Combined FDG and [F-18]fluoride whole-body PET: a feasible two-in-one approach to cancer imaging? [hoegerle 1998]Radiology. 1998 Oct;209(1):253-8. Hoegerle S 1998 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48658 |
Study title: Caries preventive effect of high fluoride and xylitol containing dentifrices1992-Cutress- |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1992-Cutress-caries preventive effect of high fluoride and xylitol containing dentifrices.pdf |
View full study record |
Document reference: 49094 |
Study title: Caries preventive effect of three topical fluorides_1% years clinical trial in Chandigarh schoolchildren of North India1984-tewari- |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1984-tewari-Caries preventive effect of three topical fluorides_1% years clinical trial in Chandigarh schoolchildren of North India.pdf |
View full study record |
Document reference: 49111 |
Study title: Caries preventive effect of two fluoride varnishes and a fluoride mouthrinse1987-seppa, Caries Res. 1987:21: 375-379 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1987-seppa-Caries preventive effect of two fluoride varnishes and a fluoride mouthrinse.pdf |
View full study record |
Document reference: 49114 |
Study title: Caries preventive effort of a fluoride-containing varnish (Duraphat) after 1 year s study1975-koch, Community Dentl Oral Epidemiol, 1975: 3: 262-266 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1975-koch-Cariespreventive effort of a fluoride-containing varnish (Duraphat) after 1 year s study.pdf |
View full study record |
Document reference: 49102 |
Study title: Caries rate, enamel fluoride concentration after fortnightly brushing with aminfluoride gelRan 1987 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Ran 1987 Caries rate, enamel fluoride concentration.pdf |
View full study record |
Document reference: 49175 |
Study title: Caries reduction and cost benefit after 3 years of sucking fluoride tablets daily at schoolK.W. Stephen, D. Campbell 1978. Brit Dent J 1978 144, 202 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1978-stephen-Caries Reduction and Cost Benefit After 3 Years of Sucking Fluoride Tablets Daily at school.pdf |
View full study record |
Document reference: 48780 |
Study title: Kostakoglu L, Leonard JP, Kuji I, Coleman M, Vallabhajosula S, Goldsmith SJ.. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma. [kostakaglu-2002]Cancer. 2002 Feb 15;94(4):879-88. Kostakoglu L 2002 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48670 |
Study title: Clinical assessment of the latrogenicGatto 1988 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Gatto 1988 Clinical assessment of the latrogenic.pdf |
View full study record |
Document reference: 49166 |
Study title: Clinical evaluations on the biocompatibility- Valutazioni cliniche sulla biocompatibilitaGatto 1989 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Gatto 1989 Valutazioni cliniche sulla biocompatibilita.pdf |
View full study record |
Document reference: 49167 |
Study title: Clinical study of an amine fluoride gel and acidulated phosphate fluoride gelShern 1976 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Shern 1976 Clinical study of an amine fluoride.pdf |
View full study record |
Document reference: 49178 |
Study title: Collective preschool caries prevention using a fluoride-containing varnish] [Article in German] |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42543 |
Study title: Comments on the biocompatibility - Osservazioni sulla biocompatibilitaGallusi 1988 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Gallusi 1988 Osservazioni sulla biocompatibilita.pdf |
View full study record |
Document reference: 49165 |
Study title: Comparision of a single application of stannous fluoride with a single application of sodium fluoride or two applications of stannous fluoride1961-Mercer |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1961-Mercer-Comparision of a single application of stannous fluoride with a single application of sodium fluoride or two applications of stannous f... |
View full study record |
Document reference: 49141 |
Study title: Comparision of three self applied topical fluoride preparationsfor control of decalcification1993-boyd |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1993-boyd - comparision of three self applied topical fluoride preparationsfor control of decalcification.pdf |
View full study record |
Document reference: 49156 |
Study title: Comparison of three prevention programs -Vergleich dreier Prophylaxe ProgrammeBüttner 1987 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Büttner 1987 Vergleich dreier Prophylaxe Programme.pdf |
View full study record |
Document reference: 49159 |
Study title: A phase II, two-centre, open-label study in patients aged 3 months to 13 years with endoscopically-proven reflux oesophagitis. |
Active substance: LANSOPRAZOLE |
Study summary document link (including results): Lansoprazole_AG-II-95-028-Synopsis.pdf |
View full study record |
Document reference: 47610 |
Study title: Investigate how absorption is influenced by volume, composition and food intake.Forsman et al |
Active substance: PHENOXYMETHYLPENICILLIN |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_1.xlsx |
View full study record |
Document reference: 49031 |
Study title: Investigate how absorption is influenced by volume, composition and food intake.Forsman et al |
Active substance: PHENOXYMETHYLPENICILLIN |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_1.xlsx |
View full study record |
Document reference: 49032 |
Study title: Levivier M, Goldman S, Pirotte B, Brucher JM, Balériaux D, Luxen A, et al.. Diagnostic yield of stereotactic brain biopsy guided by positron emission tomography with [18F]fluorodeoxyglucose. [levivier-1995]J Neurosurg. 1995 Mar;82(3):445-52. Levivier M 1995 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48675 |
Study title: Moll AC, Hoekstra OS, Imhof SM, Comans EF, Schouten-van Meeteren AY, van der Valk P, et al. Ophthalmic Genet. 2004 Mar;25(1):31-5. Fluorine-18 fluorodeoxyglucose positron emission tomography (PET) to detect vital retinoblastoma in the eye: preliminary experience. [moll-2004]Moll AC 2004 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48679 |
Study title: Control of decalcification in orthodontic patients by daily self administered application of a water free 0.4 percent stannous fluoride gel1974-stratemann |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1974-stratemann - control of decalcification in orthodontic patients by daily self administered application of a water free 0.4 percent stannous fl... |
View full study record |
Document reference: 49152 |
Study title: Controlled trial of fluoride in vitamin drops for prevention of caries in childrenLars-Eric Granath, Holger Rootzen, Elso Liljegren, Kerstin Hoist, Lennart Kohler 1978. Caries Res 12: 83-92lENNART hAMBERG 1971, THE LANCET, February 27 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1971-hamberg-Controlled trial of Fluoride in Vitamins Drops for Prevention od Caries in Children.pdf |
View full study record |
Document reference: 48782 |
Study title: Djelovanje aminofluorida - elmex gelee na: Effect of amine fluorideRajic 1977 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Rajic 1977 Djelovanje aminofluorida - elmex gelee na.pdf |
View full study record |
Document reference: 49174 |
Study title: Decrease in DMF tooth numbersSigrist 1975 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): Sigrist 1975 Decrease in DMF tooth numbers.pdf |
View full study record |
Document reference: 49179 |
Study title: The anticariogenic effectiveness od a single application of stannous fluoride in children residing in an optimum fluoride area1960-Muhler |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1960-Muhler-The anticariogenic effectiveness od a single application of stannous fluoride in children residing in an optimum fluoride area.pdf |
View full study record |
Document reference: 49140 |
Study title: the anticariogenic effects of one and two X application of stannous fluoride on the deciduous and permanent teeth of children1962-Salter |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 49144 |
Study title: The caries inhibitory effect of a fluoride gel (PreviDent) ina self-brushing home based programm for shoolchildren1994-DePaola |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1994-DePaola-the caries inhibitory effect of a fluoride gel (PreviDent) ina self-brushing home based programm for shoolchildren.pdf |
View full study record |
Document reference: 49095 |
Study title: The caries preventing effect of mouthrinsing with 0.025 percent sodium fluoride solution in Swedish children. Forsman B. Community Dent Oral Epidemiol. 1974;2(2):58-65. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 48944 |
Study title: The caries preventive effect of a fluoride varnish in the fissures of the first permanent molar1984-holm |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1984-holm-The caries preventive effect of a fluoride varnish in the fissures of the first permanent molar.pdf |
View full study record |
Document reference: 49110 |
Study title: The caries prophylactic effect of Fluorlack after years of use in paediatric/adolescent dental care: Karies prophylaktische Wirkung von Fluorlack nach mehrjahriger Anwendung in der Jugendzahnpflege1978-leiser |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1978-leiser-Karies prophylaktische Wirkung von Fluorlack nach mehrjahriger Anwendung in der Jugendzahnpflege.pdf |
View full study record |
Document reference: 49104 |
Study title: The caries-preventive effect of a fluoride varnish in the fissures of the first permanent molar. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42369 |
Study title: The clinical anticariogenic effectiveness of supplementary fluoride vitamin preparations - result at the end of four yearsDavid K. Hennon, Georg K Stookey, Joseph C Muhler 1967. Journal of dentistry for children. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1967-hennon-Ciinical Anticariogenic Effectivenoss of Supplementary Fluoride-Vitamin Preparations-Results at the end of four years.pdf |
View full study record |
Document reference: 48785 |
Study title: The combined antocariogenic effeccts of a single stannous fluoride treatement and the unsupervised use of stannous fluoride dentifrice1959-Muhler, J DENT RES 1959 38: 994 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1959-Muhler-The combined antocariogenic effeccts of a single stannous fluoride treatement and the unsupervised use of stannous fluoride dentifrice.pdf |
View full study record |
Document reference: 49139 |
Study title: Novak L, Emri M, Molnar P, Balkay L, Lengyel Z. Subcortical [18F]fluorodeoxyglucose uptake in lesional epilepsy in patients with intracranial tumour. [novak-2004]Tron L. Nucl Med Commun. 2004 Feb;25(2):123-8. Novak L 2004 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48685 |
Study title: O'Connell MT, Seal A, Nortje J, Al-Rawi PG, Coles JP, Fryer TD, et al.. Glucose metabolism in traumatic brain injury: a combined microdialysis and [18F]-2-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET) study. [oconnell-2005]Acta Neurochir Suppl. 2005;95:165-8. O'Connell MT 2005 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48686 |
Study title: A randomized, double-blind, double dummy, parallel group comparison of fluticasone propionate inhalation powder (50mcg BID) via DiskusTM with oral montelukast (5mg QD) chewable tablets in children 6–12 years of age with persistent asthma |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FPD40013-ICHE3.pdf |
View full study record |
Document reference: 28428 |
Study title: A Randomized, Double-Blind, Double-Dummy, Parallel-Group Trial Assessing the Efficacy and Safety of Fluticasone Propionate 50 or 100mcg BID via the Multi-Dose Powder Inhaler, Fluticasone Propionate 50 or 100mcg BID via the Diskhaler and Placebo in Subjects Aged 4 to 11 Years with Chronic Asthma |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FLTA2006-ICHE3.pdf |
View full study record |
Document reference: 28423 |
Study title: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, 12-Week Trial of Inhaled Fluticasone Propionate 88mcg BID versus Placebo in Propellant GR106642X in Pediatric Subjects 4 to 11 Years of Age With Asthma |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FAP30010-ICHE3.pdf |
View full study record |
Document reference: 28391 |
Study title: A randomized, double-blind, placebo-controlled study examining the effect of fluticasone propionate aqueous nasal spray in antibiotic therapy in the treatment of chronic rhinosinusitis in paediatric patients. |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FNS30003-ICHE3.pdf |
View full study record |
Document reference: 28368 |
Study title: A Randomized, Open-Label, 2-Way Crossover, Repeat-Dose Study in Pediatric Subjects with Asthma, Age 4-11 Years, to Compare Systemic Exposure of Fluticasone Propionate 2x44mcg Following Administration by Metered-Dose Inhalers Containing Hydrofluoroalkane or Chlorofluorocarbon Propellants |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FAP10006-ICHE3.pdf |
View full study record |
Document reference: 28417 |
Study title: A Randomized, Open-Label, 2-Way Crossover, Repeat-Dose Study in Pediatric Subjects with Asthma, Age 4-11 Years, to Compare Systemic Exposure of Fluticasone Propionate 2x44mcg Following Administration by Metered-Dose Inhalers Containing Hydrofluoroalkane or Chlorofluorocarbon Propellants |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FAP10006-ICHE3.pdf |
View full study record |
Document reference: 28441 |
Study title: A single centre, randomised, double blind, cross over study to investigate longitudinal growth using knemometry in children with seasonal and perennial rhinitis during treatment with fluticasone propionate aqueous nasal spray (FPANS) 100mcg/day and placebo. |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FNM40181-ICHE3.pdf |
View full study record |
Document reference: 28415 |
Study title: A Study to Determine the Systemic Activity of a Single Dose of Fluticasone Propionate via the Diskus in Asthmatic Children Inhaling at Different Inspiratory Flows |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FLTB4009-ICHE3.pdf |
View full study record |
Document reference: 28382 |
Study title: Comparison of fluticasone powder 1mg/day to budesonide powder 1mg/day in deterioration of severe asthma in children: a double-blind, randomised, multicentre study with parallel groups. |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone -Propionate-FLPB0145-ICHE3.pdf |
View full study record |
Document reference: 28404 |
Study title: Specific or superfluous? Doubtful clinical value of granulocyte scintigraphy in osteomyelitis in children. Kaiser S, Jacobsson H, Hirsch G. J Pediatr Orthop B. 2001 Apr;10(2):109-12. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43453 |
Study title: INFLUENCE ON BRONCHIAL HYPERRESPONSIVENESS USING A LONG ACTING (FORMOTEROL) AND A SHORT ACTING (SALBUTAMOL) BETA-2 SYMPATHOMIMETIC IN CHILDREN WITH BRONCHIAL ASTHMA |
Active substance: FORMOTEROL |
Study summary document link (including results): |
View full study record |
Document reference: 45268 |
Study title: INFLUENCE ON BRONCHIAL HYPERRESPONSIVENESS USING A LONG ACTING (FORMOTEROL) AND A SHORT ACTING (SALBUTAMOL) BETA-2 SYMPATHOMIMETIC IN CHILDREN WITH BRONCHIAL ASTHMA |
Active substance: FORMOTEROL |
Study summary document link (including results): FOR258 DFORD2 Art45 listing 2011.xls |
View full study record |
Document reference: 47845 |
Study title: Report on an Open Cross-Over Comparison of Flurbiprofen and Naproxen in Juvenile Spondylitis, Definite and Probable |
Active substance: FLURBIPROFEN |
Study summary document link (including results): Flurbiprofen-M84-121.pdf |
View full study record |
Document reference: 47461 |
Study title: Serum Concentrations of Flurbiprofen in Children After a Single Oral Dose of 22.5 mg or 27 mg of the Drug, following a Multidose Regime |
Active substance: FLURBIPROFEN |
Study summary document link (including results): flurbiprofen-dm7620.pdf |
View full study record |
Document reference: 48075 |
Study title: |
Active substance: FLURIBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 28346 |
Study title: |
Active substance: FLURIBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 28347 |
Study title: Open comparative trial to evaluate the effectiveness of gonorrhae in males.Fluker |
Active substance: AMOXICILLIN |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Amoxillin_9.xlsx |
View full study record |
Document reference: 48999 |
Study title: |
Active substance: FLURIBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 28348 |
Study title: |
Active substance: FLURIBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 28349 |
Study title: |
Active substance: FLURIBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 28350 |
Study title: |
Active substance: FLURIBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 28351 |
Study title: |
Active substance: FLURIBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 28352 |
Study title: |
Active substance: FLURIBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 28353 |
Study title: |
Active substance: FLURIBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 28354 |
Study title: |
Active substance: FLURIBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 28355 |
Study title: |
Active substance: FLURIBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 28356 |
Study title: |
Active substance: FLURIBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 28357 |
Study title: |
Active substance: FLURIBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 28358 |
Study title: |
Active substance: FLURIBUPROFEN |
Study summary document link (including results): |
View full study record |
Document reference: 28359 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): |
View full study record |
Document reference: 28360 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): |
View full study record |
Document reference: 28361 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): Synopsis-Fluticasone Propionate-CUTIVATE-FPO40003.pdf |
View full study record |
Document reference: 28362 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-DENB4016-ICHE3.pdf |
View full study record |
Document reference: 28369 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): Study FAD101-Fluticasone Propionate-Flixotide Diskus.xls |
View full study record |
Document reference: 28370 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): Study FAD102-Fluticasone Propionate-Flixotide Diskus.xls |
View full study record |
Document reference: 28371 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FAS30006-ICHE3.pdf |
View full study record |
Document reference: 28372 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FAS40019-ICHE3.pdf |
View full study record |
Document reference: 28373 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): Study Fluticasone_Propionate-PED-FLTA2008.xlsx |
View full study record |
Document reference: 28377 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): |
View full study record |
Document reference: 28378 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): |
View full study record |
Document reference: 28381 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): Study FMS40016-Fluticasone.xls |
View full study record |
Document reference: 28385 |
Study title: Due to the lack of good diagnostic techniques it can be difficult to diagnose asthma in young children. The symptoms can be such that anti-inflammatory medication is given as test medication; however there is a lack of clinical data in a large group of wheezy infants using objective endpoints. The aim of this study was to evaluate the effects of fluticasone propionate on lung function and symptom scores in infants with recurrent and persistent wheeze. |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FMS30060-ICHE3.pdf |
View full study record |
Document reference: 28398 |
Study title: Effect of long-term treatment with fluticasone propionate on bone density, growth and lung function in childhood asthma. |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FMS40175-ICHE3.pdf |
View full study record |
Document reference: 28388 |
Study title: Efficacy of treatment with inhaled fluticasone and the effect of priming and activation of PMN cells in children with allergy and asthma. |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FMS40229-ICHE3.pdf |
View full study record |
Document reference: 28405 |
Study title: FLU9705: a multi-centre, parallel group, randomised, double-blind study to investigate the efficacy of fluticasone propionate 100 mcg MDI bd versus placebo MDI bd both via Babyhaler™ spacer in 1 to 5 year old children with asthma or asthma-like symptoms during a 6 months study period. |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FMS40256-ICHE3.pdf |
View full study record |
Document reference: 28395 |
Study title: Nebulised Fluticasone propionate in an upper respiratory tract inflammatory disorder (rhinopharyngitis): a multicentre, randomised, blinded, parallel group study of the efficacy and safety of nebulised fluticasone propionate 0.5mg daily compared with nebulised beclomethasone dipropionate 0.8mg daily in children suffering from acute rhinopharyngitis. |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FLIC09-ICHE3.pdf |
View full study record |
Document reference: 28422 |
Study title: Pharmacodynamics of the 88mcg BID dose of the Hydrofluoroalkane propellant formulation of inhaled Fluticasone Propionate following Administration via the Metered-dose Inhaler in Pediatric Subjects 4 to 11 years of age with Asthma |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FAP19052-ICHE3.pdf |
View full study record |
Document reference: 28390 |
Study title: Prevention of Otitis media in children." 6) "A randomized, double-blind, placebo-controlled study examining the effect of fluticasone propionate aqueous nasal spray in antibiotic therapy in the treatment of chronic rhinosinusitis in paediatric patients." |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FNM40083-ICHE3.pdf |
View full study record |
Document reference: 28367 |
Study title: Report on a multicentre, randomised, double-blind, parallel-group clinical trial to compare the efficacy and safety of the dry powder formulation of fluticasone proprionate (FP) 200μg/day with fluticasone proprionate 400μg/day administered for 6 weeks from a multidose powder device (Diskus™) to paediatric patients with chronic asthma. |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FLTB3051-ICHE3.pdf |
View full study record |
Document reference: 28380 |
Study title: Systemic exposure of the fluticasone propionate from the hydrofluoroalkane propellant formulation via the metered-dose inhaler with and without a spacer in pediatric subjects 4 to 11 years of age with asthma. |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FAP19058-ICHE3.pdf |
View full study record |
Document reference: 28418 |
Study title: Treatment with inhaled corticosteroids in wheezing pre-school children: is there a predictable effect? |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone -Propionate-FMS40257-ICHE3.pdf |
View full study record |
Document reference: 28396 |
Study title: A multi-centre, randomised, open-label, parallel group clinical trial to assess the efficacy and safety of Salmeterol/Fluticasone Propionate combination product (2x 25/125μg/actuation, bd) via a hydrofluoroalkane metereddose inhaler compared with Salmeterol/Fluticasone Propionate Accuhaler™ (50/250μg bd) in adult Chinese patients with mild to moderate asthma. |
Active substance: FLUTICASONE AND SALMETEROL |
Study summary document link (including results): Fluticasone-Propionate-Sameterol-SAS30021-ICHE3.pdf |
View full study record |
Document reference: 28452 |
Study title: Investigate the relationship between relapses in H. influenzae meningitis and the ability of ampicillin to penetrate to the CSF.Coleman et al. (The journal of pediatrics May 1969) |
Active substance: AMPICILLIN |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_7.xlsx |
View full study record |
Document reference: 49008 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): |
View full study record |
Document reference: 28386 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): |
View full study record |
Document reference: 28387 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): |
View full study record |
Document reference: 28392 |
Study title: Influence of age and gender on quantitative sacroiliac joint scintigraphy. Lin WY, Wang SJ. J Nucl Med. 1998 Jul;39(7):1269-72. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43531 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone -Propionate-FAS30007-ICHE3.pdf |
View full study record |
Document reference: 28393 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): |
View full study record |
Document reference: 28400 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): |
View full study record |
Document reference: 28401 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): Study FLIC22 Fluticasone Propionate Fixotide nebules.xls |
View full study record |
Document reference: 28402 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): Study FMDT08-Fluticasone Propionate-Flixotide Diskus.xls |
View full study record |
Document reference: 28403 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): Study FPC40002-Fluticasone propionate-Cutivate - approved.xls |
View full study record |
Document reference: 28406 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): Study FLNT52-Fluticasone_Flixonase.xls |
View full study record |
Document reference: 28410 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): Study FLNT59-Fluticasone_Flixonase.xls |
View full study record |
Document reference: 28411 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): Study FLNT60-FNM30026-Fluticasone_Flixonase.xls |
View full study record |
Document reference: 28412 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): Study FPC40001-Fluticasone propionate-Cutivate - approved.xls |
View full study record |
Document reference: 28427 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): |
View full study record |
Document reference: 28429 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): Synopsis-Fluticasone Propionate-CUTIVATE-FLT411.pdf |
View full study record |
Document reference: 28430 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): |
View full study record |
Document reference: 28431 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): Synopsis-Fluticasone Propionate-CUTIVATE-FLT412.pdf |
View full study record |
Document reference: 28433 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): |
View full study record |
Document reference: 28439 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): |
View full study record |
Document reference: 28440 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): Synopsis-Fluticasone Propionate-CUTIVATE-FPL10005.pdf |
View full study record |
Document reference: 47739 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): Synopsis-Fluticasone Propionate-CUTIVATE-FPL30004.pdf |
View full study record |
Document reference: 47740 |
Study title: A multicentre, randomised, double-blind, double-dummy, parallel group comparison of three treatments : 1) salmeterol/fluticasone propionate (SFC) (50/100mcg strength) bd via DISKUS/ACCUHALER inhaler, 2) fluticasone propionate 200mcg bd via DISKUS/ACCUHALER inhaler, 3) fluticasone propionate 100mcg bd via DISKUS/ACCUHALER inhaler in children aged 4-11 years with asthma |
Active substance: FLUTICASONE AND SALMETEROL |
Study summary document link (including results): Fluticasone-Propionate-Sameterol-SAM40012-ICHE3.pdf |
View full study record |
Document reference: 28443 |
Study title: A pilot single centre, randomised, double-blind, crossover study to demonstrate the superiority of Salmeterol/fluticasone propionate combination product 50/100mcg bd versus fluticasone propionate 100mcg bd when treated for two weeks with respect to activity levels in children aged 7-15 years. |
Active substance: FLUTICASONE AND SALMETEROL |
Study summary document link (including results): Fluticasone-Propionate-Sameterol-SAM40101-ICHE3.pdf |
View full study record |
Document reference: 28448 |
Study title: A Randomized, Double-Blind, 12-Week Trial Evaluating the Safety of the Fluticasone Propionate/Salmeterol DISKUS Combination Product 100/50mcg BID Versus Fluticasone Propionate DISKUS 100mcg BID in Symptomatic Pediatric Subjects (4-11 Years) With Asthma |
Active substance: FLUTICASONE AND SALMETEROL |
Study summary document link (including results): Fluticasone-Propionate-Sameterol-SAS30031-ICHE3.pdf |
View full study record |
Document reference: 28453 |
Study title: A Stratified, Multicenter, Randomized, Double-Blind, Parallel Group, 4-Week Comparison of Fluticasone Propionate/Salmeterol DISKUS Combination Product 100/50mcg BID versus Fluticasone Propionate DISKUS 100mcg BID in Pediatric and in Adolescent Subjects with Activity-Induced Bronchospasm |
Active substance: FLUTICASONE AND SALMETEROL |
Study summary document link (including results): Fluticasone-Propionate-Sameterol-SFA100314-ICHE3.pdf |
View full study record |
Document reference: 28454 |
Study title: A Stratified, Multicenter, Randomized, Double-Blind, Parallel Group, 4-Week Comparison of Fluticasone Propionate/Salmeterol DISKUS Combination Product 100/50mcg BID versus Fluticasone Propionate DISKUS 100mcg BID in Pediatric and in Adolescent Subjects with Activity-Induced Bronchospasm |
Active substance: FLUTICASONE AND SALMETEROL |
Study summary document link (including results): Fluticasone-Propionate-Sameterol-SFA100316-ICHE3.pdf |
View full study record |
Document reference: 47594 |
Study title: An observational study to assess the health related quality of life impact of treating poorly controlled asthmatic children with Seretide(tm) 50/100mcg |
Active substance: FLUTICASONE AND SALMETEROL |
Study summary document link (including results): Fluticasone-Propionate-Sameterol-SAM3802-ICHE3.pdf |
View full study record |
Document reference: 28442 |
Study title: Comparison of stepwise treatment of asthmatic children with salmeterol/fluticasone propionate (FP) combination product (Seretide) and/or fluticasone propionate (Flixotide) based on PD20 methacholine plus symptoms or based on symptoms only (Children Asthma Therapy Optimal”) |
Active substance: FLUTICASONE AND SALMETEROL |
Study summary document link (including results): Fluticasone-Propionate-Sameterol-SAS30018-ICHE3.pdf |
View full study record |
Document reference: 28451 |
Study title: Prospective, parallel-group, randomized, open label study to evaluate the impact of additional guidance from the health professionals team on treatment compliance of children aged between 6 and 14 years old with persistent moderate or severe asthma, receiving the combination salmeterol/fluticasone propionate 50/250 mcg (Seretide) twice a day. ADERE PROJECT (Pediatric) |
Active substance: FLUTICASONE AND SALMETEROL |
Study summary document link (including results): Fluticasone-Propionate-Sameterol-ADERE-PEDIATRIC-1-ICHE3.pdf |
View full study record |
Document reference: 28444 |
Study title: Randomised, double-blind, comparator study to demonstrate the superiority of salmeterol/fluticasone propionate combination DISKUS™ 50/100mcg bd over fluticasone propionate DISKUS™/ACCUHALER™ 200mcg bd with respect to airway physiology in asthmatic children treated for 6 weeks. |
Active substance: FLUTICASONE AND SALMETEROL |
Study summary document link (including results): Fluticasone-Propionate-Sameterol-SAM40100-ICHE3.pdf |
View full study record |
Document reference: 28447 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): Study FLU-KI-4186-Fluticasone propionate-Cutivate - approved.xls |
View full study record |
Document reference: 47741 |
Study title: A double blind, double dummy, crossover study to compare the systemic pharmacodynamic effects and safety of inhaled fluticasone propionate Nebules™ 1mg bd with oral prednisolone administered for 7 days to children aged 4 to 16 years with asthma |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FLTB3055-ICHE3.pdf |
View full study record |
Document reference: 28421 |
Study title: A double blind, double dummy, placebo controlled trial of Fluticasone propionate aqueous nasal spray and oral Ketotifen in children with perennial rhinitis aged between 2 and 4 years. |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FLNQ12-ICHE3.pdf |
View full study record |
Document reference: 28364 |
Study title: A double-blind, 2x2 Factohal Study to evaluate the effects of treatment with intranasal fluticasone propionate and use of Otovent mechanical ventilation of the middle ear on the need for surgery in children aged 4-8 with chronic or recurrent otitis media. |
Active substance: FLUTICASONE |
Study summary document link (including results): Study FLNL45-Fluticasone_Flixonase.xls |
View full study record |
Document reference: 28363 |
Study title: A Double-Blind, Double-Dummy, Placebo-Controlled, Crossover Study to Compare the Potential Short-Term Growth Effect of Fluticasone Propionate Aqueous Nasal Spray, Beclomethasone Dipropionate Aqueous Nasal Spray, and Placebo in Adolescents with Perennial Allergic Rhinitis. |
Active substance: FLUTICASONE |
Study summary document link (including results): Study FNM40007-Fluticasone_Flixonase.xls |
View full study record |
Document reference: 28365 |
Study title: A double-blind, randomized, placebo-controlled study of the efficacy and safety of aqueous fluticasone propionate given once- versus twice-daily versus placebo for two weeks in adolescent patients with seasonal allergic rhinitis |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FLN-305-ICHE3.pdf |
View full study record |
Document reference: 28407 |
Study title: A double-blind, randomized, placebo-controlled study of the efficacy and safety of aqueous fluticasone propionate given once daily versus placebo for two weeks in pediatric patients with seasonal allergic rhinitis |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FLN-320-ICHE3.pdf |
View full study record |
Document reference: 28408 |
Study title: A double-blind, randomized, placebo-controlled study of the efficacy and safety of aqueous fluticasone propionate versus placebo for four weeks in pediatric patients with seasonal allergic rhinitis |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FNM30008-ICHE3.pdf |
View full study record |
Document reference: 28409 |
Study title: A Multi-Center, Randomized, Double-Blind, Parallel-Group Study to Assess the Potential Growth Effects of a One-Year Course of Fluticasone Propionate Aqueous Nasal Spray (200mcg QD) Versus Placebo in Prepubescent, Pediatric Subjects with Perennial Allergic Rhinitis |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FNM40017-ICHE3.pdf |
View full study record |
Document reference: 28414 |
Study title: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Potential Effects of a Six-Week Course of Fluticasone Propionate Aqueous Nasal Spray (200mcg QD) on the HPA-Axis in ≥2 and <4 Year Old Subjects with Allergic Rhinitis. |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FNM40183-ICHE3.pdf |
View full study record |
Document reference: 28416 |
Study title: A multi-centre, randomised, double-blind, double-dummy, parallel-group study to compare the efficacy and safety of fluticasone propionate 400μg daily with budesonide 400μg daily in children with asthma. |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FMS30037-ICHE3.pdf |
View full study record |
Document reference: 28426 |
Study title: A multi-centre, randomised, double-blind, double-dummy, parallel-group study to determine the clinical equivalence between fluticasone propionate 100μg twice daily delivered via a multidose powder inhaler (MDPI) and the Diskhaler™ in adult and paediatric patients with reversible airways disease. |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-propionate-FMDT02-ICHE3.pdf |
View full study record |
Document reference: 28424 |
Study title: Describing three children, two with meningitis and one with septicemia, from whom ampicillin-resistant Haemophilus influenzae type B were isolated from the CSF, blood or both. At least one case represents ampicillin failure in the treatment of H. influenzae meningitis because of resistence of the organism to the drug.Ousama et al. (JAMA, July 15 1974, Vol 229, No 3) |
Active substance: AMPICILLIN |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_7.xlsx |
View full study record |
Document reference: 49007 |
Study title: |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41161 |
Study title: A phase II, double-blind, randomized study to compare the immunogenicity, safety and reactogenicity of GlaxoSmithKline (GSK) Biologicals¿ Tritanrix¿-HepBlow thio/Hib2.5 Gödöllö to GSK Biologicals¿ Tritanrix¿-HepB/Hiberix¿Gödöllö when administered as a three-dose primary vaccination course to healthy infants at 6, 10 and 14 weeks of age. A dose of unconjugated Hib vaccine (plain PRP booster) will be administered at the age of 10 months to 50% of the subjects. Note: This report presents the results pertaining to the plain PRP challenge at 10 months of age. |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41159 |
Study title: "Fluoxetine Vs Placebo In Obsessive Compulsive " |
Active substance: FLUOXETINE |
Study summary document link (including results): |
View full study record |
Document reference: 28337 |
Study title: Fluoxetine Vs Placebo In Ocd Relapse Prevention |
Active substance: FLUOXETINE |
Study summary document link (including results): |
View full study record |
Document reference: 28328 |
Study title: Fluoxetine Vs Placebo In Post Natal Depression |
Active substance: FLUOXETINE |
Study summary document link (including results): |
View full study record |
Document reference: 28326 |
Study title: "Fluoxetine vs. Placebo in the Acute Treatment of Major Depressive Disorder in Children and Adolescents |
Active substance: FLUOXETINE |
Study summary document link (including results): fluoxetine B1Y-MC-X065 Clinical Study Synopsis.pdf |
View full study record |
Document reference: 28343 |
Study title: Fluoxetine: In Depression And Ocd (Compassionate Use) |
Active substance: FLUOXETINE |
Study summary document link (including results): |
View full study record |
Document reference: 28332 |
Study title: Fluoxetine/Placebo In Panic Disorder |
Active substance: FLUOXETINE |
Study summary document link (including results): |
View full study record |
Document reference: 28338 |
Study title: Impact Of Fluoxetine On Growth In Children And Adolescents |
Active substance: FLUOXETINE |
Study summary document link (including results): |
View full study record |
Document reference: 28330 |
Study title: Pharmacokinetic Assessment of Fluoxetine and Norfluoxetine in Preadolescent and Adolescent Patients |
Active substance: FLUOXETINE |
Study summary document link (including results): fluoxetine B1Y-MC-HCIU Clinical Study Summary.pdf |
View full study record |
Document reference: 47357 |
Study title: "Prozac.Epidemiological Study In Obsessional Compulsive Disorder " |
Active substance: FLUOXETINE |
Study summary document link (including results): |
View full study record |
Document reference: 28336 |
Study title: Tomoxetine + fluoxetine for Poor Metabolizer exposures |
Active substance: FLUOXETINE |
Study summary document link (including results): fluoxetine B4Z-MC-LYAQ Clinical Study Summary.pdf |
View full study record |
Document reference: 28333 |
Study title: Reimão R, Lefévre AB.: Evaluation of flurazepam and placebo on sleep disorders in childhood. Arq Neuropsiquiatr. 1982 Mar;40(1):1-13. |
Active substance: FLURAZEPAM |
Study summary document link (including results): |
View full study record |
Document reference: 28345 |
Study title: VALUTAZIONE IN PEDIATRIA DELL'ATTIVITA' IPNOINDUCENTE DEL FLURAZEPAM GOCCE (VAL 779) Rapisarda V.; Germana B. Formazione Psichiatrica, December 1, 1980 , No. 4/- (181-190) Evaluation of flurazepam and placebo on sleep disorders in childhood. Reimão R, Lefévre AB. Arq Neuropsiquiatr. 1982 Mar;40(1):1-13. |
Active substance: FLURAZEPAM |
Study summary document link (including results): |
View full study record |
Document reference: 28344 |
Study title: |
Active substance: FLURBIPROFEN |
Study summary document link (including results): Flurbiprofen-M87-097.pdf |
View full study record |
Document reference: 47460 |
Study title: Flurbiprofen in the Tretment of Juvenile Rheumatoid Arhtritis |
Active substance: FLURBIPROFEN |
Study summary document link (including results): flurbiprofen-m86055-bass.xls |
View full study record |
Document reference: 48078 |
Study title: Pharmacokinetics of Oral and Rectal Flurbiprofen in Childrene |
Active substance: FLURBIPROFEN |
Study summary document link (including results): flurbiprofen-m84016-scaroni.xls |
View full study record |
Document reference: 48076 |
Study title: Post-Tonsillectomy Treatment with Flurbiprofen and Phenylprenazone in Children |
Active substance: FLURBIPROFEN |
Study summary document link (including results): flurbiprofen-m84017-catalano.xls |
View full study record |
Document reference: 48077 |
Study title: A placebo controlled trial during the pollen season comparing the effects of intranasal Beclomethasone dipropionate and intranasal Fluticasone propionate in children and young adults with asthma and allergic rhinitis. |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FNM40054-ICHE3.pdf |
View full study record |
Document reference: 28366 |
Study title: A randomised, double-blind, double-dummy, parallel group, multicentre study to compare the effect on growth measured by stadiometry of fluticasone propionate (100μg bd) administered via DISKUS™ with budesonide (200μg bd) administered via Turbuhaler in prepubescent children. |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FMS40001-ICHE3.pdf |
View full study record |
Document reference: 28384 |
Study title: A Randomized, Double-Blind, Double Dummy, Parallel Group Comparison of Fluticasone Propionate Inhalation Powder (50mcg BID) via DiskusTM with Oral Montelukast (5mg QD) Chewable Tablets in Children 6–12 years of Age with Persistent Asthma |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FPD40012-ICHE3.pdf |
View full study record |
Document reference: 28389 |
Study title: A randomized, stratified, double blind trial to compare safety and efficacy of the Fluvirin® Vaccine (a purified surface antigen vaccine) with Connaught Inactivated Influenza Vaccine Fluzone® (a split virion vaccine) in healthy children aged 6 to 47 months of age.Nicolay 1999, Vaccine 17 (1999) 2223-2228 |
Active substance: Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed) |
Study summary document link (including results): MPL-318-01.xlsx |
View full study record |
Document reference: 49190 |
Study title: Controlled study on the efficacy of Flour-Vigantoletten 1000 in prophylaxis of rachitis -Kontrollierte Studie zur rachitisprophylaktischen Wirkung von Flour-Vigantoletten 1000.Ther d Gegenw 1976; 115: 2076-2087 Pohlandt F., 1976 |
Active substance: COLECALCIFEROL AND SODIUM FLUORIDE |
Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
View full study record |
Document reference: 48990 |
Study title: open uncontrolled study to evaluate the acceptance and tolerance of flucloxacillin suspension.Lidgren. Clinical trial on flucloxacillin suspension in children. |
Active substance: FLUCLOXACILLIN |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Flukloxacillin_2.xlsx |
View full study record |
Document reference: 49075 |
Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF IV FCA IN THE TREATMENT OF CANDIDIASIS IN THE LEUKEMIC PATIENTS |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27941 |
Study title: EFFICACY AND SAFETY OF FLUCONAZOLE IN THE TREATMENT OF FUNGAL INFECTIONS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27663 |
Study title: Anticancer Res. 2003 Jul-Aug;23(4):3513-6. Differentiating recurrent or residual nasopharyngeal carcinomas from post-radiotherapy changes with 18-fluoro-2-deoxyglucose positron emission tomography and thallium-201 single photon emission computed tomography in patients with indeterminate computed tomography findings. Tsai MH, Huang WS, Tsai JJ, Chen YK, Changlai SP, Kao CH. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28141 |
Study title: Influence of timing and dose of thyroid hormone replacement on development in infants with congenital hypothyroidismJ Pediatr 2000; 136: 292-297 Bongers-Schokking JJ., 2000 |
Active substance: LEVOTHYROXINE |
Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
View full study record |
Document reference: 48982 |
Study title: Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitis. Clinical and Experimental Allergy 29, p. 1367-1 377, 1999Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitis. Clinical and Experimental Allergy 29, p. 1367-1 377, 1999 |
Active substance: LEVOCABASTINE |
Study summary document link (including results): |
View full study record |
Document reference: 31137 |
Study title: Comparison of bisoprolol and verapamil in hypertension: influence on left ventricular mass and function−−a pilot study.Ostman−Smith I, Wettrell G, Riesenfeld T. Journal of the American College of Cardiology, 15 Nov 1999, vol. 34, no. 6, p.1813−22, Comparison of bisoprolol and verapamil in hypertension: influence on left ventricular mass and function−−a pilot study.Ostman−Smith I, Wettrell G, Riesenfeld T. Journal of the American College of Cardiology, 15 Nov 1999, vol. 34, no. 6, p.1813−22, |
Active substance: VERAPAMIL |
Study summary document link (including results): |
View full study record |
Document reference: 45541 |
Study title: Factors influencing the prediction of steady state concentrations of digoxin.Nakamura T, Kakumoto M, Yamashita K, Takara K, Tanigawara Y, Sakaeda T, Okumura K. Biological & pharmaceutical bulletin, Apr 2001, vol. 24, no. 4, p. 403−8,Factors influencing the prediction of steady state concentrations of digoxin.Nakamura T, Kakumoto M, Yamashita K, Takara K, Tanigawara Y, Sakaeda T, Okumura K. Biological & pharmaceutical bulletin, Apr 2001, vol. 24, no. 4, p. 403−8, |
Active substance: VERAPAMIL |
Study summary document link (including results): |
View full study record |
Document reference: 45538 |
Study title: Valutazione degli effetti indotti dall'uso di verapamile, flunarizina, diltiazem, nimodipina e placebo nella profilassi dell'emicrania. Studio a doppio cieco randomizzato cross−over. (Evaluation of the effects of verapamil, flunarizine, diltiazem, nimodipine and placebo in the prevention of hemicrania. A double−blind randomized cross−over study).Paterna S, Martino SG, Campisi D, Cascio IN, Marsala BA. La Clinica terapeutica, 31 Jul 1990, vol. 134, no. 2, p. 119−25, Valutazione degli effetti indotti dall'uso di verapamile, flunarizina, diltiazem, nimodipina e placebo nella profilassi dell'emicrania. Studio a doppio cieco randomizzato cross−over. (Evaluation of the effects of verapamil, flunarizine, diltiazem, nimodipine and placebo in the prevention of hemicrania. A double−blind random... |
Active substance: VERAPAMIL |
Study summary document link (including results): |
View full study record |
Document reference: 45557 |
Study title: In vitro generation of cytotoxic effectors activated by interleukin 2 (IL-2): Comparison of autologous peripheral blood stem cells (PBSC) from adults and children. Valteau-Couanet D et al. Bone Marrow Transplant June. 13, 2001, 869-75 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28274 |
Study title: A fluoride dose response evaluation in an anticaries clinical trial1992-Marks, J Dent Res(71)6:1286-1291, June 1992 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1992-Marks-a fluoride dose response evaluation in an anticaries clinical trial.pdf |
View full study record |
Document reference: 49086 |
Study title: Topical stannous fluoride as a caries preventive for preschool children1962-Burgess |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): 1962-Burgess-Topical stannous fluoride as a caries preventive for preschool children.pdf |
View full study record |
Document reference: 49142 |
Study title: Assessment of Efficacy and Systemic Safety of a New Chlorofluorocarbon-Free Formulation of Inhaled Beclomethasone Dipropionate in Asthmatic ChildrenPEDIATRIC ASTHMA, ALLERGY & IMMUNOLOGY, Volume 15, Number 3, 2002 |
Active substance: BECLAMETHASONE |
Study summary document link (including results): DM-RS-3303-05-00 pubblication.pdf |
View full study record |
Document reference: 49208 |
Study title: Efficacy and tolerability of morniflumate in the treatment of acute pharyngotonsillitis in children. Clinica,anno XXIX, 77-84, gennaio-giugno 1990R.Riondino et al, 1990. Clinica Europea 1990, Riondino |
Active substance: MORNIFLUMATE |
Study summary document link (including results): Clinica Europea 1990, Riondino.pdf |
View full study record |
Document reference: 48878 |
Study title: Treatment of acute bronchitis in childhood with morniflumate. Clinica,anno XXIX, 77-84, gennaio-giugno 1990L.Longo et al , 1990. Clinica Europea 1990 Longo |
Active substance: MORNIFLUMATE |
Study summary document link (including results): Clinica Europea 1990 Longo.pdf |
View full study record |
Document reference: 48877 |
Study title: |
Active substance: FLUTICASONE |
Study summary document link (including results): Synopsis-Fluticasone Propionate-CUTIVATE-FLD40004.pdf |
View full study record |
Document reference: 28434 |
Study title: Neurology. 1995 Jan;45(1):123-6. FDG-PET and volumetric MRI in the evaluation of patients with partial epilepsy. Gaillard WD, Bhatia S, Bookheimer SY, Fazilat S, Sato S, Theodore WH. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28201 |
Study title: Bericht über die klinische Prüfung von 9alpha-Fluorhydrocortison zur Behandlung hypotoner und orthostatischerKreislaufregulationsstörungen, Arzneim Forsch (Drug Research) 1971; 21: 1144-1149, Legeler HJ. , 1971 |
Active substance: FLUDOCORTISONE |
Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
View full study record |
Document reference: 48904 |
Study title: Corticosteroids administered by nebulization to children with bronchial asthma.Terzano C, Barkai L, Cremonesi G., Adv Ther. 2001 Nov-Dec;18:253-60. |
Active substance: FLUNISOLIDE |
Study summary document link (including results): MC-PR-3502-001-99 publication.pdf |
View full study record |
Document reference: 49211 |
Study title: Double-blind evaluation of effectiveness and safety of flunisolide aerosol for treatment of bronchial asthma in children.Piacentini G.L. et al, Allergy 1990,45, 612-616 |
Active substance: FLUNISOLIDE |
Study summary document link (including results): Published paper (Piacentini).pdf |
View full study record |
Document reference: 49212 |
Study title: Mitomycin C and 5-fluorouracil antimetabolite therapy for pediatric glaucoma filtration surgery. Snir M et al. Ophthalmic Surg Lasers. January 1, 2000, 31-7 |
Active substance: FLUOROURACIL |
Study summary document link (including results): |
View full study record |
Document reference: 28277 |
Study title: A PROSPECTIVE SURVEY OF OPPORTUNISTIC INFECTIONS IN PATIENTS RECEIVING CHEMOTHERAPY FOR ACUTE LEUKEMIAS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27481 |
Study title: CLINICAL EVALUATION OF FLUCONAZOLE (UK-49,858) IN IV DRIP ENJECTION FROM EFFICACY AND SAFETY IN PEDIATRIC SYSTEMIC MYCOSIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27933 |
Study title: ONCE-WEEKLY ORAL FCA VS. PLACEBO IN THE PREVENTION OF MUCOCUTANEOUS FUNGAL INFECTIONS IN PATIENTS DISCHARGED FROM THE HOSPITAL AFTER BONE MARROW TRANSPLANTATION. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27611 |
Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS IN HOSPITALIZED PATIENTS ON IVH |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27520 |
Study title: SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FLUCONAZOLE IN PATIENTS WITH GASTRO-INTESTINAL CANDIDIASIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27784 |
Study title: An open uncontrolled study to evaluate the effect of treatment and tolerance of a flucloxacillin nsyrup.Price et al Flucloxacillin in the treatment of infectious conditions in children. |
Active substance: FLUCLOXACILLIN |
Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Flukloxacillin_1.xlsx |
View full study record |
Document reference: 49076 |
Study title: Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitis. Clinical and Experimental Allergy 29, p. 1367-1 377, 1999Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitis. Clinical and Experimental Allergy 29, p. 1367-1 377, 1999 |
Active substance: LEVOCABASTINE |
Study summary document link (including results): |
View full study record |
Document reference: 31118 |
Study title: Safety and Efficacy of Rabeprazole in the Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Subjects |
Active substance: RABEPRAZOLE |
Study summary document link (including results): Rabeprazole-E3810-A001-202 (synopsis).pdf |
View full study record |
Document reference: 35258 |
Study title: Eiermann B, Sommer N, Winne D, Schumm F, Maier U, Breyer-Pfaff U. Renal clearance of pyridostigmine in myasthenic patients and volunteers under the influence of ranitidine and pirenzepine. Xenobiotica. 1993 Nov;23(11):1263-75.Eiermann B, Sommer N, Winne D, Schumm F, Maier U, Breyer-Pfaff U. Renal clearance of pyridostigmine in myasthenic patients and volunteers under the influence of ranitidine and pirenzepine. Xenobiotica. 1993 Nov;23(11):1263-75. |
Active substance: PYRIDOSTIGMINE |
Study summary document link (including results): |
View full study record |
Document reference: 35222 |
Study title: Efficacy and safety of aerosolized ribavirin in young children hospitalized with influenza: a double-blind, multicenter, placebo-controlled trial. Efficacy and safety of aerosolized ribavirin in young children hospitalized with influenza: a double-blind, multicenter, placebo-controlled trial. |
Active substance: PYRITINOL |
Study summary document link (including results): |
View full study record |
Document reference: 35235 |
Study title: Mehta PD, Kulczycki J, Patrick BA, Sobczyk W, Wisniewski HM. J Neurol Sci. 1992 May;109(1):64-8. Effect of treatment on oligoclonal IgG bands and intrathecal IgG synthesis in sequential cerebrospinal fluid and serum from patients with subacute sclerosing panencephalitis.Mehta PD, Kulczycki J, Patrick BA, Sobczyk W, Wisniewski HM. J Neurol Sci. 1992 May;109(1):64-8. Effect of treatment on oligoclonal IgG bands and intrathecal IgG synthesis in sequential cerebrospinal fluid and serum from patients with subacute sclerosing panencephalitis. |
Active substance: INOSINE |
Study summary document link (including results): |
View full study record |
Document reference: 30147 |
Study title: Spectrophotofluorometric assay for Isoniazid and Acetyl Isoniazid in Plasma adapted tp pediatric studies - Clin. Chem., 23(4), 745 - Olson W.A. Et al (1977) Spectrophotofluorometric assay for Isoniazid and Acetyl Isoniazid in Plasma adapted tp pediatric studies - Clin. Chem., 23(4), 745 - Olson W.A. Et al (1977) |
Active substance: RIFAMPICIN/ISONIAZID/PYRAZINAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 45141 |
Study title: Glikson M et al. The influence of pyridostigmine administration on human neuromuscular functions--studies in healthy human subjects. Fundam Appl Toxicol. 1991 Feb;16(2):288-98Glikson M et al. The influence of pyridostigmine administration on human neuromuscular functions--studies in healthy human subjects. Fundam Appl Toxicol. 1991 Feb;16(2):288-98 |
Active substance: PYRIDOSTIGMINE |
Study summary document link (including results): |
View full study record |
Document reference: 35209 |
Study title: J Nucl Med Technol. 2007 Mar;35(1):21-6.Reproducibility of a standardized quantitative analysis using fixed regions of interest to differentiate movement disorders on 123I-FP-CIT SPECT. Stokkel MP, Dibbets-Schneider P, Koestering E, Dragoiescu C, Blokland KA. J Nucl Med Technol. 2007 Mar;35(1):21-6.Reproducibility of a standardized quantitative analysis using fixed regions of interest to differentiate movement disorders on 123I-FP-CIT SPECT. Stokkel MP, Dibbets-Schneider P, Koestering E, Dragoiescu C, Blokland KA. |
Active substance: ioflupane (123l) |
Study summary document link (including results): |
View full study record |
Document reference: 41498 |
Study title: Neurology. 2001 Jan 23;56(2):266-7. SPECT imaging of the dopamine transporter in juvenile-onset dystonia. O'Sullivan JD, Costa DC, Gacinovic S, Lees AJ.Neurology. 2001 Jan 23;56(2):266-7. SPECT imaging of the dopamine transporter in juvenile-onset dystonia. O'Sullivan JD, Costa DC, Gacinovic S, Lees AJ. |
Active substance: ioflupane (123l) |
Study summary document link (including results): |
View full study record |
Document reference: 41501 |
Study title: Neurology. 2004 Dec 14;63(11):2097-103. Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkin disease. Varrone A, Pellecchia MT, Amboni M, Sansone V, Salvatore E, Ghezzi D, Garavaglia B, Brice A, Brunetti A, Bonavita V, De Michele G, Salvatore M, Pappatà S, Barone P. Neurology. 2004 Dec 14;63(11):2097-103. Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkin disease. Varrone A, Pellecchia MT, Amboni M, Sansone V, Salvatore E, Ghezzi D, Garavaglia B, Brice A, Brunetti A, Bonavita V, De Michele G, Salvatore M, Pappatà S, Barone P. |
Active substance: ioflupane (123l) |
Study summary document link (including results): |
View full study record |
Document reference: 41499 |
Study title: Acta Radiol. 1989 Nov-Dec;30(6):643-6 Influence of urography on renal function in children. A double blind study with metrizoate and iohexol. Stake G, Monn E, Rootwelt K, Golman K, Monclair T Acta Radiol. 1989 Nov-Dec;30(6):643-6 Influence of urography on renal function in children. A double blind study with metrizoate and iohexol. Stake G, Monn E, Rootwelt K, Golman K, Monclair T |
Active substance: IOHEXOL |
Study summary document link (including results): |
View full study record |
Document reference: 30361 |
Study title: Cappa M et al. The growth hormone response to pyridostigmine plus growth hormone releasing hormone is not influenced by pubertal maturation. J Endocrinol Invest. 1991 Jan;14(1):41-5Cappa M et al. The growth hormone response to pyridostigmine plus growth hormone releasing hormone is not influenced by pubertal maturation. J Endocrinol Invest. 1991 Jan;14(1):41-5 |
Active substance: PYRIDOSTIGMINE |
Study summary document link (including results): |
View full study record |
Document reference: 35210 |
Study title: Remifentanil/Propofol versus Desflurane/N2O in general surgery, opthalmic surgery and ENT surgery in children |
Active substance: REMIFENTANIL |
Study summary document link (including results): |
View full study record |
Document reference: 35286 |
Study title: Remifentanil/propofol versus remifentanil/sevoflurane in- and outpatient paediatric surgery |
Active substance: REMIFENTANIL |
Study summary document link (including results): |
View full study record |
Document reference: 35288 |
Study title: Remifentanil/Propofol versus Sevofluran/N2O für allgemeinchirurgische und HNO-Eingriffe bei Kindern: Ein Vergleich der Hämodynamik, des Einschlaf- und Aufwachverhaltens sowie der anästhesierelevanten Zeiten |
Active substance: REMIFENTANIL |
Study summary document link (including results): |
View full study record |
Document reference: 35287 |
Study title: Oh AY, Kim SD, Kim CS. Early and late reversal of rocuronium with pyridostigmine during sevoflurane anaesthesia in children. Anaesth Intensive Care. 2004 Oct;32(5):649-52Oh AY, Kim SD, Kim CS. Early and late reversal of rocuronium with pyridostigmine during sevoflurane anaesthesia in children. Anaesth Intensive Care. 2004 Oct;32(5):649-52 |
Active substance: PYRIDOSTIGMINE |
Study summary document link (including results): |
View full study record |
Document reference: 35184 |
Study title: A double-blind, placebo-controlled comparison of treatment with fluticasone propionate and levocabastine in patients with seasonal allergic rhinitis. Allergy 54, p.1173-1180, 1999A double-blind, placebo-controlled comparison of treatment with fluticasone propionate and levocabastine in patients with seasonal allergic rhinitis. Allergy 54, p.1173-1180, 1999 |
Active substance: LEVOCABASTINE |
Study summary document link (including results): |
View full study record |
Document reference: 31138 |
Study title: Dr. Benezis Essai contrôle en double aveugle etablissant l'efficacité et la tolerance de l'acide niflumique gélule par rapport au placébo et au diclofenac dans les tendinites du membre inférieur. |
Active substance: NIFLUMIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 32637 |
Study title: Dr. M. Chelly.Essai controle en ouvert evaluant l'efficacitè et la tolèrance du morniflumate suppositoire enfant versus alpha-amylase sirop dans les angines. |
Active substance: NIFLUMIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 32638 |
Study title: Bortone L, Picetti E, Mergoni M. Anaesthesia with sevoflurane in children: Nitrous oxide does not increase postoperative vomiting. Paediatric Anaesthesia. 2002; 12(9):775-9. Bortone L, Picetti E, Mergoni M. Anaesthesia with sevoflurane in children: Nitrous oxide does not increase postoperative vomiting. Paediatric Anaesthesia. 2002; 12(9):775-9. |
Active substance: NITROUS OXIDE |
Study summary document link (including results): |
View full study record |
Document reference: 32663 |
Study title: Byhahn C, Strouhal U, Westphal K. The anaesthesiologist's occupational exposure to sevoflurane and nitrous oxide during inhalation mask induction and general anaesthesia in paediatric anaesthesia. Anaesthesiologie und Reanimation. 2000; 25(1):12-6. Byhahn C, Strouhal U, Westphal K. The anaesthesiologist's occupational exposure to sevoflurane and nitrous oxide during inhalation mask induction and general anaesthesia in paediatric anaesthesia. Anaesthesiologie und Reanimation. 2000; 25(1):12-6. |
Active substance: NITROUS OXIDE |
Study summary document link (including results): |
View full study record |
Document reference: 32664 |
Study title: Goldman LJ. Anesthetic uptake of sevoflurane and nitrous oxide during an inhaled induction in children. Anesthesia and Analgesia. 2003; 96(2):400-6 Goldman LJ. Anesthetic uptake of sevoflurane and nitrous oxide during an inhaled induction in children. Anesthesia and Analgesia. 2003; 96(2):400-6 |
Active substance: NITROUS OXIDE |
Study summary document link (including results): |
View full study record |
Document reference: 32666 |
Study title: PA Averley, NM Girdler, S Bond, N Steen, J Steele. A randomised controlled trial of paediatric conscious sedation for dental treatment using intravenous midazolam combined with inhaled nitrous oxide or nitrous oxide⁄sevoflurane. Anaesthesia, 2004, 59, pages 844–852 PA Averley, NM Girdler, S Bond, N Steen, J Steele. A randomised controlled trial of paediatric conscious sedation for dental treatment using intravenous midazolam combined with inhaled nitrous oxide or nitrous oxide⁄sevoflurane. Anaesthesia, 2004, 59, pages 844–852 |
Active substance: NITROUS OXIDE |
Study summary document link (including results): |
View full study record |
Document reference: 32669 |
Study title: Minimal inhibittory concentrations of telithromycin (Ketek) against Streptococcus pneumoniae, Heamophilus influenzae and Moraxella catarrhalis strains isolated from specimen of young patients (17 years old or less) and from specimen of adults (18 years old and older) |
Active substance: telithromycin |
Study summary document link (including results): |
View full study record |
Document reference: 41557 |
Study title: Open Study to determine the concentration of telithromycin in middle ear fluid and plasma in infants/children with otitis media with effusion after multiple oral administration of 20mg/kg, once daily for 5 days or 15mg/kg twice daily for 4.5/5 days of telithromycin pediatric suspension |
Active substance: telithromycin |
Study summary document link (including results): |
View full study record |
Document reference: 41568 |
Study title: Open Study to determine the concentration of telithromycin in the extracellular and intracellular compartments of middle ear fluid in children with acute otitis media or otitis media with spontaneous effusion after single oral administration of a telithromycin pediatric suspension |
Active substance: telithromycin |
Study summary document link (including results): |
View full study record |
Document reference: 41567 |
Study title: The effect of Bricanyl Turbuhaler and Bricanyl chlorofluorocarbon (CFC) inhaler on exercise-induced asthma in children. |
Active substance: TERBUTALINE |
Study summary document link (including results): Terbutaline Bricanyl 01-2178 interventional.xls |
View full study record |
Document reference: 44414 |
Study title: Evaluation of the role of acidic and non-acidic reflux in recurrent respiratory and chronic ear, nose,and throat (ENT) diseases in children by using multichannel intraluminal impedance (MII) apparatus |
Active substance: OMEPRAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 32778 |
Study title: Omeprazole in children with reflux esophagitis-an open dose finding study and an evaluation of the safety and efficacy during maintenance treatment. Interim report 1996 |
Active substance: OMEPRAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 32794 |
Study title: PK/PD study on omeprazole in children with gastro-esophageal reflux |
Active substance: OMEPRAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 32771 |
Study title: Use of magnesium omeprazole (MOPRAL) for treating pathological gastroesophagael reflux in children (Mexico) |
Active substance: OMEPRAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 32775 |
Study title: Arguelles-Martin F. Sucralfate versus cimetidine in the treatment of reflux oesophagitis in children. Am J Med 1989; 86 (suppl 6A): 73-76. Arguelles-Martin F. Sucralfate versus cimetidine in the treatment of reflux oesophagitis in children. Am J Med 1989; 86 (suppl 6A): 73-76. |
Active substance: SUCRALFATE |
Study summary document link (including results): |
View full study record |
Document reference: 42602 |
Study title: Hermans . Primary duodenogastric reflux in children and adolescents. Eur J Pediatr 2003; 162: 598-602. Hermans . Primary duodenogastric reflux in children and adolescents. Eur J Pediatr 2003; 162: 598-602. |
Active substance: SUCRALFATE |
Study summary document link (including results): |
View full study record |
Document reference: 42604 |
Study title: Bacopoulou, 2009;Netilmicin in the neonate: pharmacokinetic analysis and influence of parenteral nutrition Pharm World Sci (2009) 31:365–368 DOI 10.1007/s11096-009-9278-z |
Active substance: NETILMICIN |
Study summary document link (including results): |
View full study record |
Document reference: 32622 |
Study title: 12.) Influence of Wobenzym treat- ment in children with increased sickness rate |
Active substance: Pancreatin Papain (HERB) Rutosid • 3 H2O Bromelain (HERB) Trypsin Chymotrypsin Amylase Lipase |
Study summary document link (including results): |
View full study record |
Document reference: 40104 |
Study title: Publication in CES0506 - Lavin B - 30/06/2006 Comparative efficacy, safety, and effect on quality of life of triamcinolone acetonide and fluticasone propionate aqueous nasal sprays in patients with fall seeasonal allergic rhinitis - Gross - 2002 (Annals of allergy asthma & immunology 89; 1: 56-62, 2002) |
Active substance: TRIAMCINOLONE |
Study summary document link (including results): |
View full study record |
Document reference: 46833 |
Study title: Publication in Rapport d'Expert sur la documentation pharmaco-toxicologique - Roquet F - 15/08/1995 A thirty day comparison of the oral toxicity of CL 30,980 : 1,4-Pregnadiene-3,20-dione, 9a-fluoro-11b-hydroxy-16a,17a-(isopropylidenedioxy)-21-(tetrahydropyran-2-yloxy)- and CL 22,353 : 1,4-Pregnadiene-3,20-dione, 9a-fluoro-11b,21-dihydroxy-16a,17a-(isopropylidenedioxy)- in rats - Kanegis LA - 26/09/1960 (Safety Evaluation.studies. PR Volume 6, 2694-2726) |
Active substance: TRIAMCINOLONE |
Study summary document link (including results): |
View full study record |
Document reference: 46838 |
Study title: Comparison of IM pethidine, diazepam and flunitrazepam as premedicants in children undergoing otolaryngological surgery - L Lindgren Br J. - 1979 (Anaesth 1979, 51 321-327) - Publication in expert report DOL01VOL2 - |
Active substance: PETHIDINE |
Study summary document link (including results): |
View full study record |
Document reference: 45868 |
Study title: The effect of oxyphenonium bromide and oxybutynin hydrochloride on detrusor contractility and reflux in children with vesicoureteral reflux and detrusor instability. - Scholtmeijer RJ, Van Mastrigt R - J Urol - 1991; 146(2):660-662 The effect of oxyphenonium bromide and oxybutynin hydrochloride on detrusor contractility and reflux in children with vesicoureteral reflux and detrusor instability. - Scholtmeijer RJ, Van Mastrigt R - J Urol - 1991; 146(2):660-662 |
Active substance: OXYBUTYNIN |
Study summary document link (including results): |
View full study record |
Document reference: 32998 |
Study title: "The influence of a whole-bone preparation on the growth of dystrophic children", Gotti D. & Nicolaj P., La clinica Pediatrica, 1951, N°5, 33 "The influence of a whole-bone preparation on the growth of dystrophic children", Gotti D. & Nicolaj P., La clinica Pediatrica, 1951, N°5, 33 |
Active substance: OSSEIN HYDROXYAPATITE COMPOUND |
Study summary document link (including results): Ossopan nr7.xls |
View full study record |
Document reference: 47720 |
Study title: The effect of oxyphenonium bromide and oxybutynin hydrochloride on detrusor contractility and reflux in children with vesicoureteral reflux and detrusor instability. - Scholtmeijer RJ, Van Mastrigt R - J Urol - 1991; 146(2):660-662The effect of oxyphenonium bromide and oxybutynin hydrochloride on detrusor contractility and reflux in children with vesicoureteral reflux and detrusor instability. - Scholtmeijer RJ, Van Mastrigt R - J Urol - 1991; 146(2):660-662 |
Active substance: OXITRIPTAN |
Study summary document link (including results): |
View full study record |
Document reference: 32926 |
Study title: Influence of therapy by Woben-zym on immune and metabolic parametrs at children with chronic hepatitis B |
Active substance: Pancreatin Papain (HERB) Rutosid • 3 H2O Bromelain (HERB) Trypsin Chymotrypsin Amylase Lipase |
Study summary document link (including results): |
View full study record |
Document reference: 40112 |
Study title: The Uninhibited Bladder in Children : Effect of Treatment on Recurrence of Urinary Infection and on Vesicoureteral Reflux Resolution - Koff A S and Murtagh D S. - J of Urology - 1983 ; (130: 1138-1141) - Publication in UK registration file - The Uninhibited Bladder in Children : Effect of Treatment on Recurrence of Urinary Infection and on Vesicoureteral Reflux Resolution - Koff A S and Murtagh D S. - J of Urology - 1983 ; (130: 1138-1141) - Publication in UK registration file - |
Active substance: OXITRIPTAN |
Study summary document link (including results): |
View full study record |
Document reference: 32918 |
Study title: Final Study report: Influence of intravenous, Intramuscular and oral administration of Konakion MM Paediatric on Bilirubin Binding to albumin in Full-Term Neonates (BK15055) |
Active substance: PHYTOMENADION |
Study summary document link (including results): |
View full study record |
Document reference: 34048 |
Study title: Publication in CES - Ruuth E - 19/10/2001 Triamcinolone acetonide aqueous nasal inhaler and fluticasone propionate have no effect on short-term growth in children with allergic rhinitis - Skoner D - 2000 ( Allergy 2000; 55(Suppl 63): 184) |
Active substance: TRIAMCINOLONE |
Study summary document link (including results): |
View full study record |
Document reference: 46832 |
Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF IV AND/OR PO O.S. FLUCONAZOLE IN THE TREATMENT OF PEDIATRIC PATIENTS WITH SYSTEMIC CANDIDIASIS. THIS IS A COMPASSIONATE TREATMENT. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27374 |
Study title: Eur Heart J. 1990 Oct;11(10):916-24. Influence of age and sex on left ventricular volumes and ejection fraction during upright exercise in normal subjects. Younis LT, Melin JA, Robert AR, Detry JM. Eur Heart J. 1990 Oct;11(10):916-24. Influence of age and sex on left ventricular volumes and ejection fraction during upright exercise in normal subjects. Younis LT, Melin JA, Robert AR, Detry JM. |
Active substance: THALLIUM 201T1 CHLORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 44564 |
Study title: MULTICENTRIC NON-COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF FCA FOR THE TREATMENT OF SEVERE SYSTEMIC CANDIDIASIS AND CRYPTOCOCCAL MENINGITIS |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 28035 |
Study title: A PROSPECTIVE RANDOMIZED TRIAL OF FCA VS. AMPHOTERICIN B FOR EMPERIC ANTI-FUNGAL THERAPY OF THE NEUTROPENIC FEBRILE PATIENTS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27986 |
Study title: Tramadol iv vs nalbuphine iv, 47 children aged 1 to 10 years old. IIS on tramadol in children undergoing endoscopic surgery for reflux oesophagitis. One-year double-blind comparison of post-op tramadol (bolus of 2 mg/kg BW + infusion of 8 mg/kg BW over 24 h) vs nalbuphine. |
Active substance: TRAMADOL |
Study summary document link (including results): |
View full study record |
Document reference: 45011 |
Study title: Influence of Beta Adrenergic Antagonists on Tear Secretion |
Active substance: TIMOLOL |
Study summary document link (including results): Influence of Beta Adrenergic Antagonists on Tear Secretion i.pdf |
View full study record |
Document reference: 47680 |
Study title: Influences of tramadol on emergence characteristics from sevoflurane anaesthesia in pediatric ambulatory surgery - Fan KT, Lee TH, Yu KL, Tang CS, Lu DV, Chen PY, Soo LY - 2000 (Kaohsiung J Med Sci, 2000; 16: 255-260)Influences of tramadol on emergence characteristics from sevoflurane anaesthesia in pediatric ambulatory surgery - Fan KT, Lee TH, Yu KL, Tang CS, Lu DV, Chen PY, Soo LY - 2000 (Kaohsiung J Med Sci, 2000; 16: 255-260) |
Active substance: TRAMADOL |
Study summary document link (including results): |
View full study record |
Document reference: 45029 |
Study title: CLINICAL EVALUATION OF DIFLUCAN ON SEVERE CANDIDEMIA |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27536 |
Study title: Levocabastine eye drops and nasal spray in seasonal allergic rhino conjunctivitis: a single-blind comparison with antazolineaphazoline eye drops and flunisolide nasal spray (17-54 yrs) |
Active substance: LEVOCABASTINE |
Study summary document link (including results): LMD43871_Interventional_Levocabastine.xls |
View full study record |
Document reference: 31094 |
Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS IN HOSPITALIZED PATIENTS IN ICU. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27877 |
Study title: Wirkung und Verträglichkeit von Tussamag Hustensaft bei Kindern mit akuter Bronchitis |
Active substance: Thymi Extractum Fluidum |
Study summary document link (including results): |
View full study record |
Document reference: 40257 |
Study title: Sysoeva N.A: Dynamics of selected homeostatic parameters in children suffering from thyroid gland pathology under the influence of combined treatment. Therapeutic Medico-Biological Vestnik, 2006, 9(2) [IIT-publication]; |
Active substance: Thyreoidea compositum |
Study summary document link (including results): |
View full study record |
Document reference: 40258 |
Study title: Anticancer Res. 2003 Jul-Aug;23(4):3513-6. Differentiating recurrent or residual nasopharyngeal carcinomas from post-radiotherapy changes with 18-fluoro-2-deoxyglucose positron emission tomography and thallium-201 single photon emission computed tomograpAnticancer Res. 2003 Jul-Aug;23(4):3513-6. Differentiating recurrent or residual nasopharyngeal carcinomas from post-radiotherapy changes with 18-fluoro-2-deoxyglucose positron emission tomography and thallium-201 single photon emission computed tomograp |
Active substance: THALLIUM 201T1 CHLORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 44518 |
Study title: Eosinophil cationic protein (ECP) and tryptase in the nasal lavage fluid (NLF) of children with grass pollen rhinitis: levocabastine effect. Allergy and Asthma Proceedings 19(2), p.75-80, 1998Eosinophil cationic protein (ECP) and tryptase in the nasal lavage fluid (NLF) of children with grass pollen rhinitis: levocabastine effect. Allergy and Asthma Proceedings 19(2), p.75-80, 1998 |
Active substance: LEVOCABASTINE |
Study summary document link (including results): |
View full study record |
Document reference: 31120 |
Study title: Epidemiologische Begleituntersuchungen yur Gruppenprophylaxe 2000 - Gutachten (Prof. Dr. K. Pieper, im Auftrag der Deutschen Arbeitsgemeinschaft fuer Jugendzahnpflege, 2001 ISBN 3/926 228 16-4) |
Active substance: COLECALCIFEROL AND SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24625 |
Study title: EFFICACY AND SAFETY OF FLUCONAZOLE IN PATIENTS WITH OROPHARINGEAL CANDIDIASIS WITHOUT AIDS |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27404 |
Study title: The influence of mucolytic treatment on patency of airways. |
Active substance: MESNA |
Study summary document link (including results): DE80H064P - Mesna.pdf |
View full study record |
Document reference: 31681 |
Study title: Study of Vogalene drops in gastro-oesophageal reflux in nursing infants clinical, radiological, endoscopic and histological assessment - Ghisolfi J., Olives J.P., Rives J.J. - 09/1979 |
Active substance: METOPIMAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 31962 |
Study title: Mecillinam in cerebrospinal fluid in childrenMecillinam in cerebrospinal fluid in children |
Active substance: PIVAMPICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 46057 |
Study title: Comparative drug trials on the efficacy of Mebendazole and Flubendazole in the treatrment of Trichuris trichiura and Ascaris lumbricoides infections In children. |
Active substance: MEBENDAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 31532 |
Study title: Dose Range Study of Flubendazole in Children vith Ascaris lumbricoides and/ or Trichuris trichiura infections.1979 |
Active substance: MEBENDAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 31533 |
Study title: Dose-range study of Flubendazole in the treatment of hookworm disease and trichuriasis. 1980 |
Active substance: MEBENDAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 31540 |
Study title: Single-blind comparison of flubendazole, mebendazole and placebo in the treatment of trichiuriasis ascariasis and hookworm disease. 1981 |
Active substance: MEBENDAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 31531 |
Study title: A randomized, double-blind, placebo-controlled trial to measure the antibody response to immunisation with diphtheria-tetanus-pertussis-inactivated poliovirus-haemophilus influenzae b and hepatitis B vaccines using |
Active substance: LIDOCAINE AND PRILOCAINE |
Study summary document link (including results): 14_DC-EMB-0002 CSR Synopsis.pdf |
View full study record |
Document reference: 47244 |
Study title: Etude de l'activite therapeutique du mucofluid enquete clinique multi-centre |
Active substance: MESNA |
Study summary document link (including results): CF77F224 - Mesna.pdf |
View full study record |
Document reference: 31651 |
Study title: Etude in vivo de l’activite mucolytique du mesna (mucofluid spray nasal a 2,5 %) + analyse statistique. |
Active substance: MESNA |
Study summary document link (including results): CE69L071 - Mesna.pdf |
View full study record |
Document reference: 31656 |
Study title: Pharmacokinetics and Middle Ear Fluid Penetration of Levofloxacin in Children Undergoing Tympanostomy Tube Placement for Serious Otitis Media |
Active substance: Levofloxacin |
Study summary document link (including results): LOFBO-PHI-I09.pdf |
View full study record |
Document reference: 45234 |
Study title: Influence of mistabron on the viscoelasticity of tracheo- bronchial secretions in children with cystic fibrosis |
Active substance: MESNA |
Study summary document link (including results): |
View full study record |
Document reference: 31665 |
Study title: An exploratory unblinded trail of Levovist (SH U 508A) used in B-mode sonography in comparison with radiologically monitored voiding cystourethrography in diagnosis of vesicoureterorenal reflux in children (with subsequent blinded reading of the results) |
Active substance: MICROPARTICLES OF GALACTOSE |
Study summary document link (including results): |
View full study record |
Document reference: 31999 |
Study title: de Gast-Bakker, D.A., et al., Age is of influence on midazolam requirements in a paediatric intensive care unit. Acta Paediatr, 2007. 96(3): p. 414-7. 2.de Gast-Bakker, D.A., et al., Age is of influence on midazolam requirements in a paediatric intensive care unit. Acta Paediatr, 2007. 96(3): p. 414-7. 2. |
Active substance: MIDAZOLAM |
Study summary document link (including results): |
View full study record |
Document reference: 32001 |
Study title: Electrophysiological effects of fenfluramine or combined vitamin B6 and magnesium on children with autistic behaviour - J. Martineau et al. - 1989 (Developmental Medicine and Child Neurology vol 31) - Publication in MAGNE-B6 Magnesium - pyridoxine Tablet & Oral Solution -Response to questions raised during the renewal process in Estonia -Raphaëlle Pivaty- 04/2004 -Electrophysiological effects of fenfluramine or combined vitamin B6 and magnesium on children with autistic behaviour - J. Martineau et al. - 1989 (Developmental Medicine and Child Neurology vol 31) - Publication in MAGNE-B6 Magnesium - pyridoxine Tablet & Oral Solution -Response to questions raised during the renewal process in Estonia -Raphaëlle Pivaty- 04/2004 - |
Active substance: MAGNESIUM LACTATE + MAGNESIUM PIDOLATE + PYRIDOXINE (VIT B6) |
Study summary document link (including results): |
View full study record |
Document reference: 31485 |
Study title: Studio comparativo tra miocamicina ed eritromicina nell'erradicazione di streptococco B-emolitico di Gruppo a ed influenza di miocamicina sulla fagocitosi dei polimorfonucleati verso streptococco autologo - M. Borzani, F. Varotto, L.Garlaschi, et al. - Riv. Inf. Ped. 1989, 1, 29-35 |
Active substance: MIDECAMYCIN |
Study summary document link (including results): |
View full study record |
Document reference: 32014 |
Study title: Estudio del vogalen gotas en los reflujos gastroesofagios del lactante confrontacion clinica-radiologica-endoscopia e histologica - Ghisolfi J., Olives J.P., Rives J.J. - 09/1979 |
Active substance: METOPIMAZINE |
Study summary document link (including results): |
View full study record |
Document reference: 31960 |
Study title: The influence of a synthetic antihistamine upon the bodyweight and height in children |
Active substance: Buclizine |
Study summary document link (including results): CE70A063-translation.pdf |
View full study record |
Document reference: 42014 |
Study title: A double blind, cross-over, randomized study with 2 periods of 2 weeks with 2weeks washout. To investigate the mechanisms for the clinical effects of budesonide on LAR, by measuring inflammatory cells and markers in bronchoalveolar lavage (BAL) fluid. Mean age (range): 24.5 years (17 - 30 years) |
Active substance: BUDESONIDE |
Study summary document link (including results): |
View full study record |
Document reference: 48404 |
Study title: Immunogenicity and safety study of two doses of Fluvirin (0.25 mL and 0.5 mL) with Vaxigrip (0.25 mL), in Healthy naive pediatric subjects aged 6 to 35 months. |
Active substance: INFLUENZA VACCINE |
Study summary document link (including results): |
View full study record |
Document reference: 48403 |
Study title: Mecillinam in cerebrospinal fluid in children; Garborg O. 1981, Clinical Pharmacokinetics, 6:475-479 Mecillinam in cerebrospinal fluid in children; Garborg O. 1981, Clinical Pharmacokinetics, 6:475-479 |
Active substance: PIVMECILLINAM |
Study summary document link (including results): |
View full study record |
Document reference: 34534 |
Study title: A phase II, controlled, single-center study to assess safety and immunogenicity of a primary vaccination course with one dose of Haemophilus influenzae type b (Hib) conjugate vaccine containing Aluminum Phosphate (Hib/AlPO4 vaccine), given alone or concomitantly with Measles, Mumps and Rubella Vaccine (MMR, Morupar®, licensed by Chiron, now Novartis Vaccines and Diagnostics), in healthy children 12-15 months of age. |
Active substance: Influenza Vaccine (Split Virion, Inactivated) |
Study summary document link (including results): |
View full study record |
Document reference: 48391 |
Study title: A Phase II, observer-blind, randomized, multicenter, controlled study of 3 Haemophilus influenzae type b (Hib) vaccines in infants. |
Active substance: Influenza Vaccine (Split Virion, Inactivated) |
Study summary document link (including results): |
View full study record |
Document reference: 48389 |
Study title: An extension, phase III, open-label, multicenter study in healthy toddlers, of two Haemophilus influenzae type b (Hib) vaccines administered as a booster dose. |
Active substance: Influenza Vaccine (Split Virion, Inactivated) |
Study summary document link (including results): |
View full study record |
Document reference: 48392 |
Study title: an observer blind, randomized, parallel groups, single-center, exploratory Phase IV study to evaluate immunogenicity of two intramuscular doses of influenza vaccine in pediatric subjects. |
Active substance: Influenza Vaccine (Split Virion, Inactivated) |
Study summary document link (including results): |
View full study record |
Document reference: 48387 |
Study title: An open label, single-center, pilot study to assess the safety, tolerability and immunogenicity of three injections of the HibCRM/AlPO4 vaccine, when given at 2, 3, 4 months of age to healthy infants. |
Active substance: Influenza Vaccine (Split Virion, Inactivated) |
Study summary document link (including results): |
View full study record |
Document reference: 48390 |
Study title: Clinical Testing of Influsplit SSW®93 |
Active substance: Influenza Vaccine (Split Virion, Inactivated) |
Study summary document link (including results): Influsplit-1993_ synopsis.pdf |
View full study record |
Document reference: 48377 |
Study title: Improved Acidosis Correction and Recovery of Mesothelial Cell Mass with Neutral-pH Bicarbonate Dialysis Solution among Children Undergoing Automated Peritoneal Dialysis, 2003 Effects of pH-neutral, bicarbonate-buffered dialysis fluid on peritoneal transport kinetics in children, 2002 Reduced Advanced Glycation Endproduct (AGE) Levels in Children on Automated Peritoneal Dialysis (PD) with PD-Fluids Containing Less Glucose Degradation Products (GDPs), 2003 |
Active substance: ISOTONIC SOLUTIONS |
Study summary document link (including results): |
View full study record |
Document reference: 30757 |
Study title: Randomised trial of pivampicillin plus pivmecillinam vs pivampicillin in children and young adults with chronic obstructive pulmonary disease and infection with Haemophilus influenzae; Johansen HK et al 1999 Curr Med Res Opin, 15: 300-309 Randomised trial of pivampicillin plus pivmecillinam vs pivampicillin in children and young adults with chronic obstructive pulmonary disease and infection with Haemophilus influenzae; Johansen HK et al 1999 Curr Med Res Opin, 15: 300-309 |
Active substance: PIVMECILLINAM |
Study summary document link (including results): |
View full study record |
Document reference: 34539 |
Study title: Clinical evaluation of perphenazine, triflupromazine, and hydroxyzine for postoperative sedation in children |
Active substance: HYDROXYZINE |
Study summary document link (including results): ADPE92B0408.pdf |
View full study record |
Document reference: 29255 |
Study title: Fluoxetine Versus Placebo in the Treatment of Children and Adolescents with Obsessive-Compulsive Disorder |
Active substance: FLUOXETINE |
Study summary document link (including results): fluoxetine B1Y-MC-HCJW Clinical Study Summary.pdf |
View full study record |
Document reference: 47359 |
Study title: Feltman R, Kosel G: Prenatal and postnatal ingestion of fluorides – forteen years of investigation - final report. J Dent Med 1961; 16: 190-1999 |
Active substance: COLECALCIFEROL AND SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 24630 |
Study title: Conclusions regarding the influence of Piracetam upon the cognitive learning symptoms of children with learning disabilities. |
Active substance: PIRACETAM |
Study summary document link (including results): DE75G011 - Piracetam.pdf |
View full study record |
Document reference: 47899 |
Study title: A Stratified, Randomized, Double-Blind, Parallel-Group Trial Assessing the Efficacy and Safety of Fluticasone Propionate via the Multi-Dose Powder Inhaler 50mcg BID, 100mcg QD, and Placebo in Subjects Aged 4 to 11 Years With Chronic Asthma. |
Active substance: FLUTICASONE |
Study summary document link (including results): Fluticasone-Propionate-FLTA2007-ICHE3.pdf |
View full study record |
Document reference: 28376 |
Study title: DTPa-HBV-IPV-103 |
Active substance: diphtheria, tetanus, acellular pertussis, hepatitis b recombinant (adsorbed), inactivated poliovirus, adsorbed conjugated haemophilus influenzae type b vaccine |
Study summary document link (including results): |
View full study record |
Document reference: 41516 |
Study title: One-year follow-up of young children hospitalized for wheezing: the influence of early anti-inflammatory therapy and risk factors for subsequent wheezing and asthma. |
Active substance: BUDESONIDE |
Study summary document link (including results): |
View full study record |
Document reference: 48438 |
Study title: AN OPEN COMPARATIVE STUDY TO COMPARE THE EFFICACY, TOLERATION AND SAFETY OF IV AND ORAL FLUCONAZOLE WITH ORAL KETOCONAZOLE IN THE PROPHYLAXIS OF FUNGAL COLONIZATION AND INFECTION IN PATIENTS WITH ALLOGENEIC BONE MARROW TRANSPLANT. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27361 |
Study title: COMPASSIONATE USE PROTOCOL FOR THE TREATMENT OF A THREE-YEAR OLD CHILD WITH SCEDOSPORIUM INFECTION |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27341 |
Study title: TO COMPARE THE EFFICACY OF FLUCONAZOLE VS. ORAL KETOCONAZOLE IN THE PREVENTION OF FUNGAL INFECTION IN PATIENTS RECEIVING CHEMOTHERAPY FOR HEMATOLOGICAL DISEASE. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 28028 |
Study title: AN OPEN NONCOMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE PREVENTION OF SYSTEMIC FUNGAL INFECTIONS IN PATIENTS RECEIVING CHEMOTHERAPY FOR HAEMOTOLOGICAL DISEASE |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27847 |
Study title: EFFICACY, SAFETY AND PRACTICABILITY OF FLUCONAZOLE VS. LOCAL CLOTRIMAZOLE THERAPY IN PATIENTS WITH VAGINAL CANDIDIASIS. |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27788 |
Study title: Hiddemann W et al. Antifungal treatment by amphotericin B and 5-fluorocytosine delays the recovery of normal hematopoietic cells after intensive cytostatic therapy for acute myeloid leukemia. Cancer. 1991 Jul 1;68(1):9-14 |
Active substance: FLUCOCYTOSIN |
Study summary document link (including results): |
View full study record |
Document reference: 27303 |
Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSES ASSOCIATED WITH DIGESTIVE MALIGNANCY |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 27925 |
Study title: OPEN, NON-COMPARATIVE STUDY OF FLUCONAZOLE IN PATIENTS WITH COCCIDIOIDAL MENINGITIS |
Active substance: FLUCONAZOLE |
Study summary document link (including results): |
View full study record |
Document reference: 28052 |
Study title: Legeler HJ. Bericht über die klinische Prüfung von 9alpha-Fluorhydrocortison zur Behandlung hypotoner und orthostatischer Kreislaufregulationsstörungen Arzneim Forsch (Drug Research) 1971; 21: 1144-1149 |
Active substance: FLUDOCORTISONE |
Study summary document link (including results): |
View full study record |
Document reference: 28210 |
Study title: |
Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
Study summary document link (including results): |
View full study record |
Document reference: 41160 |
Study title: Eur J Nucl Med Mol Imaging. 2005 Jun;32(6):674-81. Epub 2005 Mar 4. The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Walter MA, Melzer RA, Schindler C, Müller-Brand J, Tyndall A, Nitzsche EU. |
Active substance: FLUDEOXYGLUCOSE |
Study summary document link (including results): |
View full study record |
Document reference: 28108 |
Study title: Randomised trial of pivampicillin plus pivmecillinam vs pivampicillin in children and young adults with chronic obstructive pulmonary disease and infection with Haemophilus influenzaeRandomised trial of pivampicillin plus pivmecillinam vs pivampicillin in children and young adults with chronic obstructive pulmonary disease and infection with Haemophilus influenzae |
Active substance: PIVAMPICILLIN |
Study summary document link (including results): |
View full study record |
Document reference: 46067 |
Study title: Sandler MS, Heyman S, Watts H. Localization of 99mTc methylene diphosphonate within synovial fluid in osteosarcoma. AJR Am J Roentgenol. 1984 Aug;143(2):349-50. No abstract available. Sandler MS, Heyman S, Watts H. Localization of 99mTc methylene diphosphonate within synovial fluid in osteosarcoma. AJR Am J Roentgenol. 1984 Aug;143(2):349-50. No abstract available. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43990 |
Study title: Vander Borght T, Laloux P, Maes A, Salmon E, Goethals I, Goldman S; Belgian Society for Nuclear Medicine.. Guidelines for brain radionuclide imaging. Perfusion single photon computed tomography (SPECT) using Tc-99m radiopharmaceuticals and brain metabolism positron emission tomography (PET) using F-18 fluorodeoxyglucose. The Belgian Society for Nuclear Medicine. [vander-borght-2001]Acta Neurol Belg. 2001 Dec;101(4):196-209. Vander Borght T 2001 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48708 |
Study title: Statistical report of a controlled clinical study regarding the influence of piracetam upon the symptoms presented by children with learning disabilities. |
Active substance: PIRACETAM |
Study summary document link (including results): CE75F171 - Piracetam.pdf |
View full study record |
Document reference: 45903 |
Study title: Simons KS, Pickkers P, Bleeker-Rovers CP, Oyen WJ, van der Hoeven JG.. Epub 2009 Oct 22. F-18-fluorodeoxyglucose positron emission tomography combined with CT in critically ill patients with suspected infection. [simons-2010]Intensive Care Med. 2010 Mar;36(3):504-11. Simons KS 2010 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48699 |
Study title: Stauss J, Franzius C, Pfluger T, Juergens KU, Biassoni L, Begent J, et al..Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncology. [stauss-2008]Eur J Nucl Med Mol Imaging 2008; 35:1581–1588. Stauss J 2008 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48701 |
Study title: Stumpe KD, Urbinelli M, Steinert HC, Glanzmann C, Buck A, von Schulthess GK. Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography. [stumpe-1998]Eur J Nucl Med. 1998 Jul;25(7):721-8. Stumpe KD 1998 |
Active substance: Steripet |
Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
View full study record |
Document reference: 48702 |
Study title: Pulce-C, Mollon-P, Pham-E, Frantz-P, Descotes-J. Service de Pharmaco-Toxicovigilance, Hospital E. Herriot, Lyon, France. Acute poisonings with ethyle loflazepate, flunitrazepam, prazepam and triazolam in children. Veterinary and human toxicology, {Vet-Hum-Toxicol}, Apr 1992, vol. 34, no. 2, p. 141-3, ISSN: 0145-6296.Pulce-C, Mollon-P, Pham-E, Frantz-P, Descotes-J. Service de Pharmaco-Toxicovigilance, Hospital E. Herriot, Lyon, France. Acute poisonings with ethyle loflazepate, flunitrazepam, prazepam and triazolam in children. Veterinary and human toxicology, {Vet-Hum-Toxicol}, Apr 1992, vol. 34, no. 2, p. 141-3, ISSN: 0145-6296. |
Active substance: PRAZEPAM |
Study summary document link (including results): |
View full study record |
Document reference: 34637 |
Study title: Safe and effective use piritramide following sevoflurane anesthesia in children. Anesthesiology 91 (3A), p.A1280. 1999 Safe and effective use piritramide following sevoflurane anesthesia in children. Anesthesiology 91 (3A), p.A1280. 1999 |
Active substance: PIRITRAMIDE |
Study summary document link (including results): |
View full study record |
Document reference: 34303 |
Study title: Influence of Bile Acids on Postnatal Development im Preterm Infants during the first weeks of life; A controlled study with Ursodeoxycholic acid. |
Active substance: URSODEOXYCOLIC ACID |
Study summary document link (including results): EUdraCT_reduced_datafields_paediatric data_Ursodeoxycholic acid_Ursofalk suspenion_Dr Falk Pharma GmbH.xls |
View full study record |
Document reference: 39160 |
Study title: Hennon DK, Stookey GK, Beiswanger BB. Fluoride-vitamin supplements: effects on dental caries and fluorosis when used in areas with suboptimal fluoride in the water supply. JADA 1977; 95: 965-971Hennon DK, Stookey GK, Beiswanger BB. Fluoride-vitamin supplements: effects on dental caries and fluorosis when used in areas with suboptimal fluoride in the water supply. JADA 1977; 95: 965-971 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42263 |
Study title: Hennon DK, Stookey GK, Beiswanger BB. Fluoride-vitamin supplements: effects on dental caries and fluorosis when used in areas with suboptimal fluoride in the water supply. JADA 1977; 95: 965-971Hennon DK, Stookey GK, Beiswanger BB. Fluoride-vitamin supplements: effects on dental caries and fluorosis when used in areas with suboptimal fluoride in the water supply. JADA 1977; 95: 965-971 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42295 |
Study title: Hennon DK, Stookey GK, Beiswanger BB. Fluoride-vitamin supplements: effects on dental caries and fluorosis when used in areas with suboptimal fluoride in the water supply. JADA 1977; 95: 965-971Hennon DK, Stookey GK, Beiswanger BB. Fluoride-vitamin supplements: effects on dental caries and fluorosis when used in areas with suboptimal fluoride in the water supply. JADA 1977; 95: 965-971 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42327 |
Study title: In vitro fluoride uptake, distribution and retention by human enamel after 1- and 24-hour application of various topical fluoride agents. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42404 |
Study title: In vitro fluoride uptake, distribution and retention by human enamel after 1- and 24-hour application of various topical fluoride agents. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42517 |
Study title: Influence of F--releasing varnishes on the acid resistance of enamel. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42337 |
Study title: "Safety of inactivated split-virion influenza vaccine administered by the intradermal route in healthy children" |
Active substance: Virus de la gripe fraccionados |
Study summary document link (including results): |
View full study record |
Document reference: 45261 |
Study title: "Evaluation of safety and immunogenicity of inactivated flu vaccine in children with underlying disease" |
Active substance: Virus de la gripe fraccionados, inactivados que contienen antígenos equivalentes a las cepas recomendadas por la OMS (hemisferio Norte) y la decisión de la Unión Europea para cada campaña de vacunación [inactivated influenza split virion vaccine (Triton X 100)] |
Study summary document link (including results): |
View full study record |
Document reference: 41459 |
Study title: Evaluation of safety and immunogenicity of inactivated flu vaccine in children with underlying disease |
Active substance: Virus de la gripe fraccionados, inactivados que contienen antígenos equivalentes a las cepas recomendadas por la OMS (hemisferio Norte) y la decisión de la Unión Europea para cada campaña de vacunación [inactivated influenza split virion vaccine (Triton X 100)] |
Study summary document link (including results): |
View full study record |
Document reference: 41460 |
Study title: Fanning EA, Cellier KM, Leadbeater MM, Somerville CM. South Australian kindergarten children: fluoride tablet supplements and dental caries. Aust Dent J 1975: 20: 7-9Fanning EA, Cellier KM, Leadbeater MM, Somerville CM. South Australian kindergarten children: fluoride tablet supplements and dental caries. Aust Dent J 1975: 20: 7-9 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42276 |
Study title: Fanning EA, Cellier KM, Leadbeater MM, Somerville CM. South Australian kindergarten children: fluoride tablet supplements and dental caries. Aust Dent J 1975: 20: 7-9Fanning EA, Cellier KM, Leadbeater MM, Somerville CM. South Australian kindergarten children: fluoride tablet supplements and dental caries. Aust Dent J 1975: 20: 7-9 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42308 |
Study title: Feltman R, Kosel G: Prenatal and postnatal ingestion of fluorides – forteen years of investigation - final report. J Dent Med 1961; 16: 190-1999Feltman R, Kosel G: Prenatal and postnatal ingestion of fluorides – forteen years of investigation - final report. J Dent Med 1961; 16: 190-1999 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42245 |
Study title: Feltman R, Kosel G: Prenatal and postnatal ingestion of fluorides – forteen years of investigation - final report. J Dent Med 1961; 16: 190-1999Feltman R, Kosel G: Prenatal and postnatal ingestion of fluorides – forteen years of investigation - final report. J Dent Med 1961; 16: 190-1999 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42277 |
Study title: Feltman R, Kosel G: Prenatal and postnatal ingestion of fluorides – forteen years of investigation - final report. J Dent Med 1961; 16: 190-1999Feltman R, Kosel G: Prenatal and postnatal ingestion of fluorides – forteen years of investigation - final report. J Dent Med 1961; 16: 190-1999 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42309 |
Study title: Fissure sealants versus fluorine varnish on the first permanent molars: economic assessment |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42348 |
Study title: Fissure sealants versus fluorine varnish on the first permanent molars: economic assessment |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42461 |
Study title: Fissure sealing of permanent first molars in children receiving a high standard of prophylactic care. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42400 |
Study title: Fissure sealing of permanent first molars in children receiving a high standard of prophylactic care. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42513 |
Study title: Fluoride clearance of whole saliva in young school children after topical application. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42397 |
Study title: Fluoride clearance of whole saliva in young school children after topical application. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42510 |
Study title: Fluoride concentration in plaque in adolescents after topical application of different fluoride varnishes. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42537 |
Study title: Fluoride concentration in whole saliva and separate gland secretions after topical treatment with three different fluoride varnishes |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42434 |
Study title: Fluoride concentration in whole saliva and separate gland secretions after topical treatment with three different fluoride varnishes |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42547 |
Study title: Fluoride content of enamel during treatment and 2 years after discontinuation of treatment with fluoride varnishes. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42415 |
Study title: Fluoride content of enamel during treatment and 2 years after discontinuation of treatment with fluoride varnishes. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42528 |
Study title: Fluoride deposited topical applications in enamel. KOH-soluble and acquired fluoride. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42355 |
Study title: Influence of F--releasing varnishes on the acid resistance of enamel. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42450 |
Study title: Intensive fluoride varnish program in Swedish adolescents: economic assessment of a 7-year follow-up study on proximal caries incidence. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42398 |
Study title: Intensive fluoride varnish program in Swedish adolescents: economic assessment of a 7-year follow-up study on proximal caries incidence. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42511 |
Study title: Kinetics of fluorine in deciduous enamel after application of fluoride-containing varnish (Duraphat). |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42375 |
Study title: Kinetics of fluorine in deciduous enamel after application of fluoride-containing varnish (Duraphat). |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42488 |
Study title: Leverett DH, Adair SM, Vaughan BW et al. Randomized clinical trail of the effect of prenatal fluoride supplements in preventing dental caries. Caries res 1997; 31: 174-179.Leverett DH, Adair SM, Vaughan BW et al. Randomized clinical trail of the effect of prenatal fluoride supplements in preventing dental caries. Caries res 1997; 31: 174-179. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42247 |
Study title: Leverett DH, Adair SM, Vaughan BW et al. Randomized clinical trail of the effect of prenatal fluoride supplements in preventing dental caries. Caries res 1997; 31: 174-179.Leverett DH, Adair SM, Vaughan BW et al. Randomized clinical trail of the effect of prenatal fluoride supplements in preventing dental caries. Caries res 1997; 31: 174-179. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42279 |
Study title: Leverett DH, Adair SM, Vaughan BW et al. Randomized clinical trail of the effect of prenatal fluoride supplements in preventing dental caries. Caries res 1997; 31: 174-179.Leverett DH, Adair SM, Vaughan BW et al. Randomized clinical trail of the effect of prenatal fluoride supplements in preventing dental caries. Caries res 1997; 31: 174-179. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42311 |
Study title: Long-term use of fluoride lacquer in preventive care of school children in area of basic care. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42384 |
Study title: Long-term use of fluoride lacquer in preventive care of school children in area of basic care. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42497 |
Study title: Margolis FJ, Rheames HR, Freshman E et al. Fluoride: ten year prospective study of deciduous teeth and permanent dentition. Am J Dis Child 1975; 129: 794-800.Margolis FJ, Rheames HR, Freshman E et al. Fluoride: ten year prospective study of deciduous teeth and permanent dentition. Am J Dis Child 1975; 129: 794-800. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42248 |
Study title: Margolis FJ, Rheames HR, Freshman E et al. Fluoride: ten year prospective study of deciduous teeth and permanent dentition. Am J Dis Child 1975; 129: 794-800.Margolis FJ, Rheames HR, Freshman E et al. Fluoride: ten year prospective study of deciduous teeth and permanent dentition. Am J Dis Child 1975; 129: 794-800. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42280 |
Study title: Margolis FJ, Rheames HR, Freshman E et al. Fluoride: ten year prospective study of deciduous teeth and permanent dentition. Am J Dis Child 1975; 129: 794-800.Margolis FJ, Rheames HR, Freshman E et al. Fluoride: ten year prospective study of deciduous teeth and permanent dentition. Am J Dis Child 1975; 129: 794-800. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42312 |
Study title: Marthaler TM, König KG. Der Einfluß von Fluoridtablettengaben in der Schule auf den Kariesbefall 6- bis 15-Jähriger Kinder. Schweiz Monatsschr Zahnmed 1967; 77: 539-554Marthaler TM, König KG. Der Einfluß von Fluoridtablettengaben in der Schule auf den Kariesbefall 6- bis 15-Jähriger Kinder. Schweiz Monatsschr Zahnmed 1967; 77: 539-554 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42264 |
Study title: A randomized, open label, comparative multicenter study of voriconazole versus conventional amphotericin B → fluconazole in the treatment of candidemia in non neutropenic subjects |
Active substance: VORICONAZOLE |
Study summary document link (including results): 150-608 PhRMA Web Synopsis.pdf |
View full study record |
Document reference: 48051 |
Study title: Armstrong KL, Fraser DKB, Faoagali JL. Gastrointestinal bleeding with influenza virus. Med J Aust. March 11, 1991, 180-2) Armstrong KL, Fraser DKB, Faoagali JL. Gastrointestinal bleeding with influenza virus. Med J Aust. March 11, 1991, 180-2) |
Active substance: SIMETICONE |
Study summary document link (including results): |
View full study record |
Document reference: 42197 |
Study title: Driscoll WS, Heifetz SB, Korts DC. Effect of chewable fluoride tablets on dental caries in schoolchildren: results after six years of use. J Am Dent Assoc. 1978 Nov;97(5):820-4.Driscoll WS, Heifetz SB, Korts DC. Effect of chewable fluoride tablets on dental caries in schoolchildren: results after six years of use. J Am Dent Assoc. 1978 Nov;97(5):820-4. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42255 |
Study title: Driscoll WS, Heifetz SB, Korts DC. Effect of chewable fluoride tablets on dental caries in schoolchildren: results after six years of use. J Am Dent Assoc. 1978 Nov;97(5):820-4.Driscoll WS, Heifetz SB, Korts DC. Effect of chewable fluoride tablets on dental caries in schoolchildren: results after six years of use. J Am Dent Assoc. 1978 Nov;97(5):820-4. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42287 |
Study title: Driscoll WS, Heifetz SB, Korts DC. Effect of chewable fluoride tablets on dental caries in schoolchildren: results after six years of use. J Am Dent Assoc. 1978 Nov;97(5):820-4.Driscoll WS, Heifetz SB, Korts DC. Effect of chewable fluoride tablets on dental caries in schoolchildren: results after six years of use. J Am Dent Assoc. 1978 Nov;97(5):820-4. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42319 |
Study title: Driscoll WS, Nowjack-Raymer R, Heifetz SB, Li SH, Selwitz RH. Evaluation of the comparative effectiveness of fluoride mouthrinsing, fluoride tablets, and both procedures in combination: interim findings after five years. J Public Health Dent. 1990 Winter;50(1):13-7.Driscoll WS, Nowjack-Raymer R, Heifetz SB, Li SH, Selwitz RH. Evaluation of the comparative effectiveness of fluoride mouthrinsing, fluoride tablets, and both procedures in combination: interim findings after five years. J Public Health Dent. 1990 Winter;50(1):13-7. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42256 |
Study title: Driscoll WS, Nowjack-Raymer R, Heifetz SB, Li SH, Selwitz RH. Evaluation of the comparative effectiveness of fluoride mouthrinsing, fluoride tablets, and both procedures in combination: interim findings after five years. J Public Health Dent. 1990 Winter;50(1):13-7.Driscoll WS, Nowjack-Raymer R, Heifetz SB, Li SH, Selwitz RH. Evaluation of the comparative effectiveness of fluoride mouthrinsing, fluoride tablets, and both procedures in combination: interim findings after five years. J Public Health Dent. 1990 Winter;50(1):13-7. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42288 |
Study title: Driscoll WS, Nowjack-Raymer R, Heifetz SB, Li SH, Selwitz RH. Evaluation of the comparative effectiveness of fluoride mouthrinsing, fluoride tablets, and both procedures in combination: interim findings after five years. J Public Health Dent. 1990 Winter;50(1):13-7.Driscoll WS, Nowjack-Raymer R, Heifetz SB, Li SH, Selwitz RH. Evaluation of the comparative effectiveness of fluoride mouthrinsing, fluoride tablets, and both procedures in combination: interim findings after five years. J Public Health Dent. 1990 Winter;50(1):13-7. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42320 |
Study title: Fluoride deposited topical applications in enamel. KOH-soluble and acquired fluoride. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42468 |
Study title: Fluoride retention in sound and demineralized enamel in vivo after treatment with a fluoride varnish (Duraphat). |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42390 |
Study title: Fluoride retention in sound and demineralized enamel in vivo after treatment with a fluoride varnish (Duraphat). |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42503 |
Study title: Fluoride uptake in plaque-covered enamel after treatment with the fluoride lacquer Duraphat. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42368 |
Study title: Fluoride uptake in plaque-covered enamel after treatment with the fluoride lacquer Duraphat. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42481 |
Study title: Fluoride varnish versus acidulated phosphate fluoride for schoolchildren in Manipal. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42426 |
Study title: Fluoride varnish versus acidulated phosphate fluoride for schoolchildren in Manipal. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42539 |
Study title: Fluoride varnishes (Duraphat): a meta-analysis. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42367 |
Study title: Fluoride varnishes (Duraphat): a meta-analysis. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42480 |
Study title: Fluoride varnishes in caries prevention. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42533 |
Study title: Tsou VM et al. Multicenter, randomized, double-blind study comparing 20 and 40 mg of pantoprazole for symptom relief in adolescents (12 to 16 years of age) with gastroesophageal reflux disease (GERD). Clin Pediatr (Phila). 2006 Oct;45(8):741-9Tsou VM et al. Multicenter, randomized, double-blind study comparing 20 and 40 mg of pantoprazole for symptom relief in adolescents (12 to 16 years of age) with gastroesophageal reflux disease (GERD). Clin Pediatr (Phila). 2006 Oct;45(8):741-9 |
Active substance: SIMETICONE |
Study summary document link (including results): |
View full study record |
Document reference: 42203 |
Study title: Driscoll WS, Nowjack-Raymer R, Selwitz RH, Li SH, Heifetz SB. A comparison of the caries-preventive effects of fluoride mouthrinsing, fluoride tablets, and both procedures combined: final results after eight years. J Public Health Dent. 1992 Winter;52(2):111-6.Driscoll WS, Nowjack-Raymer R, Selwitz RH, Li SH, Heifetz SB. A comparison of the caries-preventive effects of fluoride mouthrinsing, fluoride tablets, and both procedures combined: final results after eight years. J Public Health Dent. 1992 Winter;52(2):111-6. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42257 |
Study title: Driscoll WS, Nowjack-Raymer R, Selwitz RH, Li SH, Heifetz SB. A comparison of the caries-preventive effects of fluoride mouthrinsing, fluoride tablets, and both procedures combined: final results after eight years. J Public Health Dent. 1992 Winter;52(2):111-6.Driscoll WS, Nowjack-Raymer R, Selwitz RH, Li SH, Heifetz SB. A comparison of the caries-preventive effects of fluoride mouthrinsing, fluoride tablets, and both procedures combined: final results after eight years. J Public Health Dent. 1992 Winter;52(2):111-6. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42289 |
Study title: Fluoride varnishes in caries prevention]. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42416 |
Study title: Fluoride varnishes in caries prevention]. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42529 |
Study title: Fluoride varnishes--a review. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42349 |
Study title: Fluoride varnishes--a review. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42462 |
Study title: Fluorine gradients in outermost surface enamel after various forms of topical application of fluorides in vivo. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42395 |
Study title: Fluorine gradients in outermost surface enamel after various forms of topical application of fluorides in vivo. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42508 |
Study title: Friis-Hasché E, Bergamnn J, Wenzel A, Thylstrup A et al. Dental health status and attitudes to dental care in families participating in a Danish fluoride tablet program. Community Dent Oral Epidemiol 1984; 12: 303-307Friis-Hasché E, Bergamnn J, Wenzel A, Thylstrup A et al. Dental health status and attitudes to dental care in families participating in a Danish fluoride tablet program. Community Dent Oral Epidemiol 1984; 12: 303-307 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42246 |
Study title: Friis-Hasché E, Bergamnn J, Wenzel A, Thylstrup A et al. Dental health status and attitudes to dental care in families participating in a Danish fluoride tablet program. Community Dent Oral Epidemiol 1984; 12: 303-307Friis-Hasché E, Bergamnn J, Wenzel A, Thylstrup A et al. Dental health status and attitudes to dental care in families participating in a Danish fluoride tablet program. Community Dent Oral Epidemiol 1984; 12: 303-307 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42278 |
Study title: A 2-week, randomized, double-blind, parallel-group study in pediatric subjects with asthma aged 4 to11 years to examine the pharmacokinetics of fluticasone propionate (FP) and salmeterol (SALM) from the FP/SALM combination product administered twice daily via the Diskus (FP 100mcg/SALM 50mcg) and the FP Diskus (FP 100mcg). Report No. RM2004/00114/00 |
Active substance: SALMETEROL |
Study summary document link (including results): |
View full study record |
Document reference: 35602 |
Study title: A Multicentre, Randomised, Double-blind, Double-dummy, Parallel Group Comparison of Three Treatments: 1) Seretide (50/100 mcg Strength)bd via Diskus/Accuhaler Inhaler, 2) Fluticasone Propionate 200 mcg bd via Diskus Inhaler, 3) Fluticasone Propionate 100mcg bd via Diskus/Accuhaler Inhaler in Children Aged 4-11 Years with Asthma. Report No. BP1999/00102/00 |
Active substance: SALMETEROL |
Study summary document link (including results): |
View full study record |
Document reference: 35594 |
Study title: A pilot single centre, randomised, double-blind crossover study to demonstrate the superiority of Salmeterol/fluticasone propionate combination product 50/100mcg bd versus fluticasone propionate 100mcg bd when treated for two weeks with respect to activity levels in children aged 7 15 years. Report No. GM2003/00237/00; |
Active substance: SALMETEROL |
Study summary document link (including results): |
View full study record |
Document reference: 35591 |
Study title: A Randomized, Double-Blind, 12-Week Trial Evaluating the Safety of the Fluticasone Propionate/Sameterol DISKUS Combination Product 100/50mcg BID Versus Fluticasone Propionate DISKUS 100mcg BID in Sympotmatic Pediatric Subjects (4-11 Years) With Asthma. Report No. RM2002/00268/00; |
Active substance: SALMETEROL |
Study summary document link (including results): |
View full study record |
Document reference: 35596 |
Study title: A Stratified, Multicenter, Randomized, Double-Blind, Parallel Group, 4-Week Comparison of Fluticasone Propionate/Salmeterol DISKUS Combination Product 100/50mcg BID versus Fluticasone Propionate DISKUS 100/50mcg BID in Pediatric and Adolescent Subjects with Activity-Induced Bronchospasm. Report No. RM2005/00343/00 |
Active substance: SALMETEROL |
Study summary document link (including results): |
View full study record |
Document reference: 35592 |
Study title: A Stratified, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Trial Evaluating the Safety and Efficacy of the Fluticasone Propionate/Salmeterol Diskus Combination Product 100/50mcg Once Daily Versus Fluticasone Propionate Diskus 100mcg Once Daily and Placebo in Symptomatic Pediatric Subjects (4-11 Years) With Asthma. Report No. RM2001/00010/07 |
Active substance: SALMETEROL |
Study summary document link (including results): |
View full study record |
Document reference: 35595 |
Study title: Marthaler TM, König KG. Der Einfluß von Fluoridtablettengaben in der Schule auf den Kariesbefall 6- bis 15-Jähriger Kinder. Schweiz Monatsschr Zahnmed 1967; 77: 539-554Marthaler TM, König KG. Der Einfluß von Fluoridtablettengaben in der Schule auf den Kariesbefall 6- bis 15-Jähriger Kinder. Schweiz Monatsschr Zahnmed 1967; 77: 539-554 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42296 |
Study title: Marthaler TM, König KG. Der Einfluß von Fluoridtablettengaben in der Schule auf den Kariesbefall 6- bis 15-Jähriger Kinder. Schweiz Monatsschr Zahnmed 1967; 77: 539-554Marthaler TM, König KG. Der Einfluß von Fluoridtablettengaben in der Schule auf den Kariesbefall 6- bis 15-Jähriger Kinder. Schweiz Monatsschr Zahnmed 1967; 77: 539-554 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42328 |
Study title: On topical application of fluorides and its inhibiting effect on caries. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42394 |
Study title: On topical application of fluorides and its inhibiting effect on caries. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42507 |
Study title: Paediatric dentistry discussion paper and case report. Management of small carious lesions in primary teeth: caries removal versus fluoride application and periodic 'observation' until exfoliation. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42360 |
Study title: Paediatric dentistry discussion paper and case report. Management of small carious lesions in primary teeth: caries removal versus fluoride application and periodic 'observation' until exfoliation. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42473 |
Study title: Petersson LG, Koch G, Rasmusson CG, Stanke H. Effect on caries of different fluoride prophylactic programs in preschool children. A two year clinical study. Swed Dent J. 1985;9(3):97-104.Petersson LG, Koch G, Rasmusson CG, Stanke H. Effect on caries of different fluoride prophylactic programs in preschool children. A two year clinical study. Swed Dent J. 1985;9(3):97-104. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42265 |
Study title: Comparison of stepwise treatment of asthmatic children with salmeterol/fluticasone propionate (FP) combination product (Seretide) and/or fluticasone propionate (Flixotide) based on PD20 methacholine plus symptoms or based on symptoms only (Children Asthma Therapy Optimal” |
Active substance: SALMETEROL |
Study summary document link (including results): |
View full study record |
Document reference: 35599 |
Study title: Summary of the efficacy and safety and safety of salmeterol 50mcg and fluticasone propionate 100mcg administered in Diskus Dry Powder Inhaler twice daily in steroid experienced children with reversible airways obstruction |
Active substance: SALMETEROL |
Study summary document link (including results): |
View full study record |
Document reference: 35601 |
Study title: Petersson LG, Koch G, Rasmusson CG, Stanke H. Effect on caries of different fluoride prophylactic programs in preschool children. A two year clinical study. Swed Dent J. 1985;9(3):97-104.Petersson LG, Koch G, Rasmusson CG, Stanke H. Effect on caries of different fluoride prophylactic programs in preschool children. A two year clinical study. Swed Dent J. 1985;9(3):97-104. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42297 |
Study title: Petersson LG, Koch G, Rasmusson CG, Stanke H. Effect on caries of different fluoride prophylactic programs in preschool children. A two year clinical study. Swed Dent J. 1985;9(3):97-104.Petersson LG, Koch G, Rasmusson CG, Stanke H. Effect on caries of different fluoride prophylactic programs in preschool children. A two year clinical study. Swed Dent J. 1985;9(3):97-104. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42329 |
Study title: Pharmacokinetics of fluoride gels in children and adults. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42357 |
Study title: Pharmacokinetics of fluoride gels in children and adults. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42470 |
Study title: Plasschaert AJM, König KG: Die Wirkung von Zahngesundheitsinformation und von Fluoridtabletten auf den Karieszuwachs bei Schulkindern. I Experimentelle Ergebnisse nach 2 Jahren Versuchsdauer. Schweiz Mschr zahnkeilk 1973; 83: 421-445Plasschaert AJM, König KG: Die Wirkung von Zahngesundheitsinformation und von Fluoridtabletten auf den Karieszuwachs bei Schulkindern. I Experimentelle Ergebnisse nach 2 Jahren Versuchsdauer. Schweiz Mschr zahnkeilk 1973; 83: 421-445 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42266 |
Study title: Plasschaert AJM, König KG: Die Wirkung von Zahngesundheitsinformation und von Fluoridtabletten auf den Karieszuwachs bei Schulkindern. I Experimentelle Ergebnisse nach 2 Jahren Versuchsdauer. Schweiz Mschr zahnkeilk 1973; 83: 421-445Plasschaert AJM, König KG: Die Wirkung von Zahngesundheitsinformation und von Fluoridtabletten auf den Karieszuwachs bei Schulkindern. I Experimentelle Ergebnisse nach 2 Jahren Versuchsdauer. Schweiz Mschr zahnkeilk 1973; 83: 421-445 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42298 |
Study title: A Phase II, Randomized, Open-Label Study to Compare the Safety and Efficacy of Sevoflurane Versus Halothane Administered with Nitrous Oxide and Oxygen in ASA Class I and II Pediatric Patients |
Active substance: SEVOFLURANE |
Study summary document link (including results): Sevoflurane-P92-124.pdf |
View full study record |
Document reference: 42160 |
Study title: A Phase III, Multicenter, Open-Label Study Evaluating the Effect of Multiple Exposure to Sevoflurane for the Maintenance of Anesthesia in Pediatric ASA Class I, II, and III Inpatients |
Active substance: SEVOFLURANE |
Study summary document link (including results): Sevoflurane-P92-098.pdf |
View full study record |
Document reference: 42158 |
Study title: A Phase III, Multicenter, Open-Label, Randomized, Comparative Study Evaluating the Effect of Sevoflurane Versus Halothane in the Induction and Maintenance of Anesthesia in Pediatric ASA Class I and II Outpatients |
Active substance: SEVOFLURANE |
Study summary document link (including results): Sevoflurane-P92-090.pdf |
View full study record |
Document reference: 42156 |
Study title: A Phase III, Multicenter, Open-Label, Randomized, Comparative Study Evaluating the Effect of Sevoflurane Versus Halothane in the Induction and Maintenance of Anesthesia in Pediatric ASA Class I and II Inpatients |
Active substance: SEVOFLURANE |
Study summary document link (including results): Sevoflurane-P92-091.pdf |
View full study record |
Document reference: 42157 |
Study title: A Phase III, Randomized, Open-Label Study to Compare the Safety, Tolerability and Recovery Characteristics of Sevoflurane Versus Halothane Administered with Nitrous Oxide and Oxygen in ASA Class I and II Pediatric Patients Undergoing Ambulatory Surgery |
Active substance: SEVOFLURANE |
Study summary document link (including results): Sevoflurane-P92-125.pdf |
View full study record |
Document reference: 42161 |
Study title: A Phase III, Single Center, Open-Label Study Evaluating the Production of Compound A When Sevoflurane is Administered for the Induction and Maintenance of Anesthesia in Pediatric ASA Class I, II, and III Patients |
Active substance: SEVOFLURANE |
Study summary document link (including results): |
View full study record |
Document reference: 42162 |
Study title: Driscoll WS, Nowjack-Raymer R, Selwitz RH, Li SH, Heifetz SB. A comparison of the caries-preventive effects of fluoride mouthrinsing, fluoride tablets, and both procedures combined: final results after eight years. J Public Health Dent. 1992 Winter;52(2):111-6.Driscoll WS, Nowjack-Raymer R, Selwitz RH, Li SH, Heifetz SB. A comparison of the caries-preventive effects of fluoride mouthrinsing, fluoride tablets, and both procedures combined: final results after eight years. J Public Health Dent. 1992 Winter;52(2):111-6. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42321 |
Study title: Effect of a fluoride varnish on primary dentition. Dental research in Finland 1982. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42392 |
Study title: Effect of a fluoride varnish on primary dentition. Dental research in Finland 1982. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42505 |
Study title: Effect of a fluoride-containinglacquer on dental caries. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42362 |
Study title: Effect of a fluoride-containinglacquer on dental caries. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42475 |
Study title: Effect of a preventive program based on professional toothcleaning and fluoride application on caries and gingivitis. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42374 |
Study title: Effect of a preventive program based on professional toothcleaning and fluoride application on caries and gingivitis. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42487 |
Study title: Effect of annual application of polyurethane lacquer containing silane-fluoride. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42436 |
Study title: Effect of annual application of polyurethane lacquer containing silane-fluoride. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42549 |
Study title: Effect of different carriers preventive measures in children highly infected with mutans streptococci. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42381 |
Study title: Effect of different carriers preventive measures in children highly infected with mutans streptococci. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42494 |
Study title: Effect of Fluor-Protector varnish on the inhibition of the carious process in milk teeth |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42437 |
Study title: Friis-Hasché E, Bergamnn J, Wenzel A, Thylstrup A et al. Dental health status and attitudes to dental care in families participating in a Danish fluoride tablet program. Community Dent Oral Epidemiol 1984; 12: 303-307Friis-Hasché E, Bergamnn J, Wenzel A, Thylstrup A et al. Dental health status and attitudes to dental care in families participating in a Danish fluoride tablet program. Community Dent Oral Epidemiol 1984; 12: 303-307 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42310 |
Study title: Füchte W. Ergebnisse einer Kariesprophylaxe mit Fluor-Kalktabletten. ZM 3/1971, 1-5Füchte W. Ergebnisse einer Kariesprophylaxe mit Fluor-Kalktabletten. ZM 3/1971, 1-5 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42258 |
Study title: Füchte W. Ergebnisse einer Kariesprophylaxe mit Fluor-Kalktabletten. ZM 3/1971, 1-5Füchte W. Ergebnisse einer Kariesprophylaxe mit Fluor-Kalktabletten. ZM 3/1971, 1-5 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42290 |
Study title: Füchte W. Ergebnisse einer Kariesprophylaxe mit Fluor-Kalktabletten. ZM 3/1971, 1-5Füchte W. Ergebnisse einer Kariesprophylaxe mit Fluor-Kalktabletten. ZM 3/1971, 1-5 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42322 |
Study title: Hamberg L. Controlled trial of fluoride vitamin drops for prevention of caries in children. The Lancet 1971; Feb 27; 441-442Hamberg L. Controlled trial of fluoride vitamin drops for prevention of caries in children. The Lancet 1971; Feb 27; 441-442 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42259 |
Study title: Hamberg L. Controlled trial of fluoride vitamin drops for prevention of caries in children. The Lancet 1971; Feb 27; 441-442Hamberg L. Controlled trial of fluoride vitamin drops for prevention of caries in children. The Lancet 1971; Feb 27; 441-442 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42291 |
Study title: Effect of Fluor-Protector varnish on the inhibition of the carious process in milk teeth |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42550 |
Study title: Effect of fluoride brushing on the dental treatment requirement in a group of junior elementary school students. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42413 |
Study title: Effect of fluoride brushing on the dental treatment requirement in a group of junior elementary school students. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42526 |
Study title: Effect of fortnightly rinsing with a 0.2% NaF solution and a fluoride varnish with 5% NaF in dental caries prevention: comparative study in students of the northern region of Sao Paulo city, Brazil, 1992-1993 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42402 |
Study title: Effect of fortnightly rinsing with a 0.2% NaF solution and a fluoride varnish with 5% NaF in dental caries prevention: comparative study in students of the northern region of Sao Paulo city, Brazil, 1992-1993 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42515 |
Study title: Effect of schoolbased fluoride varnish programmeson approximal caries in adolescents from different caries risk areas. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42425 |
Study title: Effect of schoolbased fluoride varnish programmeson approximal caries in adolescents from different caries risk areas. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42538 |
Study title: Effect on caries of different fluoride prophylactic programs in preschool children. A two year clinical study. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42396 |
Study title: Effect on caries of different fluoride prophylactic programs in preschool children. A two year clinical study. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42509 |
Study title: Hamberg L. Controlled trial of fluoride vitamin drops for prevention of caries in children. The Lancet 1971; Feb 27; 441-442Hamberg L. Controlled trial of fluoride vitamin drops for prevention of caries in children. The Lancet 1971; Feb 27; 441-442 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42323 |
Study title: Haugejorgen O, Birkeland JM. Analysis of the ups and downs of caries experience among Norwegian children aged five years between 1997 and 2003. Acta Odonttol Scand 2005; 63 (2): 115-122.Haugejorgen O, Birkeland JM. Analysis of the ups and downs of caries experience among Norwegian children aged five years between 1997 and 2003. Acta Odonttol Scand 2005; 63 (2): 115-122. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42260 |
Study title: Haugejorgen O, Birkeland JM. Analysis of the ups and downs of caries experience among Norwegian children aged five years between 1997 and 2003. Acta Odonttol Scand 2005; 63 (2): 115-122.Haugejorgen O, Birkeland JM. Analysis of the ups and downs of caries experience among Norwegian children aged five years between 1997 and 2003. Acta Odonttol Scand 2005; 63 (2): 115-122. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42292 |
Study title: Haugejorgen O, Birkeland JM. Analysis of the ups and downs of caries experience among Norwegian children aged five years between 1997 and 2003. Acta Odonttol Scand 2005; 63 (2): 115-122.Haugejorgen O, Birkeland JM. Analysis of the ups and downs of caries experience among Norwegian children aged five years between 1997 and 2003. Acta Odonttol Scand 2005; 63 (2): 115-122. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42324 |
Study title: Haugejorgen O, Birkeland JM. Evidence of reversal of the caries decline among Norwegian children. Int J Paediatr Dent 2002; 12 (5): 306-315.Haugejorgen O, Birkeland JM. Evidence of reversal of the caries decline among Norwegian children. Int J Paediatr Dent 2002; 12 (5): 306-315. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42261 |
Study title: Plasschaert AJM, König KG: Die Wirkung von Zahngesundheitsinformation und von Fluoridtabletten auf den Karieszuwachs bei Schulkindern. I Experimentelle Ergebnisse nach 2 Jahren Versuchsdauer. Schweiz Mschr zahnkeilk 1973; 83: 421-445Plasschaert AJM, König KG: Die Wirkung von Zahngesundheitsinformation und von Fluoridtabletten auf den Karieszuwachs bei Schulkindern. I Experimentelle Ergebnisse nach 2 Jahren Versuchsdauer. Schweiz Mschr zahnkeilk 1973; 83: 421-445 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42330 |
Study title: Post-treatment effect of fluoride varnishes in children with a high prevalence of dental caries in a community with fluoridated water. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42534 |
Study title: Poulsen S, Gadegaard E, Mortensen B. Cariostatic effect of daily use of a fluoride-containing lozenge compared to forthnightly rinses with 0,2% sodium fluoride. Caries Res 1981; 15: 236-242.Poulsen S, Gadegaard E, Mortensen B. Cariostatic effect of daily use of a fluoride-containing lozenge compared to forthnightly rinses with 0,2% sodium fluoride. Caries Res 1981; 15: 236-242. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42267 |
Study title: A multi-centre, double-blind, randomised, parallel group study comparing the addition of inhaled salmeterol with an increase in the dose of inhaled fluticasone propionate in asthmatic patients on a low or intermediate dose of inhaled steroid. |
Active substance: SALMETEROL (XINAFOATE) |
Study summary document link (including results): Salmeterol-Xinafoate-SMS30073-ICHE3.pdf |
View full study record |
Document reference: 42056 |
Study title: Poulsen S, Gadegaard E, Mortensen B. Cariostatic effect of daily use of a fluoride-containing lozenge compared to forthnightly rinses with 0,2% sodium fluoride. Caries Res 1981; 15: 236-242.Poulsen S, Gadegaard E, Mortensen B. Cariostatic effect of daily use of a fluoride-containing lozenge compared to forthnightly rinses with 0,2% sodium fluoride. Caries Res 1981; 15: 236-242. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42299 |
Study title: Poulsen S, Gadegaard E, Mortensen B. Cariostatic effect of daily use of a fluoride-containing lozenge compared to forthnightly rinses with 0,2% sodium fluoride. Caries Res 1981; 15: 236-242.Poulsen S, Gadegaard E, Mortensen B. Cariostatic effect of daily use of a fluoride-containing lozenge compared to forthnightly rinses with 0,2% sodium fluoride. Caries Res 1981; 15: 236-242. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42331 |
Study title: Prediction of root caries in periodontally treated patients maintained with different fluoride programmes. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42403 |
Study title: Prediction of root caries in periodontally treated patients maintained with different fluoride programmes. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42516 |
Study title: Prevention. Part 7: professionally applied topical fluorides for caries prevention. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42366 |
Study title: Prevention. Part 7: professionally applied topical fluorides for caries prevention. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42479 |
Study title: Preventive measures and caries progression: an in vitro study on fissures and smooth surfaces of human molars. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42435 |
Study title: Preventive measures and caries progression: an in vitro study on fissures and smooth surfaces of human molars. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42548 |
Study title: Professional topical fluoride applications--clinical efficacy and mechanism of action. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42391 |
Study title: Professional topical fluoride applications--clinical efficacy and mechanism of action. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42504 |
Study title: Progression of approximal caries in primary molars and the effect of Duraphat treatment. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42399 |
Study title: Progression of approximal caries in primary molars and the effect of Duraphat treatment. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42512 |
Study title: Progression of proximal caries in primary teeth in relation to radiographic scoring codes |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42427 |
Study title: Progression of proximal caries in primary teeth in relation to radiographic scoring codes |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42540 |
Study title: A Phase III, Single Center, Open-Label, Randomized, Comparative Study Evaluating the Effect of Sevoflurane Versus Halothane on Hepatic Metabolism in the Induction and Maintenance of Anesthesia in Pediatric Inpatients |
Active substance: SEVOFLURANE |
Study summary document link (including results): Sevoflurane-P92-084.pdf |
View full study record |
Document reference: 42155 |
Study title: An open-label, multi-center, phase IV study to evaluate the efficacy and safety profiles of sevoflurane in pediatric subjects of different ages undergoing inpatient surgery with general anesthesia |
Active substance: SEVOFLURANE |
Study summary document link (including results): Sevoflurane-CHIN-05-001.pdf |
View full study record |
Document reference: 42152 |
Study title: Drug Metabolism Report No. 8 - The Minimum Alveolar Concentration (MAC), and Maintenance and Recovery Characteristics of Sevoflurane in Pediatric Patients |
Active substance: SEVOFLURANE |
Study summary document link (including results): |
View full study record |
Document reference: 42159 |
Study title: Evaluation of the Clinical and Consumption Differences between Sevoflurane Innovative Drug and Sevoflurane Similar Drug - Pilot Study |
Active substance: SEVOFLURANE |
Study summary document link (including results): |
View full study record |
Document reference: 42154 |
Study title: Sevoflurane versus Halothane in the induction and maintenance of anesthesia in pediatric patients (Abbott Affiliate sponsored study - drug administered) |
Active substance: SEVOFLURANE |
Study summary document link (including results): |
View full study record |
Document reference: 42153 |
Study title: The Minimum Alveolar Concentration (MAC), and Maintenance and Recovery Characteristics of Sevoflurane in Pediatric Patients |
Active substance: SEVOFLURANE |
Study summary document link (including results): sevoflurane-ghba532.pdf |
View full study record |
Document reference: 48115 |
Study title: Korman MG et al. Influence of smoking on healing rate of duodenal ulcer in response to cimetidine or high-dose antacid. Gastroenterology. 1981 Jun;80(6):1451-3Korman MG et al. Influence of smoking on healing rate of duodenal ulcer in response to cimetidine or high-dose antacid. Gastroenterology. 1981 Jun;80(6):1451-3 |
Active substance: SIMETICONE |
Study summary document link (including results): |
View full study record |
Document reference: 42220 |
Study title: Effect on the primary dentition of mouthrinsing with a 0.2 percent neutral NaF solution: results from a demonstration program after four school years. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42406 |
Study title: Effect on the primary dentition of mouthrinsing with a 0.2 percent neutral NaF solution: results from a demonstration program after four school years. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42519 |
Study title: Effectiveness of silver diamine fluoride and sodium fluoride varnish in arresting dentin caries in Chinese pre-school children |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42351 |
Study title: Effectiveness of silver diamine fluoride and sodium fluoride varnish in arresting dentin caries in Chinese pre-school children |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42464 |
Study title: Effects of fluoride and chlorhexidine on the microflora of dental root surfaces and progression of root-surface caries. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42410 |
Study title: Effects of fluoride and chlorhexidine on the microflora of dental root surfaces and progression of root-surface caries. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42523 |
Study title: Effects of self-applied topical fluoride preparations in orthodontic patients. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42448 |
Study title: Efficacy of preventive agents for dental caries. Systemic fluorides: water fluoridation. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42388 |
Study title: Efficacy of preventive agents for dental caries. Systemic fluorides: water fluoridation. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42501 |
Study title: Enamel fluoride uptake, distribution and retention from topical fluoride agents. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42405 |
Study title: Enamel fluoride uptake, distribution and retention from topical fluoride agents. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42518 |
Study title: Erosion caused by gastric reflux in childen. Discussion of etiology, clinical appearance and therapy in two cases. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42382 |
Study title: Orenstein SR et al. Nizatidine for the treatment of pediatric gastroesophageal reflux symptoms: An open-label, multiple-dose, randomized, multicenter clinical trial in 210 children. Clin Ther. April 1, 2005, 472-83Orenstein SR et al. Nizatidine for the treatment of pediatric gastroesophageal reflux symptoms: An open-label, multiple-dose, randomized, multicenter clinical trial in 210 children. Clin Ther. April 1, 2005, 472-83 |
Active substance: SIMETICONE |
Study summary document link (including results): |
View full study record |
Document reference: 42181 |
Study title: Haugejorgen O, Birkeland JM. Evidence of reversal of the caries decline among Norwegian children. Int J Paediatr Dent 2002; 12 (5): 306-315.Haugejorgen O, Birkeland JM. Evidence of reversal of the caries decline among Norwegian children. Int J Paediatr Dent 2002; 12 (5): 306-315. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42293 |
Study title: Haugejorgen O, Birkeland JM. Evidence of reversal of the caries decline among Norwegian children. Int J Paediatr Dent 2002; 12 (5): 306-315.Haugejorgen O, Birkeland JM. Evidence of reversal of the caries decline among Norwegian children. Int J Paediatr Dent 2002; 12 (5): 306-315. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42325 |
Study title: Heifetz SB, Horowitz HS, Meyers RJ, Li SH. Evaluation of the comparative effectiveness of fluoride mouth rinsing, fluoride tablets, and both procedures in combination: interim findings after zwo years. Pediatric Dentistry 1987; 9: 121-125.Heifetz SB, Horowitz HS, Meyers RJ, Li SH. Evaluation of the comparative effectiveness of fluoride mouth rinsing, fluoride tablets, and both procedures in combination: interim findings after zwo years. Pediatric Dentistry 1987; 9: 121-125. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42262 |
Study title: Heifetz SB, Horowitz HS, Meyers RJ, Li SH. Evaluation of the comparative effectiveness of fluoride mouth rinsing, fluoride tablets, and both procedures in combination: interim findings after zwo years. Pediatric Dentistry 1987; 9: 121-125.Heifetz SB, Horowitz HS, Meyers RJ, Li SH. Evaluation of the comparative effectiveness of fluoride mouth rinsing, fluoride tablets, and both procedures in combination: interim findings after zwo years. Pediatric Dentistry 1987; 9: 121-125. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42294 |
Study title: Heifetz SB, Horowitz HS, Meyers RJ, Li SH. Evaluation of the comparative effectiveness of fluoride mouth rinsing, fluoride tablets, and both procedures in combination: interim findings after zwo years. Pediatric Dentistry 1987; 9: 121-125.Heifetz SB, Horowitz HS, Meyers RJ, Li SH. Evaluation of the comparative effectiveness of fluoride mouth rinsing, fluoride tablets, and both procedures in combination: interim findings after zwo years. Pediatric Dentistry 1987; 9: 121-125. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42326 |
Study title: Verapamil versus flunarizina nella terapia preventiva dell'emicrania. (Verapamil versus flunarizine in the preventive therapy of hemicrania).Lastilla M, Achille P, Savarese MA, Frascella G. La Clinica terapeutica, 31 Mar 1990, vol. 132, no. 6, p. 401−4, Verapamil versus flunarizina nella terapia preventiva dell'emicrania. (Verapamil versus flunarizine in the preventive therapy of hemicrania).Lastilla M, Achille P, Savarese MA, Frascella G. La Clinica terapeutica, 31 Mar 1990, vol. 132, no. 6, p. 401−4, |
Active substance: VERAPAMIL |
Study summary document link (including results): |
View full study record |
Document reference: 45559 |
Study title: Erosion caused by gastric reflux in childen. Discussion of etiology, clinical appearance and therapy in two cases. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42495 |
Study title: Evaluation of a fluoride-containing varnish in children with low caries incidence. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42377 |
Study title: Evaluation of a fluoride-containing varnish in children with low caries incidence. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42490 |
Study title: Evaluation of a routine for prevention and treatment of fissure caries in permanent first molars. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42401 |
Study title: Evaluation of a routine for prevention and treatment of fissure caries in permanent first molars. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42514 |
Study title: Evaluation of non-invasive treatment applied to occlusal surfaces. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42358 |
Study title: Evaluation of non-invasive treatment applied to occlusal surfaces. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42471 |
Study title: Factors governing the use of topical fluorides: time and patient acceptability. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42338 |
Study title: Factors governing the use of topical fluorides: time and patient acceptability. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42451 |
Study title: Fanning EA, Cellier KM, Leadbeater MM, Somerville CM. South Australian kindergarten children: fluoride tablet supplements and dental caries. Aust Dent J 1975: 20: 7-9Fanning EA, Cellier KM, Leadbeater MM, Somerville CM. South Australian kindergarten children: fluoride tablet supplements and dental caries. Aust Dent J 1975: 20: 7-9 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42244 |
Study title: A 2-year report on caries prevention by fluoride varnishes in a community with fluoridated water. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42417 |
Study title: A 2-year report on caries prevention by fluoride varnishes in a community with fluoridated water. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42419 |
Study title: A 2-year report on caries prevention by fluoride varnishes in a community with fluoridated water. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42530 |
Study title: A 2-year report on caries prevention by fluoride varnishes in a community with fluoridated water. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42532 |
Study title: A 24-month study comparing sealant and fluoride varnish in caries reduction on different permanent first molar surfaces. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42346 |
Study title: A 24-month study comparing sealant and fluoride varnish in caries reduction on different permanent first molar surfaces. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42459 |
Study title: A clinical estimation of the fluoride used during application of a fluoride varnish. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42408 |
Study title: A clinical estimation of the fluoride used during application of a fluoride varnish. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42521 |
Study title: A cluster randomised controlled trial to evaluate the effectiveness of fluoride varnish as a public health measure to reduce caries in children. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42363 |
Study title: A cluster randomised controlled trial to evaluate the effectiveness of fluoride varnish as a public health measure to reduce caries in children. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42476 |
Study title: A combined application of ART-fluoride varnish for immigrant junior field-workers: 12-months follow-up field trial in rural Anatolia. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42356 |
Study title: Relationship between caries and fluoride uptake by enamel from two fluoride varnishes in a community with fluoridated water. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42531 |
Study title: Results of a 32-month fluoride varnish study in Sherbrooke and Lac-Megantic, Canada. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42353 |
Study title: Results of a 32-month fluoride varnish study in Sherbrooke and Lac-Megantic, Canada. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42466 |
Study title: Results of a promising open trial to prevent baby bottle tooth decay: a fluoride varnish study. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42439 |
Study title: Results of a promising open trial to prevent baby bottle tooth decay: a fluoride varnish study. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42552 |
Study title: Results of the combined use of remodent and fluorine lacquer for dental caries prevention in preschoolers] |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42433 |
Study title: Results of the combined use of remodent and fluorine lacquer for dental caries prevention in preschoolers] |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42546 |
Study title: Review of the anticaries effectiveness of professionally applied and self-applied topical fluoride gels. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42407 |
Study title: A combined application of ART-fluoride varnish for immigrant junior field-workers: 12-months follow-up field trial in rural Anatolia. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42469 |
Study title: A polarized light and scanning electron microscope study of the effect of Duraphat treatment on in vivo caries. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42370 |
Study title: A polarized light and scanning electron microscope study of the effect of Duraphat treatment on in vivo caries. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42483 |
Study title: A review on fluoride varnishes: an alternative topical fluoride treatment. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42352 |
Study title: A review on fluoride varnishes: an alternative topical fluoride treatment. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42465 |
Study title: Review of the anticaries effectiveness of professionally applied and self-applied topical fluoride gels. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42520 |
Study title: Relationship between caries and fluoride uptake by enamel from two fluoride varnishes in a community with fluoridated water. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42418 |
Study title: Sealant and fluoride varnish in caries: a randomized trial. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42347 |
Study title: Sealant and fluoride varnish in caries: a randomized trial. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42460 |
Study title: Stephen KW, Campbell D. Caries reduction and cost benefit after 3 years of sucking fluoride tablets daily at school: a double-blind trail. Br Dent J 1978; 144: 202-206.Stephen KW, Campbell D. Caries reduction and cost benefit after 3 years of sucking fluoride tablets daily at school: a double-blind trail. Br Dent J 1978; 144: 202-206. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42268 |
Study title: Stephen KW, Campbell D. Caries reduction and cost benefit after 3 years of sucking fluoride tablets daily at school: a double-blind trail. Br Dent J 1978; 144: 202-206.Stephen KW, Campbell D. Caries reduction and cost benefit after 3 years of sucking fluoride tablets daily at school: a double-blind trail. Br Dent J 1978; 144: 202-206. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42300 |
Study title: Stephen KW, Campbell D. Caries reduction and cost benefit after 3 years of sucking fluoride tablets daily at school: a double-blind trail. Br Dent J 1978; 144: 202-206.Stephen KW, Campbell D. Caries reduction and cost benefit after 3 years of sucking fluoride tablets daily at school: a double-blind trail. Br Dent J 1978; 144: 202-206. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42332 |
Study title: Strübig W, Aeckerle-Witten B, Lange-v.d. Burchard G. Karies-statische Ergebnisse nach 2-jähriger Tablettenfluoridierung. Öff Gesundheitswesen 1982; 44: 462-.Strübig W, Aeckerle-Witten B, Lange-v.d. Burchard G. Karies-statische Ergebnisse nach 2-jähriger Tablettenfluoridierung. Öff Gesundheitswesen 1982; 44: 462-. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42269 |
Study title: Strübig W, Aeckerle-Witten B, Lange-v.d. Burchard G. Karies-statische Ergebnisse nach 2-jähriger Tablettenfluoridierung. Öff Gesundheitswesen 1982; 44: 462-.Strübig W, Aeckerle-Witten B, Lange-v.d. Burchard G. Karies-statische Ergebnisse nach 2-jähriger Tablettenfluoridierung. Öff Gesundheitswesen 1982; 44: 462-. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42301 |
Study title: Widenheim J, Birkhed D, Granath L et al. Pre-eruptive effect of NaF tablets on caries in children from 12 to 17 years of age. Community Dent Oral Epidemiolog 1986, 14: 1-4.Widenheim J, Birkhed D, Granath L et al. Pre-eruptive effect of NaF tablets on caries in children from 12 to 17 years of age. Community Dent Oral Epidemiolog 1986, 14: 1-4. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42303 |
Study title: Widenheim J, Birkhed D, Granath L et al. Pre-eruptive effect of NaF tablets on caries in children from 12 to 17 years of age. Community Dent Oral Epidemiolog 1986, 14: 1-4.Widenheim J, Birkhed D, Granath L et al. Pre-eruptive effect of NaF tablets on caries in children from 12 to 17 years of age. Community Dent Oral Epidemiolog 1986, 14: 1-4. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42335 |
Study title: Widenheim J, Petersson LG, Koch G. Fluorine concentration in primary tooth enamel in 6-year-olds after 3 years of daily intake of fluoride-containing tablets (Fludent). Swed Dent J. 1984;8(4):203-7.Widenheim J, Petersson LG, Koch G. Fluorine concentration in primary tooth enamel in 6-year-olds after 3 years of daily intake of fluoride-containing tablets (Fludent). Swed Dent J. 1984;8(4):203-7. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42240 |
Study title: Aasenden R, Peebles TC. Effects of fluoride supplementation from birth on human deciduous and permanent teeth. Arch Oral Biol 1974; 19: 321-326.Aasenden R, Peebles TC. Effects of fluoride supplementation from birth on human deciduous and permanent teeth. Arch Oral Biol 1974; 19: 321-326. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42241 |
Study title: Aasenden R, Peebles TC. Effects of fluoride supplementation from birth on human deciduous and permanent teeth. Arch Oral Biol 1974; 19: 321-326.Aasenden R, Peebles TC. Effects of fluoride supplementation from birth on human deciduous and permanent teeth. Arch Oral Biol 1974; 19: 321-326. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42273 |
Study title: Aasenden R, Peebles TC. Effects of fluoride supplementation from birth on human deciduous and permanent teeth. Arch Oral Biol 1974; 19: 321-326.Aasenden R, Peebles TC. Effects of fluoride supplementation from birth on human deciduous and permanent teeth. Arch Oral Biol 1974; 19: 321-326. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42305 |
Study title: Allmark C, Green HP, Linney et al. A community study of fluoride tablets for schoolchildren in Portsmouth. Results after six years. Br Dent J 1982; 153: 426-430.Allmark C, Green HP, Linney et al. A community study of fluoride tablets for schoolchildren in Portsmouth. Results after six years. Br Dent J 1982; 153: 426-430. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42249 |
Study title: Allmark C, Green HP, Linney et al. A community study of fluoride tablets for schoolchildren in Portsmouth. Results after six years. Br Dent J 1982; 153: 426-430.Allmark C, Green HP, Linney et al. A community study of fluoride tablets for schoolchildren in Portsmouth. Results after six years. Br Dent J 1982; 153: 426-430. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42281 |
Study title: Allmark C, Green HP, Linney et al. A community study of fluoride tablets for schoolchildren in Portsmouth. Results after six years. Br Dent J 1982; 153: 426-430.Allmark C, Green HP, Linney et al. A community study of fluoride tablets for schoolchildren in Portsmouth. Results after six years. Br Dent J 1982; 153: 426-430. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42313 |
Study title: Andersson R, Grahnen H. Fluoride tablets in pre-school age – effect on primary and permanet teeth. Swed Dent J 1976; 69: 137-143.Andersson R, Grahnen H. Fluoride tablets in pre-school age – effect on primary and permanet teeth. Swed Dent J 1976; 69: 137-143. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42242 |
Study title: Andersson R, Grahnen H. Fluoride tablets in pre-school age – effect on primary and permanet teeth. Swed Dent J 1976; 69: 137-143.Andersson R, Grahnen H. Fluoride tablets in pre-school age – effect on primary and permanet teeth. Swed Dent J 1976; 69: 137-143. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42274 |
Study title: Andersson R, Grahnen H. Fluoride tablets in pre-school age – effect on primary and permanet teeth. Swed Dent J 1976; 69: 137-143.Andersson R, Grahnen H. Fluoride tablets in pre-school age – effect on primary and permanet teeth. Swed Dent J 1976; 69: 137-143. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42306 |
Study title: Strübig W, Aeckerle-Witten B, Lange-v.d. Burchard G. Karies-statische Ergebnisse nach 2-jähriger Tablettenfluoridierung. Öff Gesundheitswesen 1982; 44: 462-.Strübig W, Aeckerle-Witten B, Lange-v.d. Burchard G. Karies-statische Ergebnisse nach 2-jähriger Tablettenfluoridierung. Öff Gesundheitswesen 1982; 44: 462-. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42333 |
Study title: Strübig W, Gülzow HJ. Die Abhängigkeit des Fluoridgehaltes im Zahnschmelz von regelmäßiger oder unkontrollierter Fluoridaufnahme. Dtsch zahnärztl Z 1979; 34: 172-175Strübig W, Gülzow HJ. Die Abhängigkeit des Fluoridgehaltes im Zahnschmelz von regelmäßiger oder unkontrollierter Fluoridaufnahme. Dtsch zahnärztl Z 1979; 34: 172-175 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42270 |
Study title: De Liefde B, Herbison GP. Prevalence of developmental defects of enamel and denatl caries in New Zealand children receiving differing fluoride supplementation. Community Dent Oral Epidemiol 1985; 13: 164-167De Liefde B, Herbison GP. Prevalence of developmental defects of enamel and denatl caries in New Zealand children receiving differing fluoride supplementation. Community Dent Oral Epidemiol 1985; 13: 164-167 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42243 |
Study title: De Liefde B, Herbison GP. Prevalence of developmental defects of enamel and denatl caries in New Zealand children receiving differing fluoride supplementation. Community Dent Oral Epidemiol 1985; 13: 164-167De Liefde B, Herbison GP. Prevalence of developmental defects of enamel and denatl caries in New Zealand children receiving differing fluoride supplementation. Community Dent Oral Epidemiol 1985; 13: 164-167 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42275 |
Study title: De Liefde B, Herbison GP. Prevalence of developmental defects of enamel and denatl caries in New Zealand children receiving differing fluoride supplementation. Community Dent Oral Epidemiol 1985; 13: 164-167De Liefde B, Herbison GP. Prevalence of developmental defects of enamel and denatl caries in New Zealand children receiving differing fluoride supplementation. Community Dent Oral Epidemiol 1985; 13: 164-167 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42307 |
Study title: DePaola PF, Lax M. the caries-inhibiting effect of acidulated phosphate-fluoride chewable tablets: a two-year double-blind study. J Dent Assoc 1968; 76: 554-557.DePaola PF, Lax M. the caries-inhibiting effect of acidulated phosphate-fluoride chewable tablets: a two-year double-blind study. J Dent Assoc 1968; 76: 554-557. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42253 |
Study title: DePaola PF, Lax M. the caries-inhibiting effect of acidulated phosphate-fluoride chewable tablets: a two-year double-blind study. J Dent Assoc 1968; 76: 554-557.DePaola PF, Lax M. the caries-inhibiting effect of acidulated phosphate-fluoride chewable tablets: a two-year double-blind study. J Dent Assoc 1968; 76: 554-557. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42285 |
Study title: DePaola PF, Lax M. the caries-inhibiting effect of acidulated phosphate-fluoride chewable tablets: a two-year double-blind study. J Dent Assoc 1968; 76: 554-557.DePaola PF, Lax M. the caries-inhibiting effect of acidulated phosphate-fluoride chewable tablets: a two-year double-blind study. J Dent Assoc 1968; 76: 554-557. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42317 |
Study title: Discroll WS, Heifetz SB, Brunelle JA. Caries-preventive effects of fluoride tablets in schoolchildren four years after discontinuation of treatments. J Am Dent Assoc 1981; 103: 878-881.Discroll WS, Heifetz SB, Brunelle JA. Caries-preventive effects of fluoride tablets in schoolchildren four years after discontinuation of treatments. J Am Dent Assoc 1981; 103: 878-881. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42254 |
Study title: Widenheim J, Petersson LG, Koch G. Fluorine concentration in primary tooth enamel in 6-year-olds after 3 years of daily intake of fluoride-containing tablets (Fludent). Swed Dent J. 1984;8(4):203-7.Widenheim J, Petersson LG, Koch G. Fluorine concentration in primary tooth enamel in 6-year-olds after 3 years of daily intake of fluoride-containing tablets (Fludent). Swed Dent J. 1984;8(4):203-7. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42272 |
Study title: Widenheim J, Petersson LG, Koch G. Fluorine concentration in primary tooth enamel in 6-year-olds after 3 years of daily intake of fluoride-containing tablets (Fludent). Swed Dent J. 1984;8(4):203-7.Widenheim J, Petersson LG, Koch G. Fluorine concentration in primary tooth enamel in 6-year-olds after 3 years of daily intake of fluoride-containing tablets (Fludent). Swed Dent J. 1984;8(4):203-7. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42304 |
Study title: Strübig W, Gülzow HJ. Die Abhängigkeit des Fluoridgehaltes im Zahnschmelz von regelmäßiger oder unkontrollierter Fluoridaufnahme. Dtsch zahnärztl Z 1979; 34: 172-175Strübig W, Gülzow HJ. Die Abhängigkeit des Fluoridgehaltes im Zahnschmelz von regelmäßiger oder unkontrollierter Fluoridaufnahme. Dtsch zahnärztl Z 1979; 34: 172-175 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42302 |
Study title: Strübig W, Gülzow HJ. Die Abhängigkeit des Fluoridgehaltes im Zahnschmelz von regelmäßiger oder unkontrollierter Fluoridaufnahme. Dtsch zahnärztl Z 1979; 34: 172-175Strübig W, Gülzow HJ. Die Abhängigkeit des Fluoridgehaltes im Zahnschmelz von regelmäßiger oder unkontrollierter Fluoridaufnahme. Dtsch zahnärztl Z 1979; 34: 172-175 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42334 |
Study title: Studies of fluoride varnishes in Finland. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42422 |
Study title: Studies of fluoride varnishes in Finland. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42535 |
Study title: The caries-preventive effect of a fluoride varnish in the fissures of the first permanent molar. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42482 |
Study title: The caries-protective efficacy of 2 fluoride varnishes in a 2-year controlled clinical trial |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42343 |
Study title: The caries-protective efficacy of 2 fluoride varnishes in a 2-year controlled clinical trial |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42456 |
Study title: The clinical effect of application of a urethane lacquer containing silane fluorine. A one-year study. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42376 |
Study title: The clinical effect of application of a urethane lacquer containing silane fluorine. A one-year study. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42489 |
Study title: The clinical effect of application of fluoride varnish. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42438 |
Study title: The clinical effect of application of fluoride varnish. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42551 |
Study title: The comparative efficacy of local anticaries agents][Article in Russian |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42371 |
Study title: The comparative efficacy of local anticaries agents][Article in Russian |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42484 |
Study title: The effect of Duraphat lacquer on the condition of the permanent teeth in children consuming fluoridated table salt. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42386 |
Study title: The effect of Duraphat lacquer on the condition of the permanent teeth in children consuming fluoridated table salt. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42499 |
Study title: The effect of five years' implementation of caries-preventive methods in Swedish high-risk adolescents. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42372 |
Study title: The effect of five years' implementation of caries-preventive methods in Swedish high-risk adolescents. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42485 |
Study title: The effect of prophylactic measures on the gingival health of school children. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42345 |
Study title: Discroll WS, Heifetz SB, Brunelle JA. Caries-preventive effects of fluoride tablets in schoolchildren four years after discontinuation of treatments. J Am Dent Assoc 1981; 103: 878-881.Discroll WS, Heifetz SB, Brunelle JA. Caries-preventive effects of fluoride tablets in schoolchildren four years after discontinuation of treatments. J Am Dent Assoc 1981; 103: 878-881. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42286 |
Study title: Discroll WS, Heifetz SB, Brunelle JA. Caries-preventive effects of fluoride tablets in schoolchildren four years after discontinuation of treatments. J Am Dent Assoc 1981; 103: 878-881.Discroll WS, Heifetz SB, Brunelle JA. Caries-preventive effects of fluoride tablets in schoolchildren four years after discontinuation of treatments. J Am Dent Assoc 1981; 103: 878-881. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42318 |
Study title: Comparison of intra-examiner reproducibility in scoring caries in primary teeth of two scoring systems used to monitor caries progression. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42541 |
Study title: 19. Influence of oral intake of Saccharomyces boulardii on Escherichia coli in enteric flora.; Pediatric Nephrology 2006 ; 21 (6) : 807-810 |
Active substance: Saccharomyces boulardii |
Study summary document link (including results): |
View full study record |
Document reference: 40173 |
Study title: Post-treatment effect of fluoride varnishes in children with a high prevalence of dental caries in a community with fluoridated water. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42421 |
Study title: Application of fluoride varnish Duraphat with a cotton carrier respectively a syringe for cartridges--a comparison study. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42472 |
Study title: Assessing the effect of fluoride varnish on early enamel carious lesions in the primary dentition |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42336 |
Study title: Assessing the effect of fluoride varnish on early enamel carious lesions in the primary dentition |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42449 |
Study title: Bibby BG, Wilkins E, Witol E. A preliminary study of the effects of fluoride lozenges and pills on dental caries. Oral Surg Oral Med Oral Pathol 1955; 8 : 213-216.Bibby BG, Wilkins E, Witol E. A preliminary study of the effects of fluoride lozenges and pills on dental caries. Oral Surg Oral Med Oral Pathol 1955; 8 : 213-216. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42250 |
Study title: Bibby BG, Wilkins E, Witol E. A preliminary study of the effects of fluoride lozenges and pills on dental caries. Oral Surg Oral Med Oral Pathol 1955; 8 : 213-216.Bibby BG, Wilkins E, Witol E. A preliminary study of the effects of fluoride lozenges and pills on dental caries. Oral Surg Oral Med Oral Pathol 1955; 8 : 213-216. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42282 |
Study title: Bibby BG, Wilkins E, Witol E. A preliminary study of the effects of fluoride lozenges and pills on dental caries. Oral Surg Oral Med Oral Pathol 1955; 8 : 213-216.Bibby BG, Wilkins E, Witol E. A preliminary study of the effects of fluoride lozenges and pills on dental caries. Oral Surg Oral Med Oral Pathol 1955; 8 : 213-216. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42314 |
Study title: Busse H, Geiger L. Fluoridierungsmaßnahmen und Kariesprävalenz bei Schülern in der ehemaligen DDR. Oralprophylaxe 1990; 12: 145-153Busse H, Geiger L. Fluoridierungsmaßnahmen und Kariesprävalenz bei Schülern in der ehemaligen DDR. Oralprophylaxe 1990; 12: 145-153 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42251 |
Study title: Busse H, Geiger L. Fluoridierungsmaßnahmen und Kariesprävalenz bei Schülern in der ehemaligen DDR. Oralprophylaxe 1990; 12: 145-153Busse H, Geiger L. Fluoridierungsmaßnahmen und Kariesprävalenz bei Schülern in der ehemaligen DDR. Oralprophylaxe 1990; 12: 145-153 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42283 |
Study title: Application of fluoride varnish Duraphat with a cotton carrier respectively a syringe for cartridges--a comparison study. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42359 |
Study title: Busse H, Geiger L. Fluoridierungsmaßnahmen und Kariesprävalenz bei Schülern in der ehemaligen DDR. Oralprophylaxe 1990; 12: 145-153Busse H, Geiger L. Fluoridierungsmaßnahmen und Kariesprävalenz bei Schülern in der ehemaligen DDR. Oralprophylaxe 1990; 12: 145-153 |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42315 |
Study title: Caries incidence after topical application of varnishes containing different concentrations of sodium fluoride: 3-year results |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42365 |
Study title: Caries incidence after topical application of varnishes containing different concentrations of sodium fluoride: 3-year results |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42478 |
Study title: Caries increment in primary teeth after application of Duraphat fluoride varnish. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42361 |
Study title: Caries increment in primary teeth after application of Duraphat fluoride varnish. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42474 |
Study title: Caries prevention by means of deep impregnation of the dental enamel with fluoride lacquer] [Article in German] |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42414 |
Study title: Caries prevention by means of deep impregnation of the dental enamel with fluoride lacquer] [Article in German] |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42527 |
Study title: Caries prevention with Duraphat in a new application form]. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42412 |
Study title: The effect of prophylactic measures on the gingival health of school children. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42458 |
Study title: Comparative evaluation of the role of NaF, APF & Duraphat topical fluoride applications in the prevention of dental caries--a 2 1/2 years study. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42431 |
Study title: The effect of topical fluoride treatment on enamel fluoride uptake and the tensile bond strength of an orthodontic bonding resin. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42350 |
Study title: The effect of topical fluoride treatment on enamel fluoride uptake and the tensile bond strength of an orthodontic bonding resin. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42463 |
Study title: The trace efficacy of dental caries prevention in children |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42429 |
Study title: The trace efficacy of dental caries prevention in children |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42542 |
Study title: The use of a fluoride varnish and helium-neon laser light in preventing caries of the deciduous teeth] [Article in Russian |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42378 |
Study title: The use of a fluoride varnish and helium-neon laser light in preventing caries of the deciduous teeth] [Article in Russian |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42491 |
Study title: Three-year study of the effect of fluoride varnish (Duraphat) on proximal caries progression in teenagers. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42387 |
Study title: Three-year study of the effect of fluoride varnish (Duraphat) on proximal caries progression in teenagers. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42500 |
Study title: Topical application of fluoride varnish for dental caries prevention in ollectives following a 3-year testing period][Article in German |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42385 |
Study title: Topical application of fluoride varnish for dental caries prevention in ollectives following a 3-year testing period][Article in German |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42498 |
Study title: Trials - results - conclusions. Duraphat - Fluor Protector |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42340 |
Study title: Trials - results - conclusions. Duraphat - Fluor Protector |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42453 |
Study title: Two-year trial of the fluoride-containing varnishes Duraphat and Carex]. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42389 |
Study title: Two-year trial of the fluoride-containing varnishes Duraphat and Carex]. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42502 |
Study title: Uptake of KOH-soluble and KOH-insoluble fluoride in sound human enamel after topical application of a fluoride varnish (Duraphat) or a neutral 2% NaF solution in vitro. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42354 |
Study title: Uptake of KOH-soluble and KOH-insoluble fluoride in sound human enamel after topical application of a fluoride varnish (Duraphat) or a neutral 2% NaF solution in vitro. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42467 |
Study title: use of a fluoride varnish in caries prevention. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42383 |
Study title: use of a fluoride varnish in caries prevention. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42496 |
Study title: use of fluoride varnish in the prevention of caries. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42379 |
Study title: use of fluoride varnish in the prevention of caries. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42492 |
Study title: Widenheim J, Birkhed D, Granath L et al. Pre-eruptive effect of NaF tablets on caries in children from 12 to 17 years of age. Community Dent Oral Epidemiolog 1986, 14: 1-4.Widenheim J, Birkhed D, Granath L et al. Pre-eruptive effect of NaF tablets on caries in children from 12 to 17 years of age. Community Dent Oral Epidemiolog 1986, 14: 1-4. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42271 |
Study title: Influence of age on quantitative sacro-iliac joint imaging. Dodig D, Popović S, Domljan Z. Eur J Nucl Med. 1984;9(4):177-9. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 44016 |
Study title: Caries prevention with fluoride varnish in a socially deprived community |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42444 |
Study title: Caries prevention with fluoride varnish in a socially deprived community |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42557 |
Study title: Caries prevention with fluoride varnishes among preschool children. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42344 |
Study title: Caries prevention with fluoride varnishes among preschool children. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42457 |
Study title: Caries prophylaxis by local application of sodium fluoride lacquer |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42441 |
Study title: Caries prophylaxis by local application of sodium fluoride lacquer |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42554 |
Study title: Caries prophylaxis by means of local application of sodium fluoride lacquer |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42442 |
Study title: Caries prophylaxis by means of local application of sodium fluoride lacquer |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42555 |
Study title: Caries prevention with Duraphat in a new application form]. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42525 |
Study title: Caries prevention with Duraphat in a new applications form]. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42411 |
Study title: Caries prophylaxis by topical application of sodium fluoride varnish |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42440 |
Study title: Caries prophylaxis by topical application of sodium fluoride varnish |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42553 |
Study title: Caries-preventive effect of a fluoride-containing lacquer, Duraphat, evaluated in a clinical study |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42373 |
Study title: Caries-preventive effect of a fluoride-containing lacquer, Duraphat, evaluated in a clinical study |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42486 |
Study title: Caries-preventive effect of fluoride varnish with different fluoride concentrations. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42423 |
Study title: Caries-preventive effect of fluoride varnish with different fluoride concentrations. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42536 |
Study title: Caries-preventive effects of fluoride products when used in conjunction with fluoride dentifrice. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42445 |
Study title: Caries-preventive effects of fluoride products when used in conjunction with fluoride dentifrice. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42558 |
Study title: Chemical changes and surface morphology of acid-etching of human enamel treated with topical fluoride agents in vitro. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42364 |
Study title: Chemical changes and surface morphology of acid-etching of human enamel treated with topical fluoride agents in vitro. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42477 |
Study title: Christen F, Hotz P. [Long-term effect of fluoride prophylaxis: a follow-up study of 151 subjects 13 to 15 years after tablet fluoridation] SSO Schweiz Monatsschr Zahnheilkd. 1981 Nov;91(11):932-9. German.Christen F, Hotz P. [Long-term effect of fluoride prophylaxis: a follow-up study of 151 subjects 13 to 15 years after tablet fluoridation] SSO Schweiz Monatsschr Zahnheilkd. 1981 Nov;91(11):932-9. German. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42252 |
Study title: Christen F, Hotz P. [Long-term effect of fluoride prophylaxis: a follow-up study of 151 subjects 13 to 15 years after tablet fluoridation] SSO Schweiz Monatsschr Zahnheilkd. 1981 Nov;91(11):932-9. German.Christen F, Hotz P. [Long-term effect of fluoride prophylaxis: a follow-up study of 151 subjects 13 to 15 years after tablet fluoridation] SSO Schweiz Monatsschr Zahnheilkd. 1981 Nov;91(11):932-9. German. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42284 |
Study title: Even-Sapir E, Flusser G, Lerman H, Lievshitz G, Metser U. SPECT/multislice low-dose CT: a clinically relevant constituent in the imaging algorithm of nononcologic patients referred for bone scintigraphy. J Nucl Med. 2007 Feb;48(2):319-24. Even-Sapir E, Flusser G, Lerman H, Lievshitz G, Metser U. SPECT/multislice low-dose CT: a clinically relevant constituent in the imaging algorithm of nononcologic patients referred for bone scintigraphy. J Nucl Med. 2007 Feb;48(2):319-24. |
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
Study summary document link (including results): |
View full study record |
Document reference: 43365 |
Study title: Christen F, Hotz P. [Long-term effect of fluoride prophylaxis: a follow-up study of 151 subjects 13 to 15 years after tablet fluoridation] SSO Schweiz Monatsschr Zahnheilkd. 1981 Nov;91(11):932-9. German.Christen F, Hotz P. [Long-term effect of fluoride prophylaxis: a follow-up study of 151 subjects 13 to 15 years after tablet fluoridation] SSO Schweiz Monatsschr Zahnheilkd. 1981 Nov;91(11):932-9. German. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42316 |
Study title: Clinical evaluation of Duraphat and Fluor-Protector preparations in caries prevention |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42339 |
Study title: Clinical evaluation of Duraphat and Fluor-Protector preparations in caries prevention |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42452 |
Study title: Clinical evaluation of Duraphat varnish in the prevention of dental caries in children and in the control of cervical hypersensitivity in adults. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42443 |
Study title: Clinical evaluation of Duraphat varnish in the prevention of dental caries in children and in the control of cervical hypersensitivity in adults. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42556 |
Study title: Clinical evaluation of home fluoride-containing varnish. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42380 |
Study title: Clinical evaluation of home fluoride-containing varnish. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42493 |
Study title: Clinical experience with the use of Duraphat lacquer. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42341 |
Study title: Clinical experience with the use of Duraphat lacquer. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42454 |
Study title: Clinical experience with the use of Duraphat shellac. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42446 |
Study title: Clinical experimental field studies of the caries-preventive effect of a fluoride lacquer] |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42432 |
Study title: Clinical experimental field studies of the caries-preventive effect of a fluoride lacquer] |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42545 |
Study title: Collective preschool caries prevention using a fluoride-containing varnish] [Article in German] |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42430 |
Study title: Comparative assessment of the caries prevention effectiveness of different fluorine preparations] [Article in Russian] |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42393 |
Study title: Comparative assessment of the caries prevention effectiveness of different fluorine preparations] [Article in Russian] |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42506 |
Study title: Comparative clinical and radiological studies on Fluor ProtectorR and DuraphatR. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42342 |
Study title: Comparative clinical and radiological studies on Fluor ProtectorR and DuraphatR. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42455 |
Study title: Comparative evaluation of the role of NaF, APF & Duraphat topical fluoride applications in the prevention of dental caries--a 2 1/2 years study. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42544 |
Study title: Comparative study of the increase in acid solubility resistance of enamel using different fluoride treatments]. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42409 |
Study title: Comparative study of the increase in acid solubility resistance of enamel using different fluoride treatments]. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42522 |
Study title: Comparison of intra-examiner reproducibility in scoring caries in primary teeth of two scoring systems used to monitor caries progression. |
Active substance: SODIUM FLUORIDE |
Study summary document link (including results): |
View full study record |
Document reference: 42428 |